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Corticosteroid Effects and Senescence in Cultured
Endothelium
ABSTRACT
A dissertation submitted in partial fulfillment of the
requirements for the degree Doctor of Philosophy at
Virginia Commonwealth University
Stephen A. Gudas
Virginia Commonwealth University
Advisor: Milton M. Shelley
Cultures of human umbilical vein endothelial cells
were treated with heparin-corticosteroid combinations to
determine effects on cellular growth.

Standard

proliferation assays, colony formation assays, and
cytoflourometric analysis were the methods employed.
Dexamethasone (DEX) and hydrocortisone (HC) were
inhibitory to growth of HUVEC when EtOH was used as a
solvent and fully supplemented medium (20%
employed.

serum) was

When DMSO was the solvent, growth enhancement

sometimes occurred when (DEX) was the test steroid; growth
inhibition occurred with this steroid when a reduced (1%)
serum component was used.

Since significant inhibition of

cell colony formation in response to DEX administration
was observed, the results suggest that low density growth
of HUVEC was inhibited by steroid treatment, w!1ile higher
density growth was faci�itated.

cytoflourometric analysis

of HUVEC treated with DEX-heparin combinations indicated

X

that this treatment increased cellular size and possibly
increased the number of endothelial cells in the s and/or
G2-M phases of the cell cycle in early passage HUVEC.

Senescent expression was studied in HUVEC using a
cell counting method to determine the percentage of
senescent cells in these cultures.

The effects of culture

gender and passage number on senescent expression were
determined for various plating densities and passage split
ratios.

When primary cultures of HUVEC were passed at a

1:10 split ratio and subsequently passed at a 1: 5 split
ratio, male cultures expressed a greater degree of
cellular senescence than to female cultures.
When differences in confluent cell density between male
and female primary cultures were corrected for by plating
at standard density (1.25 x 10 5 cells/flask), there were
no significant differences in total cells, total senescent
cells, or percentages of senescent cells between male and
female cultures, a phenomenon which was true in both five
and seven day assessments.

When cultures of both male and

female HUVEC were passed at high density (l:4 split
ratio), significantly greater senescent expression
occurred in later passages vs. earlier passages, a1 effect
not seen when the cultures were passed at a lower density
(1:16 split ratio).

There was a trend for both male and

female cultures passed at a lower density to express less

xi
senescence when contrasted with male and female cultures
passed at a higher density.

The results suggest that

cellular density at passage may be more important than
gender in the expression of senescence in HUVEC.

Part I
Effect of Corticosteroids on Cultured Human Umbilical Vein
Endothelial Cells

Introduction
This study addresses the in vitro growth
characteristics of human umbilical vein endothelial cells
(HUVEC} subjected to treatment with corticosteroids and
heparin.

The rationale for the studies using steroids and

heparin is based on in vivo studies; it has been
demonstrated that tumor suppression by inhibition of tumor
angiogenesis can be effected by combined treatment with
heparin and selected corticosteroids (Folkman, 1985a).
The mechanism by which angiogenesis is inhibited is
unknown, although a recent report has suggested that the
mechanism is related to heparin-corticosteroid induced
dissolution of the vascular basal lamina (Ingber et al.,
1986).

In reviewing the literature, however, it becomes

apparent that the effects of steroids, or steroid-heparin
combinations, on proliferation of endothelial cells (EC)
are not completely documented.

Since cellular

proliferation, along with cellular migration, is a major
cellular kinetic process necessary for the formation of
blood vessels, studies of the effect of steroids and
heparin on the proliferation of endothelial cells in
culture were initiated.

The rationale for the in vitro

experiments is that these studies may help to define the
mechanism of the anti-angiogenic effect seen in vivo.
1

Review of Literature
The following review is divided into four sections.
The first section describes the results of in vivo studies
which have examined the effect of corticosteroids and
heparin upon angiogenesis.

The second section summarizes

findings regarding the effect of various corticosteroids
upon cellular growth in general.

The third section

introduces the history and methodology of culturing HUVEC,
the cells used in the present study.

Lastly, the fourth

section delineates the research addressing the in vitro
effect of corticosteroids upon functional parameters of
endothelial cells, with emphasis on HUVEC.
Corticosteroids and angiogenesis in vivo
Angiogtnesis or neovascularization, the formation of
new blood vessels from the established microvasculature,
occurs in response to various pathologic or physiologic
stimuli.

Pathologic angiogenesis includes vessel growth

occurring in response to inflammation, wound healing,
tumors, and other disease processes such as psoriasis and
It is well recognized that

sclerodern,a (Furcht, 1986).

�eovascularization of tumors is necessary for their
2
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continued growth.

In fact, cell populations which acquire

the ability to induce angiogenesis, but are normally
devoid of this capacity, have an increased risk of
neoplastic transformation (Zilch & Gullino, 1982).
The process of angiogenesis involves both
proliferation and migration of EC lining the
microvasculature (Shelley et al., 1984).

Factors, then,

which influence endothelial cellular proliferation and/or
migration are of immediate interest in the study of new
blood vessel formation.

Intriguing recent reports have

demonstrated that angiogenesis can be inhibited in vivo
by selective treatment with heparin and various
corticosteroids (Folkman, 1985a,b; Folkman et al., 1983;
Crum et al., 1985). In vitro studies examining the
positive or negative influence of various corticosteroids
on the proliferation of EC would assist in

understanding

the cellular kinetics involved with the anti-angiogenic
phenomenon.

Any pharmacologic agents which might

influence the proliferation and/or migration of EC could
alter the growth of new blood vessels.
Proliferation of EC is an important component of
many pathological reactions, such as inflammation, wound
healing, and the formation of atherosclerotic lesions.
Factors affecting the migration of vascular cells are also

4

central to both the repair of damage and pathological
changes in the vascular structure (Gee & Minta, 1984).
Due to the fact that endothelial damage and the extent of
repair can affect the integrity of the existing
endothelial barrier, determinants of endothelial cellular
proliferation and migration are also integral aspects in
the process of atherosclerosis, which may develop after
injury to the endothelium (Schwartz et al., 1981). Factors
which maintain viability of the vascular endothelium and
protect it from injury

may indirectly prevent or

attennuate the atherosclerotic process (Folkman, 1984).
The identification of pharmacological agents which
suppress proliferation of EC is of interest regarding
possible therapeutic manipulation of diseases involving
angiogenesis, such as growth of malignant tumors, diabetic
retinopathy, neovascular glaucoma, corneal inflammation,
and scleroderma.

Corticosteroids are already used

clinically to suppress ocular neovascularization, but
their effectiveness is thought to be related largely to
their anti-inflammatory properties.

Whether these

steroids directly affect proliferation of EC is uncertain,
and information concerning their possible effects on the
proliferation of EC would greatly facilitate understanding
of the mechanism of corticosteroid suppression of
neovascularization.

5

The concept of anti-angiogenesis as a means of
controlling tumors by regulating their blood supply is not
new.
area.

Recently Folkman (1985a) summarized studies in this
Despite evidence that heparin alone can promote and

facilitate angiogenesis,

heparin in the presence of

cortisone or hydrocortisone could inhibit angiogenesis,
when used in the mouse skin or lung, in the rabbit cornea,
or on the chick chorioallantoic membrane (CAM).

The

results of these studies utilizing in vivo models
demonstrated that under certain conditions, heparin could
become a negative regulator of angiogenesis.

The

possibility was also raised that the anti-angiogenic
effect of hydrocortisone was independent of its
glucocorticoid activity.

Folkman (1985a) employed 11-

alpha epicortisol, a stereoisomer of hydrocortisone having
no glucocorticoid or mineralocorticoid activity, and found
that anti-angiogenic activity was sustained.
Crum et al. (1985), in further studies,
characterized seven corticosteroids with heparin dependent
anti-angiogenic (angiostatic) activity but no
glucocorticoid or mineralocorticoid activity,
demonstrating the existence of a class of steroids for
which inhibition of angiogenesis appears to be the
principal function.

They suggested that angiostatic
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activity appears to be associated with certain alterations
of the pregnane structure and is governed mainly by
specific structural configurations on the D ring.

The

absence of either the 17-hydroxyl or both the 17-hydroxyl
and carbons 20 and 21 on the D ring led to successive
decreases in angiostatic activity.

Also, Crum et al.

(1985) found that dexamethasone, which originally
exhibited no anti-angiogenic activity when used at
concentrations maximally effective for hydrocortisone,
displayed a potent angiostatic effect when given at a
lower concentration.

This finding stresses the importance

of determining a broad and inclusive dose-response
relationship in establishing optimally effective
corticosteroid-heparin combinations in angiostatic
activity.
Ingber et al. (1986) suggested that induction of
capillary basement membrane dissolution may be involved in
the mechanism of anti-angiogenesis observed in the
heparin-corticosteroid treated chorioallantoic membrane
(CAM).

The CAM, when treated with combinations of

angiostatic steroids and heparin, exhibited capillary
basement membrane fragmentation and eventually complete
loss of fibronectin and laminin from regions of capillary
involution.

The authors, however, admittedly pointed out

that it could not be clearly determined whether the

7

basement membrane breakdown was a primary effect of
corticosteroid treatment or secondary to the loss of
endothelial cell viability.

Thus, the necessity of

ascertaining the effect of heparin-corticosteroids on
proliferation of EC is further supported.
Corticosteroids and Cellular Growth in Vitro
There is a wide body of literature which explores
the effect of corticosteroids, both natural and synthetic,
upon the growth characteristics of various cultured cells.
Many of the studies have been performed upon fibroblast
cell lines in culture.

The results of these in vitro

studies have been equivocal.

Some cell lines exhibit

enhanced proliferation, DNA synthesis, and increased
metabolism when treated with steroids; while others show
an inhibition of cellular growth.

It is thought that

target cells may biotransforrn the molecular structure of
corticosteroids in a specific unique way;

a particular

steroidal molecular structure is apparently essential for
eliciting a particular biologic response (Berliner, 1965).
Cells more resistant to cortisol effects, for example,
will selectivity inactivate the hormone in greater
quantities than will more sensitive cells.
Ponec et al.

(1977) added various corticosteroids to

logarithmically growing cultures of primary human skin
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fibroblasts, and determined their effect on cellular
growth using a cell counting assay.

These steroids

inhibited proliferation of the human fibroblasts at

concentrations (lo-5 M to 10-8 M) which fell in a range

expected to occur during the topical treatment of skin
disorders.

Inhibition was independent of the source (baby

foreskin or adult arm skin) and cell passage number of the
fibroblasts.

Building on this study, Ponec et al. (1979)

found that when steroids were added at a later stage of
cellular growth, when cell density was increased,
fibroblasts showed a reduced sensitivity or even an
insensitivity to growth inhibition.

The inhibition in

early growth stages was transient and mo�t pronounced when
the culture medium was not renewed.

In contrast, Rosner &

Cristafalo (1979), using the Coulter counter method to
examine the effect of hydrocortisone on the proliferative
activity of various vertebrate fibroblast-like cell lines,
found that addition of hydrocortisone to human fetal
foreskin and human fetal lung-derived cell lines (W-138)
was growth enhancing.

Serum was required in the medium

for this enhancement to occur.

However, they also found

that steroids caused growth inhibition in a number of
other vertebrate cell lines.

Their results suggested that

the proliferative response to hydrocortisone demonstrated
a cell-type specificity, as well as steroid-molecular
structure specificity, mediated by high affinity

9

glucocorticoid binding sites.

That hydrocortisone acted

to conserve the cycling state of human embryonic lung
fibroblasts was suggested by Ban et al. (1980), who
supported previous findings of Cristafalo (1972).

They

noted that hydrocortisone extended the population life
span of these cells, without changing the maximum
population doubling potential.

It appeared that

hydrocortisone delayed the progression of fibroblasts to a
non-cycling state.
Baker et al. (1978) reported that dexamethasone,
maximally effective at 0.25 uM, enhanced the mitogenic
response of human diploid foreskin fibroblasts to
epidermal growth factor (EGF).

Binding studies with 1251-

labeled EGF suggested that dexamethasone caused this
permissive effect by modulating cell surface receptors for
EGF.

Thus, glucocorticoids may modulate cell growth

indirectly by altering cell responsiveness to growth
factors or serum.

Cristafalo (1979) delineated

experiments looking at the specific binding of
glucocorticoid hormones in human fibroblast WI-38 cells.
They concluded that the stimulation of WI-38 cell
proliferation by hydrocortisone involved specific
glucocorticoid receptors whose concentration per cell is
under cell cycle control.

They also compared cells with a

cumulative population doubling level (CPDL) of 30 with
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cells with a CPDL of 57, and found that there was an age
associated decrease in specific glucocorticoid binding
sites.

The latter might explain a previously observed

loss of responsiveness to hydrocortisone observed in aging
cultures (Kalimi & Seifter, 1979; Rosner & Cristafalo,
1979).

Also, significantly, hydrocortisone effected an

increased life span for WI-38 cells, in terms of
cumulative population doublings and chronological time.
Because the effect of hydrocortisone was serum-dependent,
it was suggested that the steroid was an amplifier of the
serum stimulation of growth.

It was later shown that the

responsive period of WI38 cultures is limited to a brief
period (up to 12 hours) following subcultivation, although
cultures may remain responsive to glucocorticoid
conditioned medium throughout the growth cycle (Finlay et
al., 1985).
Barrack & Hollenberg (1981) showed that the growth
promoting action of serum in human skin fibroblast
cultures can be attributed to the presence in the serum of
a number of specific growth factors, and outlined their
finding that glucocorticoids that had an 11 beta hydroxyl
group (e.g., dexamethasone) enhanced several fold the
mitogenic activity of synthetic polypeptides on
fibroblasts.

Supporting the findings of Rosner &

Cristafalo (1979) above, Conover et al. (1983)
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demonstrated that the increased ( 3 H]thymidine
incorporation caused by insulin-like growth factor
(somatomedin-C) in combination with human hypopituitary
serum could be dramatically increased with further
addition of dexamethasone or hydrocortisone.

This

synergistic effect was corroborated by cell replication
studies.

Wu et al. (1981)

found that hydrocortisone

enhanced cell growth in HeLa cells in serum free medium,
yet inhibited cell growth in serum-supplemented cultures.
Hydrocortisone increased twofold the 125r-labeled EGF

binding within 24 hours after the addition of
pharmacological concentrations of this steroid.

Since a

higher concentration of steroid was needed to affect the
binding capacity of labeled EGF than was required to
elicit the growth response, the growth response appeared
to be independent of EGF.
Further regarding glucocorticoid-serum-growth factor
interactions, it is held that glucocorticoids can either
sensitize or desensitize various cell types to the action
of serum or growth factors added to cell cultures.
Gospodarowicz and Moran (1975) found that at plateau
values of fibroblast growth factor (FGF) (between 2.5 and
5 ng/ml), FGF, dexamethasone, and insulin added to
cultures of BALB/c

3 T3

fibroblasts were 82% as effective

as saturating concentrations (10%) of serum in stimulating
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DNA synthesis.

Quinlan and Hochstadt (1977) extended

these findings, demonstrating that FGF, dexamethasone, and
insulin could induce mitogenesis and mitosis in quiescent
3 T3

cells in 0.8% serum induced G0 -arrest.

In contrast,

Rubin (1977) found that hydrocortisone inhibited yet
insulin stimulated the coordinate response of uridine
uptake and thymidine incorporation into DNA in chick
embryo fibroblasts.
Jarvelainen et al. (1982) determined the
proliferative effects of hydrocortisone on cultured human
aortic smooth muscle cells.

At concentrations of 10 uM or

greater, hydrocortisone retarded cell growth markedly, as
judged by decreased incorporation of [ 3 H] thymidine by the
cells, and decreased DNA content of the cultures.
Longenecker, Kilty, & Johnson (1982) found that
dexamethasone inhibited the growth of bovine smooth muscle
cells (BSMC) in vitro when FGF was absent from the growth
medium.

Curiously, this inhibition was abolished when FGF

was present.

Thus, it again appears that glucocorticoids

indirectly modulate cell growth in this cell type by
changing the cellular responsiveness to various growth
factors or serum.

Dexamethasone inhibited maximal

obtainable saturation densities in BSMC, but this effect
could apparently be overcome by FGF.
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Glucocorticoid induced inhibition of cell
proliferation in murine growth cartilage in vitro was
shown to be receptor-mediated (Silberman & Maor, 1985).
Berliner et al.(1978) found that hydrocortisone could
induce cell spreading in rat glial cells 24 hours after
its addition to the culture medium; this spreading
correlated with an increase in the fraction of the
peripheral cytoplasm occupied by microfilaments.
As pointed out in this review, many authors have
examined the effects of various steroids upon cellular
growth in a variety of cells in vitro, although the
majority of these studies have been performed upon
fibroblasts.

These studies have demonstrated that

corticosteroids, both natural and synthetic, can either
stimulate, inhibit, or have no effect on cellular growth
in various non-endothelial human and animal cell lines
(Finlay et al., 1985).

The presence of various

concentrations of serum, and stage of cellular growth
(i.e. passage number in vitro) are important variables
which can alter the response of a particular cell line to
corticosteroid influence, and they should be entertained
in studies measuring the effect of corticosteroids upon
cellular proliferation.

The concentration of steroids,

the time frame of steroid administration, and the presence
of various additional growth factors all appear to be
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modulating factors in the expression of proliferation
effects upon cultured cells.
HUVEC in Culture
The human umbilical vein has been used as a source
of endothelial cells for over two decades.

Mayuma (1963)

reported the use of this vessel as a source of endothelial
cells in culture,

and became the first individual to
Using a

describe a pure culture of human endothelium.

trypsin incubation method for cell removal, he grew HUVEC
in 20% umbilical cord serum or horse serum, 80% YLH
medium, and 200 ug/ml streptomycin.

Cells came to lie

flat in 3-4 days, and spread out, forming an epithelial
like sheet at 7-14 days.

Unfortunately, Mayuma (1963)

could not get the EC to replicate in vitro, and the cells
began to degenerate in 14-21 days.

Mitotic figures were

rarely seen; there was some contamination with
"fibroblast-like cells'' (which, one can speculate, could
have been smooth muscle cells or fibroblasts); and,

curiously, some cells were binucleate or multinucleate.
This pioneer investigation led to many subsequent
researchers using the human umbilical vein as a source of
uncontaminated and uniform cells for study.

Mayuma (1963)

described the beneficial reasons for using HUVEC as a
source of EC for study: they are of fetal origin; they can
be obtained fairly easily; the human umbilical vein has no

15

tributaries, making it easy to cannulate and handle; and
the lumen of the vessel has an adequate volume for trypsin
to dislodge the endothelia.

Gimbrone (1976) summarized

methods utilized in culturing endothelial cells, and
agreed that the recovery of EC from the human umbilical
vein was technically uncomplicated, and could provide a
continuously available supply of normal human vascular
tissue for experimental use.
Expanding on Mayuma's work, Fryer, Birnbaum, &
Luttrell (1966) examined sections of the umbilical cord
after trypsinization of the umbilical vein, and found that
the endothelial cells detached readily, leaving the
internal elastic lamina of the vein intact.

The cells,

grown on double cover slips and Rose chambers, were
polygonal or slightly elongated in shape, and 40 to 50 um
at their longest axis.

These authors also did not observe

replication or migration of the cells in culture.

They

also cultured the umbilical artery, outlining the
difficulties in perfusion of this relatively smaller
vessel. EC derived from the umbilical artery initially
differed from those of the vein only by the presence of a
small number of fibroblasts, which, in older cultures,
overgrew the endothelial cells.

16

Jaffe et al. (1972) were the first authors to use
collagenase rather than trypsin, and were able to obtain
EC that grew to confluence in primary cultures.

Saba,

Zucker, & Mason (197 3 ), following the method of Jaffe et
al. (1972), also utilized collagenase to isolate EC from
the human umbilical vein.

The cells were exposed to

platelets, neoplastic cells, or both to determine possible
interactions.

Although platelets did not adhere to EC,

degenerating EC produced a slight aggregation of
platelets.

They concluded that, in response to certain

stimuli, the EC release an activity or factor which
inhibits platelet aggregation.

But even more importantly,

it was underscored that the availability of uniform EC
grown in tissue culture would open numerous new avenues
for investigation of the function and properties of these
cells.
Gimbrone et al. (1974) found that control of
digestion time and concentration of collagenase were
critical for successful cell isolation and culture.

Using

standard cell proliferation studies utilizing ( 3 HJ
thymidine, they further characterized EC as behaving as a
density dependent population with respect to DNA
synthesis, and for this reason, stated that HUVEC could be
used for studies examining the mechanism of endothelial
cellular growth and regeneration.

Using HUVEC with a
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controlled scraping model to effect a wounded monolayer,
Shelley et al. (1977) demonstrated that small defects in
the endothelium could be repaired with migration alone,
without proliferation of cells.

Henrikson et al. (1975)

found that the replicative ability of HUVEC was correlated
with cell density at the time of seeding.

high cell seeding densities

Paradoxically,

(greater than 1 x 10 4

cells/cm2 ) inhibited cellular proliferation.

They

determined that the optimum cell seeding density

for

success in cellular proliferation was in the range of 500700 cells/mm 2 .
Wall et al. (1978), in order to more fully
understand vascular repair mechanisms following
endothelial injury, studied the proliferative response of
HUVEC to cell free plasma derived serum, whole blood
serum, fibroblast growth factor (FGF), and macrophage
conditioned

medium in vitro.

They concluded that

proliferation of EC in pre-confluent cultures was
dependent on plasma factors, since all four parameters
above enhanced EC proliferation.

Interestingly, in HUVEC,

proliferation, migration, and repopulation of irradiated
and/or wounded cultures appeared to be independent of
platelet factors.

DeGroot et al. (1983) defined

experimental conditions allowing HUVEC to grow in serum
free medium.

Although serum was needed for a short period
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of time to allow attachment and spreading of EC after
trypsinization, the cells could be grown in Medium RPMI1640, supplemented with transferrin, insulin, and human
serum albumin.

Although ECGF enhanced growth, these

authors concluded that it was not absolutely required for
proliferation and subcultivation of HUVEC.
Cultures of HUVEC have the following
characteristics: monolayer formation, production of Factor
VIII antigen, production of prostacyclin, and the presence
of Weibel-Palade (WP) bodies

(Zetter, 1981).

The

ultrastructure of human umbilical vessel endothelium in
situ was studied in detail by Parry & Abramovich (1972).
There was a paucity of glycogen in the venous EC.

Rough

endoplasmic reticulum (RER) was more abundant than in the
umbilical artery EC.

The latter was particularly well

developed in the 15 week fetus; almost all RER at that
time was in the form of widely dilated channels and
cisternae.

Weibel Palade bodies, endothelial cell

specific organelles (Weibel & Palade, 1964), were numerous
throughout pregnancy in human umbilical vein EC, and the
Golgi are well developed.

These findings correlate well

with studies of HUVEC ultrastructure in vitro
(Haudenschild et al., 1975).

These authors described WP

bodies in abundance, peripheral pinocytosis vesicles, and
•

•

both thick (100 A) and thin (60-70 A) filaments in HUVEC
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McDonald et al. (1973) also described primary

in culture.

and subcultured HUVEC as consisting of closely apposed
large polygonal cells, 20-50 uM in diameter; under EM,
they were phenotypically similar and revealed features
consistent with EC in situ.
Cultured EC have provided a powerful approach to
study the characteristics and function of the endothelium
(de Groot et al., 1983).

Mechanistic studies of the

biology of HUVEC have been facilitated by the
establishment of accepted in vitro cell culture
conditions, the definition of endothelial cellular
phenotypes, and the identification of polypeptide growth
factors which promote the growth of EC.

These advances in

techniques have afforded methods which allow serial
cultivation of HUVEC over many passages (Maciag et al.,
1981; Thornton et al., 1983).

The discovery of

endothelial cell growth factor (ECGF) was a major
breakthrough in culture methodology (Maciag et al., 1979).
ECGF, originally a partially purified growth factor
derived from bovine hypothalamus, is used by researchers
to stimulate
1981,1982;
1980).

replication of EC (Maciag et al., 1979,

Gordon et al., 1983;

Knaver & Cunningham,

ECGF was found to contain a significant level of

mitogenic activity when tested in a HUVEC growth assay
(Maciag et al., 1979).

Recently, the structure of ECGF
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and the gene coding for ECGF have been described (Jaye et
ai., 1986). These authors showed that ECGF was an acidic
form of fibroblast growth factor.

It was found that angiogenic basic FGF and FGF-like
growth factors had a strong affinity for heparin
et al., 1984).

(Shing

Apparently, these growth factors acted in

a synergistic fashion with heparin (Thornton et al.,
1983), and are protected and stabilized by heparin
(Gospodarowicz and Cheng, 1986).

It was suggested that

heparin could be involved in the modulation of growth
factor activity, thus indirectly participating in the
control of cellular growth (Schreiber et al., 1985).
These authors felt that ECGF induced a conformational
change in the heparin molecule which increased or
stabilized the biological activity of the growth factor
mitogen.

Exactly how heparin participates in the

mitogenic events induced by ECGF is unknown.

Since EC

possess high affinity binding sites for ECGF, it was
proposed that these same binding sites could be activated
by an ECGF-heparin complex (Maciag et al., 1984).

It is

of interest that heparin binding angiogenic factors are
found in both normal tissues and tumors (Shing et al.,
1985).

Folkman & Klagsburn (1987) have summarized the

intense research productivity regarding angiogenic factors
in the past few years, tracing the discovery of these
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factors and describing their significance in understanding
growth regulation of the vascular system jn vivo.

Effect of Steroids upon EC in vitro
Maca et al. (1978a) studied the effects of various
steroids, including dexamethasone, hydrocortisone, and
prednisone on the morphology and growth characteristics of
cultured HUVEC grown in serum-containing media, but in the
absence of ECGF and heparin.

They found that

corticosteroids caused an increase in cell surface area
and protein synthesis and content, without an increase in
DNA synthesis or cellular replication.

Dexamethasone was

approximately 10 times more effective than hydrocortisone
in causing these changes; prednisone was least effective.
Other steroids that were tested, including aldosterone,
testosterone, progesterone, estradiol, and estriol were
ineffective in this manner.

Maca et al. (1978b) also

found that dexamethasone decreased adhesiveness of
cultured leukemia and lymphoma cells to confluent cultured
endothelium; hydrocortisone was also effective in this
manner.

The effects of corticosteroids on HUVEC have also

been examined by Piovella et al. (1982), who found that
dexamethasone-treated cells displayed larger cytoplasms
and larger nuclei, the latter with more prominent
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nucleoli.

Preliminary studies in our laboratory using

dexamethasone with HUVEC have corroborated these findings.
Piovella et al. (1982) also observed that dexamethasone
increased the amount of fibronectin matrix in cultured
HUVEC, suggesting that this increased matrix was
responsible for the more flattened aspects of cells and
their better spreading on the culture dish.
Using the HUVEC culture system, Almasio et al.
(1984) also found that dexamethasone induced production of
a more cohesive and complete extracellular matrix, causing
the EC to assume a more polygonal shape, with abundant
cytoplasm.

There was a greater degree of confluence and

each cell covered a greater area.

Earlier, Piovella et

al. (1980) cultured HUVEC in the presence or absence of
dexamethasone, and with daily counts reported a greater
number of cells in the steroid-treated cultures in
comparison to control cultures for the first five days.
However, by day six both control and dexamethasone
treated cultures reached confluence without significant
differences in cell counts.
treated cultures,

In comparison to the non

the confluent monolayer appeared

tighter in the steroid treated cultures (Piovella et al.,
1980).

The preservation of adhesion in the dexamethasone

treated cultures was possibly related to the increased
fibronectin extracellular matrix observed, the latter

23

demonstrated by immunofluorescence.

It is well known that

the extracellular matrix plays a pivotal role in the
modulation of EC behavior in vivo (Madri & Pratt, 1986).
Within this conceptual framework, the same preservation of
adhesion might have affected the cell counts in the
experiment, with the relatively less adhesion in the non
steroid treated cultures reflected in a lower cell count,
thus making the early increased cell number observed in
the dexamethasone treated cultures more apparent than
real.

The availability of space into which cells can

replicate is also an important factor, and crowded near
confluent EC cultures will necessarily have a lower growth
rate if evaluated at that time (Goldsmith et al., 1984).
Although it appears that dexamethasone initially
accelerated growth in cultured EC, this finding was
neither repeated nor corroborated by others, nor were
other corticosteroids tested.
Goldsmith et al. (1984) used cytofluorometric
techniques and found that approximately 2-8% of EC in
primary confluent HUVEC were in the proliferative phases
(S, G2 and M) of the cell cycle.

Unfortunately, the

proliferative characteristics of later passage HUVEC were
not examined with cytofluorometry; no author has utilized
this technique to assess the effects of corticosteroids on
endothelial cellular kinetics.
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Berliner (l981), repeating her earlier studies
concerning the effect of hydrocortisone upon HUVEC,
developed a defined medium which supported maximum levels
of cell division.

She found that both insulin and FGF

increased the incorporation of 3H thymidine in HUVEC when
hydrocortisone was present- the steroid alone did not
increase incorporation of the radionuclide.
Hydrocortisone also increased cell spreading in serum
containing medium.

Although her defined medium did not

contain serum, it was pointed out that plating and
maintenance of cells in serum containing medium was
necessary before transfer to defined medium, otherwise the
cells would not divide.

In this, she supported the

findings of De Groot et al. (1983), who found serum
containing medium necessary for initial plating before
serum-free medium could be used to support growth of the
cells.
Hoshi & McKeehan (1984) tested various hormones and
growth factors, including steroids, on HUVEC
proliferation.

Although they inferred that steroids

examined at concentrations reported to be active for other
cells were not mitogenic for HUVEC, they did not indicate
which steroids or concentrations were tested, nor were
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quantitative data offered.

Very little concerning steroid

effects on HUVEC could be concluded from their report.
Longenecker, Kilty, & Johnson (1982) tested primary
and cloned strains of bovine aortic endothelial cells
(BAEC) for their response to glucocorticoids.

The growth

of EC was inhibited by dexamethasone in the presence of
FGF.

Since there was no inhibition of proliferation of EC

in the absence of FGF,

it is possible that

glucocorticoids mildly inhibit the maximal response of EC
to FGF.

However, these influences were corticosteroid

specific and concentration dependent, but independent of
serum concentration.

Also, when deprepsion of growth did

occur, it was relatively mild (i.e., less than 20% of
controls), and growth depression was inconsistent.
Perhaps even more important, the authors pointed out that
the steroid responses observed were due to relatively
acute treatment periods (up to five or six days), and for
that reason may potentially differ from responses that
might occur to chronic exposure of EC to glucocorticoid
excess throughout a culture life span, or from responses
that might occur in the endothelium in vivo over the
course of many months or years.

Longenecker et al. (1983)

later studied four clones of BAEC and found that the EC
exhibited a rather striking clonal heterogeneity with
regards to their sensitivity to glucocorticoid treatment.
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Only one clone exhibited an FGF dependent dexamethasone
induced inhibition of cellular growth, and that inhibition
was abolished by the use of extracellular matrix (ECM)
derived from bovine aortic smooth muscle cells (BASMC) as
a growth substratum.

The authors suggested that clonal

variability, among other variables commonly encountered in
the culture of endothelial cells, could be eliminated by
the use of ECM coated culture dishes.
Harrison & McKee (1981) found that 17-beta estradiol
caused an increased rate of replication in HUVEC, as
measured by greater DNA content and [ 3 H] thymidine
incorporation in the treated cultures.

Corvazier et al.

(198 4 ), in contrast, found that 17-beta estradiol had no
effect on endothelial cell proliferation, nor did
progesterone.

The latter authors did report that ethinyl

estradiol increased cellular proliferation when the
plating density was 4 x 10 4 cells/flask or greater.
Using a 51cr release assay, Jarvelainen et al.
(1985) tested hydrocortisone, dexamethasone, and
prednisolone on HUVEC.

All corticoids stabilized the EC

monolayer as demonstrated by a decrease in the release of
51cR.

Paralleling other research studies employing

dexamethasone, this particular steroid was maximally
effective at a lower concentration than the other
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steroids.

They proposed that the beneficial effect of

glucocorticoids observed empirically in the treatment of
certain hemorrhagic disorders such as purpura might
partially be explained by the strengthened endothelial
integrity observed in their assay system.
A number of authors have studied the effect of
corticosteroids upon prostaglandin release from EC.
Rosenbaum et al. (1986), using cultured rabbit
microvascular EC, found that dexamethasone effected a time
and concentration dependent decrease in prostaglandin
accumulation in the culture media, and a reduced basal and
ionophore stimulated PGE2 release.

Hydrocortisone and

corticosterone were less potent inhibitors of PGE2
secretion, while aldosterone, progesterone, and

dihydrotesterone did not inhibit PGE2 release.

Lewis et

g.J,.. (1986) corroborated this finding in HUVEC, outlining
the effects of dexamethasone and hydrocortisone on
prostacyclin (PGI2) and PGE2 release.

Dexamethasone

reduced prostaglandin formation in cells stimulated by
histamine, bradykinin, calcium ionophore, or mechanical
agitation.
effects.

Hydrocortisone had less potent, but similar
Here again, since neither testosterone nor

progesterone affected prostaglandin production, the effect
seemed to be glucocorticoid specific.

Decaterina &

Weksler (1986), also studying HUVEC, found that inhibition
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of PGI2 production in the presence of hydrocortisone
averaged 15% less than the inhibition

presence of dexamethasone.

seen in the

Corvazier et al. (1984) tested

the natural sex hormone 17-beta estradiol and the
synthetic hormone ethinyl-estradiol on prostacyclin
release in HUVEC and found no effect with either steroid.
Since vasodilatation precedes migration and proliferation
of EC in angiogenesis in vivo (Folkman, 1984), and since
prostacyclin (PGI2) is a potent vasodilator as well as a

platelet aggregation inhibitor, perhaps the inhibition of
prostacyclin activity by corticosteroids may be partially
responsible for the antiangiogenic effect of these
corticosteroids observed in vivo.

Sei�lan et al. (1983)

stimulated secretion of prostaglandins from cultured
female porcine EC by using the sex steroids 17 beta
estradiol and testosterone; male EC could not be
stimulated in this manner.

Since female, but not male, EC

could convert testosterone to estradiol, the latter's
induced stimulation of prostacyclin production may explain
in part the beneficial role generally attributed to
naturally occurring estrogens in cardiovascular diseases.
Mendsolsohn et al. (1982a, 1982b) studied the
glucocorticoid induction of angiotensin converting enzyme
(ACE) production in BAEC.

Using confluent monolayers of

BAEC, they found that dexamethasone increased ACE activity
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six to seven fold over control cultures.

Since ACE

converts angiotensin I to angiotensin II, the latter a
strong vasoconstrictor, the process might be facilatory to
angiostasis (see above).

Also, since ACE plays a role in

the inactivation of bradykinin, a vasodilator, an increase
in ACE activity would further contribute to the
vasoconstrictive effect of corticosteroids, and favor the
phenomenon of angiostasis.

Lam et al. (1985) supported

these findings, and reported that dexamethasone (1 uM)
increased ACE activity in BAEC in a time-dependent
fashion, and that this steroid and irradiation interacted
to raise cellular ACE activity.

However, dexamethasone

and increased cellular ACE activity unfortunately did not
appear to modify the endothelial cytotoxcity induced by
irradiation.
In summary, due to the tremendous importance of the
endothelium in inflammation and repair, tumor and other
disease mediated angiogenesis, and permeability, a large

body of literature has examined the effects of
corticosteroids on endothelial cell function.

Inhibition

of prostacyclin release by EC and facilitation of ACE
activity by corticosteroids, dexamethasone in particular,
are processes whose single or combined effect would be to
induce vasoconstriction in local vascular beds.

Whether

these mechanisms play a role in corticosteroid-heparin
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induced angiostasis is not known.

However, few published

reports have explored the influence of corticosteroids
upon endothelial cellular proliferation, a basic component
of angiogenesis, and the results of these reports have
been inconclusive.

In addition, no authors have used

cytofluorometry to address these effects upon HUVEC
population kinetics.

Experiments using cellular growth

assays and cytofluorometry on heparin-corticosteroid
treated EC will increase our understanding of the role of
these substances in endothelial cell proliferation and
hopefully provide a rationale for the clinical use of
these pharmacological agents in pathological processes and
disease syndromes in which endothelial cellular
proliferation plays a significant role.
The primary aim of this research was to establish
the effects of heparin and selected corticosteroids upon
growth characteristics of HUVEC in culture.
cultures of HUVEC were used in these studies.

Monolayer
Direct

cellular proliferation studies, utilizing cell counting
and analysis of population doubling, were performed in
order to determine the effect of heparin and
corticosteroids on the growth characteristics of EC.
Specifically, corticosteroids known to be antiangiogenic
in vivo were added to culture media at various times after
culture plating to determine the effect on cellular
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proliferation.

A variable response by EC to

corticosteroids was found, depending on a number of
. factors, including type of steroid solvent, time frame of
steroidal administration, and length of time of
corticosteroid exposure.

Our results suggest that EC are

influenced by many factors when responding to heparin
corticosteroid administration.

The results do not lend

unequivocal support to the hypothesis that heparin and
corticosteroids induce angiostasis partly due to the
suppression of endothelial cellular proliferation.

Materials and Methods
Experimental Methodology
Culture of HUVEC.

Harvest of endothelial cells from

umbilical cord veins was based on the method of Gimbrone
et al. (1974).

Term umbilical cords, detached from the

placenta, were obtained from the Labor and Delivery Room
of the Department of Obstetrics and Gynecology at the
Medical College of Virginia.

Using sterile technique,

unclamped umbilical cord segments of at least 10 cm. in
length were cannulated at bot� ends using one way
stopcocks and blood was flushed by a perfusion of 200-400
ml. of phosphate buffered saline solution (PBS), pH 7.20.
The lumen of the vein was filled with 0.1% collagenase
(Clostridium histolyticum, type I, Sigma Chemical Company,
St. Louis, MO) in PBS with calcium and magnesium [Cacl2

(anhyd), 0.10 gm/L, and MgC12·6 H2o, 0.10 gm/LJ, and the

stopcocks closed.

The cord segment was then incubated in

a bath of PBS at 37 degrees centigrade for 15 minutes.
The collagenase solution was collected in a 15 ml. conical
centrifuge tube with an equal volume of Hank's Balanced
Salt Solution (HBSS) without calcium or magnesium.
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The EC
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were then pelleted by centrifugation at 200 x g for five
minutes.
Defined fetal bovine serum (FBS, Hyclone
Laboratories, Logan, UT) was used in media preparation, as
this serum is supplied with an analysis so that the types
and amounts of endogenous steroids in the serum would be
known.

Other media and reagents were obtained from Gibco

Laboratories (Grand Island, NY) or Meloy Laboratories
(Springfield, VA).

The pelleted EC were resuspended in

complete Medium 199 (CM-199) containing the following
ingredients:

Medium 199 with Earle's Salts and L

glutamine, lOOU/ml penicillin, 100 pg/ml streptomycin,
0.25 pg/ml Fungizone, 20% FBS, 90 µg/ml heparin (sodium
salt, grade 1, from porcine intestinal mucosa, Sigma

Chemical Co., St. Louis, MO), and 20 ug/ml endothelial
cell growth factor (ECGF, Tissue Culture Grade, Meloy
Laboratories, Springfield, VA.

ECGF was also a generous

gift of Dr. Thomas Maciag of Jerome Holland Research
Center of the American Red Cross, Rockville, MD).
Thornton et al. (1983) described the use of low
concentrations of ECGF along with heparin, since heparin
potentiates the effects of ECGF.

Cultures were grown in

gelatin coated T-25 flasks (Corning).

Gelatin (0.2%

wt/vol) promotes the attachment and growth of HUVEC
(Gordon et al., 1983; Folkman et al., 1979; Thornton et
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g,l., 1983; Walker et al., 1984).

Cultures were then

continuously incubated at 37 degrees C in a humidified
atmosphere of 95% air, 5%

co 2 •

Identification of HUVEC.

The endothelial nature of the

cultured cells was determined by observing the typical
"cobblestone" morphological appearance of the monolayer
when viewed under phase contrast microscopy (Nikon
Inverted Phase Contrast Microscope, Model M), and by
immunofluorescent staining for the factor VIII antigen.
Direct immunofluorescent staining for factor VIII antigen
was performed on selected confluent cultures using
fluorescein-conjugated rabbit anti-human factor VIII
related antigen (Atlantic Antibodies, Scarborough, ME)
according to the protocol of Maciag et al (1981).
Addition of Corticosteroids.

Dexamethasone (DEX),

dehydroepiandrosterone (DHEA), and hydrocortisone (HC)
(Sigma Chemical Co., St. Louis, MO)

were dissolved in

either absolute ethyl alcohol (EtOH} or dimethyl sulfoxide
(DMSO).

The corticosteroid dilutions were adjusted so

that the DMSO concentration in the media was standardized
at 0.1%.

When EtOH was used as a steroid solvent, the

maximum concentration was 0. 2 %
run at these concentrations.

Control cultures were also
For each steroid dosage,
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triplicate flasks were evaluated; for control cultures,
quadruplicate flasks were evaluated.

Trypsinization and Cell Counting.

At selected times after

subculturing, depending on the experimental paradigm being
used,

cultures were washed with HBSS without calcium or

magnesium, rinsed briefly with 0.025% trypsin-0.01% EDTA,
and incubated at 37 degrees C for six minutes.

Either CM-

199 or counting medium (Medium 199 plus 20% FBS, and
antibiotic-antimycotic solution) was added and a single
cell suspension was obtained by repeated aspiration.

The

cells were counted in quadruplicate using a hemacytometer.
A trypan blue exclusion procedure (0.4% trypan blue mixed
with the cell suspension at a 1:5 ratio) was used to
determine the viability of harvested cells.
Percentage of Attachment and Population Doubling.

For

percentage of attachment (PA) determination, quadruplicate
flasks for the selected experimental manipulation were
seeded at established cell densities (1.2 5 x 10 5
cells/flask).
for
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After incubation at 37 degrees C and 5%

or 48 hours, several flasks were washed with

co 2

appropriate media and the cells harvested and counted.
The PA is the number of cells harvested divided by the
number of cells seeded.

This value determined the number
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of cells present on the day steroids were added to the
culture system, and was used in calculating growth rates
and population doublings of HUVEC between either two and
five or between two and seven days.

The remaining flasks,

after washing with media, were returned to the incubator
until harvested according to the particular experimental
protocol.

The number of population doublings (PD) between

seeding and ultimate harvesting was determined as follows:
PD=

log
log 2

When corticosteroids were tested, the control flasks
contained EC from the same subculture as the experimental
flasks, and were subsequently handled in identical
fashion, using medium including either EtOH or DMSO
without corticosteroid.

Control cultures without steroids

or solvent were also studied.

Population doublings were

compared using ANOVA and a Duncan Multiple Range Test to
test for significant differences.

Fixation of EC.

Cultures were fixed for preservation of

morphology according to the following procedure.

After

removing the medium from the flasks, each flask was washed
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twice in fresh phosphate buffered solution with calcium
and magnesium.

Then,

2.5% glutaraldehyde in 0.1 M sodium

cacodylate (pH = 7.3) was added to each flask, and the
flask fixed at room temperature for one hour.

After

fixation, the flasks were rinsed once with 0.1 M sodium
cacodylate buffer containing 7% sucrose.

The cultures

were then stored in the sucrose-cacodylate buffer at 4
degrees C until further evaluation was undertaken.
Absorbed Serum.

Hyclone FBS was absorbed with a a

charcoal-dextran mixture to remove endogenous steroids by
the following procedure.

The absorption material was

prepared by mixing 3.75 gm. of activated charcoal with
0.375 gm. of dextran, and dissolving both in 100 ml. of
deionized-distilled water.

After thorough mixing, 10 ml.

of the absorption preparation was removed and centrifuged
at 2,000 g for five minutes.

The pellet was recovered,

and then added to 100 ml. of FBS.

The serum-charcoal

dextran mixture was then refrigerated at 4 degrees C for
24 hours with constant, gentle stirring.

At the end of

this time period, the mixture was removed from
refrigeration and centrifuged at 10,000 g for 20 minutes.
The clear supernatant was collected and this absorbed
serum immediately frozen at -16 degrees C until use in the
appropriate experiment.
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Colony Forming Assay.

As an alternative method for

assessing proliferation capacity of selected endothelial
cell cultures, subcultured EC from a selected passage were
harvested, counted, and seeded into T-25 flasks at clonal
densities (1,000 cells/flask).

After sufficient time to

allow colony formation (eight to eleven days), the colony
containing flasks were fixed as described above.

Fixed

cultures were rinsed twice in distilled water, and stained
with 0.5% azure II and 0.5% methylene blue in 0.5% sodium
borate.

The number of colonies (at least 50 cells per

colony) were counted for each flask, and experimental
flasks and control flasks were compared using an ANOVA and
a Duncan Multiple Range test to determine significant
differences.
Cytofluorometry.

The EC were prepared for cell cycle

analysis according to the following procedure: The cells
were trypsinized as described and suspended in 4 to 10 ml.
of CM-199 in a gelatin-free plastic centrifuge tube, and
counted.

The cells were then centrifuged at 1000 x g for

5 minutes, and after removing the supernatant, the cells
were vortexed and resuspended in 1.5 ml. of PBS without
calcium or magnesium.

While vortexing, 3 ml. of 95%

ethanol was added dropwise.

The cells were allowed to fix

in this ethanol solution for one hour on ice.

If desired,

the cells could remain in this fixative up to one week
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before additional processing.

After centrifugation and

supernatant removal, 10 to 20 ml. of staining solution

(3.8 x 10-3 M sodium citrate, 2 mg/ml RNase, 0.05 mg/ml

propidium iodide in distilled water) was added, and the
cells stained on ice for three hours.

The cells were then

centrifuged, the supernatant removed, and the pellet
resuspended in PBS at a concentration of 1 x 10 6 cells/ml.
After filtering the cells through several sizes of nylon
mesh (74 pm, 44 pm, 37 pm), the suspension underwent cell
cycle analysis in a Coulter EPICS V Cell Sorter (Coulter
Diagnostics, Hialeah, Fl.).

DNA histograms were generated

and the percentages of cells in the G0 + G1, S, and G2 + M
phases of the cell cycle were determined using a computer

algorithm designed for the EPICS V System (Parametric
Analysis I, by
Hialeah, Fl.).

c.

Bruce Bagwell, Coulter Diagnostics,

Light scatter analysis using the cell

sorter provided relative information on the average size
of the cells in the cell population tested.

The main

purpose of using cytofluorometry was to determine the
effect of corticosteroids on endothelial cellular size.
The claim that corticosteroid administration increases the
size of the EC (Maca et al., 1978) was addressed by
obtaining cell size information from the cell sorter.
Early experiments indicated that a dose related increase
in EC size occurs after subculturing the cells in the
presence of dexamethasone.

Although limited flow
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cytometric data regarding EC from the human umbilical vein
were reported by Goldsmith et al. (1984), there are no
reports in the literature describing the effects of
corticosteroid treatment upon the cell cycle kinetics of
HUVEC.

Experimental Designs
Effect of Corticosteroids Dissolved in EtOH.

In order to

determine the effects of corticosteroids, as well as the
effects of ETOH as a solvent on the log phase growth of
HUVEC, flasks were plated with first, second, or third
passage HUVEC at standard density (1.2 5 x 10 5 cells/ 2 5
cm 2 flask).

CM-199 containing corticosteroids dissolved

in EtOH at various doses (DEX (1 pM, 0.5 VM) or HC (1 �M)}
were added to the culture flasks at two days after
plating, just as the cells were about to enter the
logarithmic phase of cellular growth.

Three separate

control groups were also examined: no EtOH, 0.2% EtOH, and
0.1 % EtOH.

Cultures were refed with either control or

steroid containing media on the fourth or fifth day after
plating.

The flasks were subsequently trypsinized and

counted on the seventh day after plating.

Cellular growth

determinations between two and seven days after plating
were made for the various control and corticosteroid
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concentrations.

The population doubling which occurred

between two and seven days, which takes into account the
number of cells present on the day of steroid
administration, was calculated for each corticosteroid
dosage.
Effect of Corticosteroids Dissolved in DMSO.

In order to

determine the effects of DMSO as a solvent, as well as a
single steroid feeding on the second day on the log phase
growth of HUVEC, flasks were plated with second or fourth
passage HUVEC at standard density.

DEX (5 µM, 1 µM, 0.5

µM, 0.1 µM); HC (20 µM, 10 µM, 5 µM, 1 µM); or DHEA (50
µM, 20 µM, 10 µM, 5 µM) dissolved in DMSO were added to
the culture flasks at two days after plating.

The DMSO

concentration was adjusted to 0.1% in all steroid
containing media.

HUVEC in CM-199 alone or CM-199 with

0.1% DMSO served as control groups.

After this initial

feeding with steroids or control media, the cultures were
not fed for the remainder of the experiment.

At seven

days, the flasks were trypsinized, cells were counted, and
cellular growth and population doublings between two and
seven days were determined.
Effect of Charcoal Filtered FBS.

In order to determine

the effects of filtered FBS upon the growth of steroid
treated HUVEC, CM-199 was prepared using Hyclone FBS which
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was filtered twice through activated charcoal to remove
endogenous steroids.

All other media ingredients were

identical to those used in preparing CM-199.
passage HUVEC

Second

were plated at standard density, and DEX,

HC, or DHEA dissolved in DMSO at the same doses as
outlined immediately above were added to the culture
flasks at two days after plating.

Control flasks were

plated with and without the DMSO solvent at the standard
final concentration of 0.1%.

The cultures were not refed

during the experiment, and the flasks were trypsinized and
counted on the seventh day after plating.
This experiment was repeated for DEX alone at the
same dosages (5 µM, 1 µM, 0.5 µM, 0.1 µM) utilizing cells
from the same cord but at a later passage (passage 4).

In

this experiment, both unabsorbed and charcoal filtration
absorbed FBS containing media were employed and the
results compared.
Comparison of Male and Female HUVEC.

In order to compare

the effects of corticosteroids on male and female HUVEC, a
wider dosage range of DEX was used.

Second passage

cultures derived from paired male and female HUVEC
harvested on the same day and passaged under identical
conditions were used in these experiments.

DEX (5 µM, 1

µM, 0,5 µM, O.l µM, 0.01 µM, or 0.002 jlM) dissolved in
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DMSO was added to either male or female cultures of HUVEC
at two days after plating.
involved.

There was no refeeding step

Since these cultures grew fairly rapidly,

confluence was reached in many flasks by the sixth day.
Due to this, the decision was made to evaluate the
experiment on the sixth, rather than the seventh, day,
lest cells be lost to the culture media.
Effect of Reduced (1%) FBS.

DEX at the same doses used in

the male-female comparison experiments was tested using
media with a reduced serum component.

One percent instead

of the usual 20% FBS was used in preparing culture media
for this experiment; all other media ingredients were
identical to those used in CM 199.

The six dosages of

DEX, dissolved in DMSO, were added to second passage HUVEC
at two days after plating.
concentration was 0.1%.

Again, the final DMSO

The flasks were trypsinized and

counted on the seventh day after plating with no refeeding
step following the initial steroid administration.

This

experiment was repeated for 0.1 �M DEX and 0.001 pM DEX
utilizing fourth passage cells derived from the same cord
as cells used for the reduced serum experiments above.

In

this experiment, media containing either 1% FBS or 20% FBS
was employed and the results compared.

The experiment was

again repeated for DEX at a slightly wider dose range (5

µM, 1 pM, 0.1 pM, or 0.01 pM), utilizing third passage
cells obtained from a different cord.
Effect of Repeated Steroid Dosing.

In all above

experiments employing DMSO as a steroid solvent, cultures
were fed only on the second day, with final count
performed on the sixth or seventh day.

In order to

determine the effect of a second steroid feeding on the
log phase of growth of HUVEC when treated with DMSO
dissolved steroids , DEX (1.0 }lM, 0.5 pM, 0.1 µM, or 0.01
}lM) was dissolved in DMSO and added to second passage
cultures of HUVEC on the second and fourth day after
plating at standard density.

The cultures were

trypsinized and counted on the seventh day to ascertain
the effect of a second steroid feeding on the log phase
growth of HUVEC.

This experiment was repeated for the

same four DEX doses utilizing fourth passage endothelial
cells derived from a different cord.
Effect of Steroids on Proliferation of HUVEC at Four Days.
In order to determine if corticosteroid administration had
an earlier effect on endothelial cellular proliferation
than was seen at seven days, DEX at the same four doses
used in the repeated steroid dosing experiments above was
dissolved in DMSO and added to the culture flasks on the
second day after plating.

Without any further refeeding,
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the flasks were trypsinized and counted on the fourth day,
two days after steroid administration.

The purpose of

these interventions was to determine if DEX had any early
effect on the proliferation of HUVEC that might be masked
after growing for seven days as in preceding experiments.
This four day cell counting experiment was repeated using
the same four doses of DEX utilizing fourth passage
endothelial cells derived from a different cord.
Dexamethasone and Colony Formation of HUVEC.

Employing an

alternate method of proliferation assessment, DEX (1 pM or
0.1 }l-M) was used in a colony forming assay to determine
the effect of this steroid upon growth of HUVEC.

Four

variations were used in these experiments, in order to
determine the influence of DEX on both plating and growth
of HUVEC.

Seventh passage HUVEC were used in all colony

formation assay experiments.

The first variation tested

the effect of DEX on growth only as measured by colony
formation.

Triplicate flasks for the two DEX doses and

for the control group were plated at colony formation
density (1,000 cells/flask).

At four hours after plating,

the flasks were washed in plain medium 199, and
immediately thereafter fed with CM-199 containing the
desired DEX concentration or with CM 199 with 0.1% DMSO
alone (control).

The cultures were fed twice more at

three day intervals with the appropriate steroid or DMSO
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media, and fixed and evaluated on the ninth day after
plating.
The second variation tested the effect of DEX on
plating only.

Triplicate flasks for 1 uM DEX or 0.1 uM

DEX and control flasks were plated at colony formation
density in CM 199 with the appropriate DEX dosage or CM
199 with 0.1% DMSO alone, respectively.

At four hours

after plating, the cultures were washed with plain medium
199, and immediately thereafter fed with CM-199.

The

cultures were fed twice more at three day intervals with
CM-199, and fixed and evaluated on the ninth day after
plating.

The third variation tested the effects of

dexamethasone on both plating and growth.

In this

experiment, triplicate flasks were plated at colony
formation density in CM-199 with either 1 µM DEX or O.lyM
DEX, or CM-199 with 0.1% DMSO alone.

At four hours after

plating, the cultures were washed with plain medium 199
and immediately thereafter fed with CM containing the
desired DEX concentration or with CM-199 with 0.1% DMSO
(control).

The cultures were fed twice more at three day

intervals with the appropriate steroid or DMSO medium, and
fixed and evaluated on the ninth day after plating.
The fourth variation was designed to test the effect
of the wash step four hours after plating.

In this
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experiment, the cultures were plated and fed in CM-199
exclusively.

Two groups were evaluated, one with and one

without the wash step with plain medium 199 at four hours
after plating, prior to the first feeding with CM-199.
Otherwise, the treatment of the groups was the same: the
cultures were fed twice more with CM-199, and fixed and
evaluated on the ninth day after plating.
Cytoflurometry Experiments.

In order to determine the

effect of corticosteroids on the percentage of cells in
the various phases of the cell cycle and on cellular size
in HUVEC,

cultures were plated at standard density.

DEX

(1 ).lM, 0.5 ).lM) was dissolved in EtOH and added to the
culture flasks on the second and fourth day after plating.
The final concentration of EtOH in the steroid-containing
media was 0.2% for 1 µM DEX and 0.1% for 0.5 µM DEX.

Two

control groups were also examined: no EtOH and 0.2% EtOH.
Cells were harvested on the seventh day and prepared for
flow cytometry as described.

The percentages of cells in

the G0 + G1, S, and G2 + M phases of the cell cycle were
determined; light scatter analysis provided information

concerning the relative size of the control and steroid
treated cells.

Results
Effect of Glucocorticoids Dissolved in Alcohol
The purpose of our experiments was to determine if
dexamethasone-heparin or hydrocortisone-heparin
combinations affected the log phase of cellular growth in
HUVEC.

In early experiments in our laboratory, EtOH was

used as a corticosteroid solvent, and its final
concentration in the medium was 2.0%, 0.2% or 0.1%.

When

2.0% EtOH was used as a solvent, it was toxic to the
cells, and the concentration was lowered for subsequent
experiments.

For 1 }lM DEX, the EtOH concentration was

0.2%; for 0.5 pM DEX, it was 0.1%.

Controls were run at

both concentrations, and the cultures were fed with
corticosteroid-containing media on the second and fifth
day after plating.

The cell number harvested at seven

days and the number of population doublings between two
and seven days are shown in Figures la and lb
respectively.

The graphs illustrate the pooled cell

counts and population doublings from four experiments at
the above steroid doses and control conditions.

An ANOVA

and Duncan's multiple range test were the test statistics
used to examine the population doublings in this and all
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other experiments reported here.

Both steroid doses were

associated with inhibition of cellular growth at seven
days.

Regarding population doublings, DEX at 1 pM caused

a significant decrease in population growth compared to
the control.

DEX at lJlM also effected a significant

inhibition of population doubling when compared to either
0.1% or 0.2% EtOH solvents, which both caused slight, but
not significant, inhibition of population doubling when
compared to controls.

Thus, alcohol was only slightly

toxic to the cells at the concentrations employed, causing
some minor growth suppression.

The results indicate that

1 uM DEX demonstrated a greater inhibition of growth than
0.5 uM DEX, suggesting a dose response.

However, only two

doses were tested; a wider dose range was needed to
substantiate a graded, dose-related inhibition of cellular
and population growth.
Hydrocortisone (HC) was tested at 1 pM, in 0.2%
EtOH.

Controls were run at this alcohol concentration,

and also without alcohol.

Cultures were fed with steroid

containing or control medium on the second and fifth day
after cell plating, with cell harvest on the seventh day.
The results from pooled cell counts and population
doublings from three experiments conducted at 1 pM HC and
control conditions are shown in Figures 2a and 2b,
respectively.

Cultures exposed to alcohol at 0.2%
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displayed only slightly suppressed cellular growth at
seven days.

At the 1 µM concentration, HC caused growth

inhibition, but this was not significant.

Although 1 µM

HC effected a slight decrease in the number of population
doublings at seven days, it was not significant (Figure
2b).

Since only one dose was tested, it cannot be

ascertained whether there was a dose response.
single experiment, 10

JlM

In a

HC dissolved in a final media

concentration of 0.1% EtOH was tested.

Both 0.1% EtOH

control and HC at 10 pM led to a significant inhibition of
population growth, compared to the EtOH-free control
group, so it could not be concluded that HC at this
relatively high dose was growth inhibitory to HUVEC (data
not shown).
A limited number of doses were used initially,
especially for HC.

It was clear from these findings that

more extensive dose-response information was needed.

In

these initial experiments, the cultures were fed twice
with steroid containing medium, and this factor may have
potentiated the inhibitory effect of corticosteroids upon
HUVEC.

Also, the use of EtOH as a solvent was questioned.

Although used by previous researchers (Almasio et al.,
1984; Maca et al., 1978a; Piovella et al., 1980;), it was
possible that EtOH as a solvent might affect the response
of HUVEC to corticosteroid intervention.
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Dimethylsulfoxide (DMSO) was proposed as a better solvent,
due to its relative non-reactivity

with steroids, and its

lack of effect upon various cellular functions (M.Y.
Kalimi, personal communication).

All subsequent

experiments reported in this paper were performed with a
uniform DMSO concentration (0.1%)

in the media used for

the DMSO-control and all steroid doses.

Each experiment

also contained a control group not exposed to DMSO or
steroids.

In addition, all experiments were performed

with heparin included in the media.
Effect of Corticosteroids Dissolved in DMSO
To determine the effect of DMSO as a solvent, of a
single feeding with steroids on day two, and of a wider
range of doses on the growth of HUVEC in the log phase,
several experiments were carried out.

In addition to DEX

and HC at a wider dose range, another corticosteroid
dehydroepiandrosterone (DHEA) - was tested.
and HC, DHEA is not a glucocorticoid.

Unlike DEX

DHEA is a

quantitatively major steroid secreted by the adrenal
cortex (15-30 mg/day in humans), and plays a role in
adrenal androgen metabolism.

DHEA is converted to

androst-4-ene 3,17, dione, which in turn is converted to
either testosterone or estrogen or is excreted as
androsterone and etiocholanolone in the urine.
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CM-199 containing DEX at four doses, containing DMSO
(0.1%) without steroid, or containing no added steroid or
solvent, was administered to HUVEC in culture on the
second day after plating, with cellular harvest and
counting performed on the seventh day.

The additional

steroid feeding used in the EtOH solvent experiments was
omitted.

The data represent the pooled results of two

experiments conducted under identical parameters and
conditions.

For flasks receiving HC and DHEA, which were

run simultaneously and are reported below, the basic
experimental procedure regarding cell plating, steroid
addition, and cell harvest was the same.

There was little

difference between control and 0.1% DMSO control cultures,
suggesting that DMSO as a solvent had little effect on the
growth of HUVEC.

The control groups served as controls

for all three steroids.

The data illustrating the cell

number for DEX at seven days are depicted in Figure Ja.
All four doses of DEX (5 _µM, 1 µM, 0.5 pM, & 0.1 �M)
effected a paradoxical increase in cellular growth.
population doublings are shown in Figure Jb.

The

Compared to

DMSO control, all four DEX doses caused a significant
increase in population growth at seven days, although
there was not a dose response.
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The four doses of HC employed in DMSO solvent
experiments were relatively higher than those used for
DEX.

Since HC is a less potent glucocorticoid than DEX,

slightly increased doses of the former were used.

Also,

since 1 µM HC in a previous experiment (Figure 2b)
effected a decrease in growth, albeit non-significant,
higher doses might have been expected to manifest a
similar inhibitory effect.

However, as was the case with

DEX, all four HC doses demonstrated a paradoxical increase
in cellular growth at seven days (Figure 4a).

All four HC

doses caused a significant increase in population
doublings at seven days, compared to DMSO control (Figure
4b).
The significant increases in population doubling
observed following both DEX and HC treatment led to the
idea that the cells possibly overcome the initial
inhibitory effects of the corticosteroid, and rebound
strongly, therefore leading to a relative increase in
growth at seven days.

This conceptual question was

addressed in later experiments, when the proliferation of
steroid-treated HUVEC was measured at four days.
As with DEX and HC, DHEA at the doses tested caused
an increase in cell number (Figure 5a).

Statistical

analysis of the population doublings (Figure 5b) indicated
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that the PD achieved with DHEA 50 µM, 20 µM, and 5 µM were
significantly higher than those attained by the DMSO
control group.

A dose response was not found.

DHEA at 10

p.M, although causing growth enhancement, was not
significantly different from the DMSO control group.
In the first set of corticosteroid-heparin treatment
experiments using DMSO as a solvent, all three steroids
tested caused growth enhancement in HUVEC.

Since the same

two cell lines derived from the same two umbilical cords
were used for all three steroids, it could be possible
that these cell lines responded to corticosteroid
treatment by growth facilitation.

It cannot be ruled out,

however, that an initial decrease in cellular growth may
have occurred, and was overcome by a subsequent increase
in cellular growth as the cells recovered from the
pharmacological treatment by seven days.

Note these

findings are in contrast to those found by Piovella et al.
{1980) and Maca et al.

(1978a), who reported an early

increase in cell numbers under the influence of DEX which
stabilized by the sixth day after plating so that cell
numbers in control and treatment flasks were comparable.
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Effect of Absorbed Serum
The purpose of charcoal-dextran absorption of the
Hyclone FBS used in these experiments was to remove
endogenous steroids that might affect the interaction of
the cells with the test steroid.

Theoretically, freeing

the media of endogenous steroids would free receptors on
the endothelial cell, and make it more responsive to
exogenously added steroids.

Both absorbed and unabsorbed

FBS were used in a final concentration of 20%.

In the

first of these experiments, DEX was tested in this
absorbed medium and compared to DEX administered to HUVEC
in CM-199 with unabsorbed serum.

DEX at the same doses

used in the initial DMSO solvent experiment was added to
HUVEC growing for two days.

As in previous experiments

using the DMSO solvent system, only one steroid feeding
was done.

At seven days, the cell number and population

doublings (Figures 6a and 6b respectively) were compared
between the absorbed and the unabsorbed group.
In comparison to absorbed serum, obviously greater
growth in the HUVEC occurred when the unabsorbed serum was
used.

This could suggest that endogenous steroids in the

serum used in routine media preparation might be
facilitative to cellular growth in HUVEC.

Alternatively,

other growth factors in serum might be altered by the
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charcoal filtration process.

Using absorbed serum, very

little variation from the DMSO control was observed when
DEX was added to the cultures.
DEX at 5 JlM and 1 }lM

For the absorbed group,

was associated with a significant

decrease in population doublings compared to controls, but
not to DMSO controls.

Therefore, it cannot be concluded

that the relative decrease seen in the DEX treated flasks
was due to the corticosteroid alone.

The difference

between control and DMSO control is greater for the
absorbed group than for the unabsorbed group.

Apparently

the charcoal filtered serum, with its endogenous steroids
removed, allowed DMSO to exert a more suppressive effect
on cellular growth.
In the unabsorbed group, all four doses of DEX
caused a significant decrease in population doublings at
seven days (Figure 6b).

This is an interesting finding,

since DEX at the same doses was growth enhancing in
previous experiment (Figures Ja and 3b).

Growth

inhibition occurred in some DEX doses in absorbed serum
containing media, although it was significant only in the
media containing unabsorbed serum.
Since the use of absorbed serum suggested a possible
trend toward inhibition of growth, it was decided to
retest DEX, and, in addition, to examine the effects of
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absorbed serum upon RC-heparin and DHEA-heparin
administration.

In followup experiments, DEX, HC, and

DHEA were again tested using the dosages employed in the
initial DMSO solvent experiments, but this time employing
media containing absorbed serum.

A simultaneous

comparison with unabsorbed serum was not done in this
experiment.

The results using DEX are shown in Figures 7a

and 7b, which display the cell number and population
doublings at seven days, respectively.

In this

experiment, DEX at 5 µM and at 1 p.M caused growth
inhibition and population growth inhibition while DEX at
0.5 pM and at 0.1 J..1M caused growth facilitation.

These

differences are not significant. DEX at 5 pM and 1 JlM
doses caused population doublings to be significantly
lower than controls, but not lower than DMSO controls
(Figure 7b).

As in Figure 6b, then, the decrease in

population doublings observed was not due to
corticosteroid intervention alone.

As they did in the

preceding absorbed FBS experiment, the two highest doses
of DEX again caused growth inhibition.

It is interesting

that in both experiments, the higher DEX doses (5 µM, 1
µM) caused growth levels that were significantly lower
than controls, but not DMSO controls.

Again, the results

may well reflect a greater suppression of cell and
population growth by DMSO in the absorbed serum.
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When HC was used (20 pM, 10 µM, 5 pM, 1 pM) with
absorbed serum, all four doses effected an increase in
cellular and population growth at seven days (Figures 8a
and 8b).

A dose response was not observed.

The

population doublings for all HC doses except 10 pM were
significantly greater than the DMSO control group.
However, the 10 )lM dose of HC still caused an increase in
population growth.

Apparently, the facilatory effect of

HC upon cellular growth of HUVEC, demonstrated for
unabsorbed serum (Figure 4b), does not appear to be
influenced by using absorbed serum.
When DHEA (50 pM, 20 pM, 10 yM, and 5 pM) was used
with absorbed serum, a variable response was found.
Figures 9a and 9b display the cellular and population
growth respectively at seven days for the various doses of
DHEA.
growth

In absorbed serum, 10 µM DHEA inhibited population
which was significantly less than control, but not

DMSO control groups; therefore this inhibition was not due
solely to corticosteroid intervention.

Addition of DHEA

(20 µM) caused a non significant increase in cellular and
population growth at seven days, compared to DMSO control,
but the population growth

observed at this dose was still

less than that for the control group.

For two doses of

DHEA, 50 µM and 5 µM, neither growth inhibition nor
facilitation occurred.

This is in contrast to the
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facilitory effect of DHEA when unabsorbed serum was used
(Figures 5a and 5b).

Since the experiments with absorbed

serum were run simultaneously for DEX, HC, and DHEA,
comparison for each steroid was to the same control and
DMSO control treatment groups.
In summary, when DEX, HC, and DHEA were tested in
media containing absorbed serum, the inhibitory effect of
DEX, at least at higher doses, appeared to be somewhat
sustained, while the facilitory effect of HC seen in DMSO
solvent experiments (albeit with unabsorbed medium) was
unaffected by the absorbed serum.

DHEA at the doses used

resulted in a variable response.

In this second group of

experiments employing medium containing absorbed FBS, a
non significant difference between control and DMSO
control groups was again observed (Figure 6b).

This

difference was relatively greater than that observed when
unabsorbed serum was used.
Comparison of Male and Female HUVEC
For some time in our laboratory, it had been
observed that female and male HUVEC appeared to grow quite
differently in culture.

It was noticed that female HUVEC

tended to grow more rapidly yet enter the senescent phase
of a culture's life span later, and overall senesce at a
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slower rate when compared to male HUVEC.

Experiments to

assess this observation quantitatively are in progress.
It was decided to compare the cellular and population
growth response of DEX-heparin treated female and male
HUVEC.

Also, two additional doses of DEX (0.01yM and

0.002 pM) were examined for their effects in both the
female and male cultures.

Steroids were dissolved in DMSO

and added to the cultures on the second day after plating.
For both the female and male treatment and control
cultures, cell harvest was on the sixth, instead of the
customary seventh, day.

The cellular and population

growth was thus assessed slightly earlier than previous
assays.

However, the cultures were confluent at the time

of trypsinization and further delay would have resulted in
lost cells.

Cell lines for the female and male HUVEC used

in this experiment were derived from cords started on the
same day, and passed identically.

The male and female

cells utilized were of the same age and passage number.
For the female HUVEC (Figures lOa, 10b), there was
no dose-response effect when six doses of DEX were used.
However, the trend was again noticed that the higher doses
of DEX (5 µM, 1 µM, and 0.5 )lM) caused a slight decrease
in population growth (Figure 10b), while the lower doses
of DEX (0.1 µM, 0.01 µM, and 0.002 JlM) caused a slight
increase in population growth.

These differences,
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however, were not significant.

Again, it was also

observed that when using unabsorbed serum there was very
little difference between control and DMSO control flasks
regarding cellular or population growth assays.
It can be pointed out that the cell number and
population doublings in the male treatment and control
groups (Figures lla, llb) were somewhat lower than the
corresponding values in the female treatment and control
groups (Figures lOa, 10b).

This observation lends support

to the suggestion that female and male HUVEC grow at
different rates.

There was little difference between the

control and DMSO control groups when male cells were
utilized.

Apparently, the slight inhibition of cellular

and population growth that occurs in 0.1% DMSO alone in
the medium, when compared to DMSO-free control groups, is
not sex-specific and is a property shared by cells derived
from either gender umbilical cord.

A variable response

was found among the male HUVEC treated with the six DEX
doses.

DEX at doses of 0.5 µM and 0.002 pM caused a

slight (n.s.) inhibition in cellular growth at six days.
The remaining DEX doses (5 pM, 1 µM, 0.1 µM and 0.01 yM)

caused a facilitation in cellular growth at six days.
at 0.01 pM caused a significantly greater increase in
population doubling when compared to DMSO control.

In

addition, the increase in population growth effected by

DEX
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DEX at 0.01 µM was significantly different from control,
0.5 )lM, and 0.002 µM DEX.

Here, compared to female HUVEC,

the higher doses of DEX (5 pM, 1 �M) caused an increase,
rather than a decrease in cellular growth.

However, a low

dose of DEX (0.01 pM) caused a significant increase in
cellular and population growth, which corroborates
previous findings with lower doses of DEX (Figures 6b,
7b) •

To summarize, in female HUVEC, the differences
between treatment and DMSO control groups were not
significant, but it was observed that the higher doses of
DEX were manifested in a slight decrease in population
growth, while the lower doses of DEX in a slight increase.
The results for male HUVEC were less clear, but
nonetheless DEX at 0.01 fM caused a significant increase
in population growth, which supports a trend for lower
doses of DEX enhancing growth, a finding suggested by
previous experiments.
Effect of Dexamethasone in Reduced (1%) Serum
Growth of HUVEC in culture does not occur when serum
is omitted from the media, unless serum substitutes are
used.

While optimal growth of these rather fastidious

cells occurs with heparin, ECGF, and 20% FBS, reduction of
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the serum component in the medium to a concentration as
In

low as 1% can support low level growth of the cells.

order to determine whether DEX could affect cells under
suboptimal growth conditions, six doses of DEX were used
in combination with 1% FBS.

As in all previous

experiments using DMSO as a solvent, the cultures were fed
with experimental media on the second day.

The cell

numbers (Figure 12a) demonstrated that all six doses of
DEX caused a decrease in cell number at seven days, when
compared to the DMSO control group.

All doses of DEX

except 0.5 pM caused a population growth that was
significantly lower than DMSO control and control.

The

results are similar to our earlier experiments with DEX
when ETOH was the steroid solvent.

Apparently, using

medium with a reduced serum component (1%) allows the
inhibitory effect of DEX treatment to be more fully
expressed.
Next, two doses of DEX (0.1 JlM and 0.01 pM) were
employed in a comparison experiment using fully
supplemented media (20% FBS) or reduced serum medium (1%
FBS).

The same cell line as used in the 1% FBS experiment

immediately preceding (Figures 12a, 12b) was used in the
comparison experiment, except that the cells were at a
later passage.

A regular control group was not run, and

all statistical comparisons were made with the DMSO
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control group.

Figures 13a and 13b depict the effect of

DEX in media containing 20% and 1% FBS upon cellular and
population growth, respectively.
growth in 20% FBS as expected.

There was much greater

With 1% FBS in the culture

medium, a non-significant decrease in cellular and
population growth was observed for both DEX doses.

With

20% FBS, growth enhancement at seven days was observed.
Both the 0.1 pM and the 0.01 pM doses of DEX caused a
significant increase in the number of population
doublings, when compared to DMSO controls.

A dose

response over this range was not observed.

Again, the

reduced serum (1%) appeared to unmask an inhibitory effect
of DEX or to prevent the stimulation observed with 20%
FBS.

The growth enhancement seen with 20% FBS was

consistent with that found earlier when DMSO was used as a
solvent (Figures 3b, llb).
The 1% vs. 20% FBS comparison experiment was
repeated using a slightly wider dose range of DEX (5 )lM, 1
)lM, 0.5 pM, 0.01 �M) using third passage cells from a
different cord.

There was little difference in cellular

or population growth between 0.1% DMSO controls and
controls when either the 1% or the 20% FBS was used
(Figure 14a, 14b).

Using 1% serum, growth was slightly,

but not significantly, facilitated at seven days at the
lower doses of DEX (0.1 �M, 0.01 �M); however, DEX at
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doses of 5 pM and 1 µM had no effect.

When 20% FBS was

used, a relatively high dose of DEX (5 pM) caused a
significant increase in population growth compared to DMSO
controls (Figure 14b).

Actually, all doses of DEX when

used with 20% FBS enhanced population growth.

This was

consistent with earlier DEX experiments when 20% serum
containing medium was used (Figures 3b,llb,13b).
In summary, a dose response was not observed in the
above three experiments employing a reduced serum
component in the culture medium.

Using 1% serum allowed

DEX to exert an inhibitory effect on the growth of HUVEC
in two of three experiments, although this was not
significant in one of them.

When 20% FBS was used in

comparison experiments, cellular growth and population
growth were enhanced,
solvent experiments.

much as it was in the initial DMSO
Even when using higher doses of DEX

(5 )lM, 1 pM) that had proven inhibitory previously
(Figures 3b,7b,9b), growth enhancement occurred with 20%
FBS containing medium.

Since DEX in medium containing 20%

FBS either facilitated or inhibited growth, depending on
the cell line used, these findings can be related to the
clonal specificity theory of Longenecker et al. (1982),
who reported that EC exhibited a clonal heterogeneity
regarding their response (inhibitory or facilitory) to
glucocorticoid treatment.
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Effect of Repeated Steroid Dosing
When EtOH was used as a solvent in our early
experiments, the cultures were fed twice, at two and five
days, with corticosteroids.

In all previous experiments

employing corticosteroid-heparin combinations and DMSO as
a solvent, the cells were fed with steroid containing
medium only once on the second day after plating.
were counted at seven days.

Cells

The purpose of the next

experiments was to determine the effect of a second
steroid feeding on the log phase growth of HUVEC when DMSO
was used as a solvent.

In these experiments, cultures

were fed on the second and fourth day after plating, and
counted on the seventh day.

DEX at doses of 1.0

y.M, 0.1 }lM, 0.01 J1M was used.

pM, 0.5

Table 1 shows that at seven

days, all four doses of DEX caused a decreased cell count.
Apparently the second steroid feeding at four days after
plating sustained the inhibitory effect of DEX seen in
some previous experiments.

However, while all four doses

of DEX caused a decreased population growth at seven days,
none were significantly different from DMSO controls.
When the experiment was repeated using later passage
cells from a different cord, growth enhancement occurred
(Table 2) despite the second steroid feeding.

Three of

the four doses of DEX caused a significantly greater
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population growth (Table 2) when compared with DMSO
control.

Thus, it was observed that when cultures of

HUVEC were fed twice with steroid medium, a non
significant inhibition occurred in one experiment, while a
significant enhancement of cellular and population growth
occurred in a second experiment.

Since these experiments

were conducted under identical conditions (except for the
passage number), the clonal specificity response again
appears to be supported (Longenecker et al., 1982).
Effect of Steroids on Proliferation of HUVEC at Four Days
Following the observations of Piovella et al.
(1980), who noticed an enhancement of growth for the first
five days of steroid treatment of HUVEC but level growth
at seven days, and our own conflicting findings using
seven day assays, it was decided to determine if steroids
had an earlier effect on cellular proliferation and
population growth than could be seen at seven days.

These

experiments were run simultaneously with those examining
the effects of a second steroid feeding, using the same
cultures at the same passage numbers.

The purpose of

these lines of inquiry was to determine if DEX had any
early effect on the growth of HUVEC that might be masked
after the cultures were allowed to grow for several
additional days.

DEX at doses used for the second steroid
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feeding experiment just described were employed; cells
were steroid-fed at two days and harvested at four days.
All four doses caused inhibition of cellular growth at
four days (Table 3); of these doses, 1 yM and 0.1
significantly different from DMSO controls.

pM were

The

relatively less inhibition caused by the lower steroid
dose (0.01 JlM) was noted.

It was possible, then, that DEX

caused an early inhibition of cellular growth in HUVEC
that might well have been overcome and not be evidenced at
a later time, say seven days.
The four day cellular and population growth assays
were repeated using the same steroid doses, but with later
passage cells from a different cord.

Early growth

inhibition was again observed (Table 4), as all doses of
DEX effected a decrease, albeit non-significant, in cell
number and consequently in population doublings at four
days.

Again there appeared to be less inhibition of

cellular and population growth at the lower DEX dose (0.01
uM).

The conclusions from this second experiment were

similar to those made above: DEX at the doses tested
causes an early inhibition of cellular growth in HUVEC
that might well be overcome, and not be evident, if the
cultures are harvested at a later time (seven days).

69

Colony Forming Assay
A colony forming assay, an alternate method of
cellular proliferation assessment, was used to test DEX at
doses of 1 µM and 0.1 µM HUVEC.

A colony forming assay

may be a more sensitive growth assay, since it measures
the ability of single cells to grow and form a colony of
cells following plating at low density.

In the first

colony formation variation, the effect of DEX upon growth,
and not upon attachment, was examined.

The cells were

plated at colony formation density (1,000 cells/ 2 5 cm 2 ) in
CM- 199, and after four hours were washed and then fed
with the appropriate steroid containing medium.

The

cultures were fed a total of three times with either
steroid or DMSO control medium.

Both DEX doses caused

effective and significant inhibition of colony formation,
i.e. there were significantly fewer colonies in the DEX
treated flasks after nine days of growth (Figure 15).
In the second colony formation variation, the effect
of DEX on attachment only was examined.

In this

experiment, the cultures were plated at colony formation
density for four hours in CM-199 with the appropriate DEX
dosage (1 µM or 0.1 pM) or CM-199 with 0.1% DMSO alone.
After the four hour incubation with steroid, the cultures
were washed and then fed with CM-199 without steroids or
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DMSO.

After a total of three such feedings, the cultures

were fixed and evaluated at nine days.

No difference in

the number of colonies of HUVEC was observed at nine days,
suggesting that a short attachment period in steroid
If

medium would not affect subsequent colony growth.

possibly there was a slowing of the growth of HUVEC in
this initial four hour period, it did not effect the
number of viable colonies observed at nine days.
In the third variation, the effect of DEX on both
attachment and growth was determined.

In this experiment,

cells were plated in steroid or DMSO containing medium for
four hours, washed, and subsequently fed three more times
with the steroid or DMSO control medium.

The steroid

treatment caused significantly fewer colonies to form when
compared to the DMSO control group (Figure 15).

There

appeared to be a dose-response, but this assertation is
made cautiously.

Note the lower number of colonies in the

steroid treated flasks both plated in and subsequently fed
with steroid containing media (Variation 3), when compared
to steroid treated flasks in the first experiment
(Variation 1), when the effect of DEX was assessed for
growth alone.

These data suggest that plating with

steroid media even for the relatively short period of four
hours further inhibits colony formation in HUVEC, when
steroid treatment is then continued.
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Cytofluorometry
Phase contrast microscopy revealed that the
dexamethasone-treated cultures contained EC with larger
cytoplasmic and nuclear areas and more prominent nucleoli,
supporting the observation of Piovella et al. (1982).

The

increase in cellular size was confirmed by light scatter
analysis using the cytofluorometer.

Figures 16, 17, 18,

and 19 show the effect of dexamethasone on relative
endothelial cellular size for control, control plus 0.2%
ETCH, 0.5 JlM dexamethasone, and 1 )111 dexamethasone,
respectively.

From these data, it can be seen that an

increase in concentration of dexamethasone paralleled an
increase in cellular size.

This effect may be dose

related (Figures 18, 19).
Goldsmith et al. (1984) used flow cytometric
analysis of both bovine aortic endothelial cells (BAEC)
and HUVEC to

examine the proliferative characteristics of

repeatedly subcultured endothelial cells.

They found that

confluent primary HUVEC had approximately 2-8% of the
cells in the proliferative phases (S,G2, and M) of the
cell cycle.

Although the authors evaluated the effect of

cell passage upon cell cycle profiles for BAEC, only
primary HUVEC were studied.

Preliminary work in our

laboratory, utilizing cytofluorometric analysis of EC
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cultures treated with dexamethasone in the presence of
heparin, demonstrated that this treatment increased the
number of EC in the S and/or G2-M phases of the cell cycle
in early passage HUVEC (Table 5).

The decreased

population doubling observed when certain cultures were
treated with DEX-heparin combinations was paradoxical,
then, since greater population growth would have been
anticipated with more cells in the proliferative cell
cycle phases.

Discussion
Since angiogenesis can be inhibited in vivo by
treatment with heparin and various corticosteroids
(Folkman, 1985a,b; Folkman et al., 1983: Crum et al.,
1985), in vitro experiments examining the effect of
corticosteroids on cultured HUVEC were undertaken to
determine if the mechanism of anti-angiogenesis involves
suppression of cellular proliferation.

Several papers

(Maca et al., 1978; Piovella et al., 1980, 1982;
Longenecker et al., 1983) have dealt with
on cultured EC.

steroid effects

In order to elaborate further the effect

of these steroids upon growth characteristics of HUVEC,
the current study has extended previous research by
testing the glucocorticoids DEX and HC in the presence of
heparin and ECGF under a variety of conditions.

This

study has also examined the effects of DHEA, a
corticosteroid not used by previous researchers, upon
cellular proliferation and population growth in HUVEC.

In

our study, a variable response of HUVEC to corticosteroids
was found, depending on a number of factors, including the
time frame of steroidal administration, the type of
steroid solvent, and the length of exposure to
corticosteroids.

These equivocal findings involving HUVEC
73
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were similar to those of Longenecker et al. (1983), who
suggested that bovine aortic endothelial cells (BAEC)
exhibit a rather striking clonal heterogeneity regarding
their sensitivity to glucocorticoid treatment.
Using HUVEC grown under optimal conditions with FBS,
ECGF, and heparin {Thornton et al., 1983), our results
have corroborated some aspects of previous inquiries
involving steroid effects; in other areas the findings are
in contrast to earlier reports.

The increased growth

observed in HUVEC in many of our experiments (when
steroids were dissolved in DMSO) was also reported by
Piovella et al. {1980, 1982),

who found that DEX caused

an initial increase in cell number, but that the confluent
density of HUVEC matched controls at six days.

However,

the increases we observed were sustained at confluence
(seven days).

Growth inhibition, as observed in some of

our experiments, was also noted by Longenecker et al.
(1983) in DEX-treated BAEC.

However, they found that DEX

inhibited cellular growth in only one of four clones that
they studied.

Growth inhibition of HUVEC treated with DEX

and HC, which occurred consistently when EtOH was used as
a steroid solvent in this study, stands in contrast to the
findings of Piovella et al. (1980) as well as to our
findings when DMSO was the solvent.

The present study

also has corroborated and, by employing cytofluorometric
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light scatter analysis, added a quantitative dimension to,
earlier reports (Maca et al., 1978; Piovella et al., 1980,
1982) that dexamethasone increases cellular size in HUVEC.
It was clear that when EtOH was used as a solvent
for corticosteroids in the HUVEC culture system employed
here, growth inhibition occurred that was reproducible in
several experiments terminated at seven days.

Growth

inhibition significantly greater than the slight amount
caused by the EtOH solvent was evident using two doses of
DEX, (1 pM, 0.5 pM), and was consistently, although not

significantly, inhibited when HC at 1 µM was used.

The

fact that the cultures were fed twice with steroid
containing media in contrast to a single feeding when DMSO
was the solvent may have sustained early growth
inhibition, but we cannot conclude this unequivocally,
since an earlier (four day) growth assessment was not done
in experiments utilizing EtOH as a solvent.

Also, since

single feeding treatment regimens were not employed in the
EtOH solvent experiments, we cannot ascertain whether
recovery from early growth inhibition or even subsequent
enhancement might have occurred if the cultures were fed
once and harvested at seven days, as in most of the DMSO
solvent experiments.
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When DMSO was used as a solvent for DEX, HC, and
DHEA, cellular and population growth enhancement was
frequently observed.

In these experiments, there was a

slight and insignificant depression cf growth caused by
the DMSO solvent itself, suggesting that this solvent did
not stimulate growth of HUVEC.

In contrast to the growth

inhibition seen when DEX was used with EtOH as a solvent,
when four doses of DEX dissolved in DMSO were used,
significant growth enhancement was initially seen at seven
days.

Subsequently, when unabsorbed and absorbed serum

were compared regarding responses to DEX treatment, the
unabsorbed group, which was comparable to the first DMSO
solvent experiment except that a different culture was
used, exhibited growth inhibition.

And in a later

experiment comparing 20% and 1% FBS containing media,
growth enhancement occurred when the 20% FBS containing
media was used.

Thus, it seems clear that DEX is not

consistent in its effect on cellular and population growth
at confluence (seven days) in HUVEC when fully
supplemented media, a DMSO solvent, and a single steroid
feeding are employed.
Since 1 pM HC (Figure 2b) effected a non-significant
decrease in growth when ETOH was the solvent, higher doses
might have been expected to manifest a similar inhibitory
effect. However, when DMSO was the solvent, all four HC
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doses demonstrated a paradoxical increase in cellular
growth at seven days.

This enhancement with HC was

significant, and was sustained when absorbed serum was
used in the media.

Thus, the growth facilitory effects of

HC upon HUVEC when DMSO was used as a solvent did not
This

appear to be affected by using absorbed serum.
finding suggests that hydrocortisone, a natural
glucocorticoid, might be more consistent than

dexamethasone, a synthetic glucocorticoid, under different
experimental conditions in enhancing growth in HUVEC.
When DHEA was used with DMSO as a solvent,
significant growth enhancement also occurred.

In

contrast, when DHEA was tested using absorbed serum in the
media, a variable response was found.

Since neither

growth facilitation or inhibition occurred when two doses
of DHEA were used, it appeared that DHEA had little
definitive effect on the growth characteristics of HUVEC
when absorbed serum was used.
To summarize, in contrast to the experiments
employing EtOH as the solvent, when DMSO was used as the
solvent, there was a tendency for growth enhancement to
occur, but this was not observed in all experiments.

In

earlier research (Piovella et al., 1980), an early
increase in cell number was seen but this enhancement was
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not sustained at seven days.

In the present study, this

enhancement was sustained at least for five days after
steroid administration on the second day of culture.
However, Piovella et al. (1980) administered steroids at
the time of cell plating; that is, two days earlier than
in the present experiments, so the steroid-treated cells
may have reached confluence earlier, allowing the control
cultures to catch up by the end of the six day assessment
period, therefore causing the cell numbers in control and
steroid treated cultures to be comparable.

In comparison,

in our culture system, the cells were exposed to steroids
for shorter periods of time, allowing early growth
stimulation to still be operational at the end of the
seven day assessment; thus growth enhancement was
observed.

However, since only a seven day assessment was

carried out in these experiments, the possibility of an
early growth inhibition occurring during the first few
days following steroid treatment followed by a later
growth enhancement manifesting at seven days cannot be
completely ruled out.

The results of our four day

assessment experiments, which showed steroid-induced
cellular growth inhibition two days after steroid
treatment, support this contention.
It should be noted that in the first experiments in
which DMSO was used as a solvent, cells derived from the
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same umbilical cord were used for all three steroids
tested.

It may be that these cells respond to

corticosteroid treatment by facilitation of growth, and
that this response might be culture specific, much like
the clonal variability responses seen in BAEC by
Longenecker et al.

(1983).

One might speculate that the

majority of cells from this cord would respond to steroid
treatment with growth facilitation, and that a minority of
cells would respond with inhibition, yielding an overall
increase in culture growth following treatment with DEX,
HC, or DHEA.
There was a consistent lack of a dose response in
most of the experiments reported in this study.

This was

particularly true for experiments which employed media
containing a full serum supplement (20% FBS) and steroids
dissolved in DMSO.

The full serum supplement in the media

possibly may serve to down regulate steroid receptors on
the endothelial cellular surface; the receptors may then
not be in a propitious state to respond to exogenously
administered steroids.

Possibly for this reason, at the

steroid doses that we employed,

a dose response regarding

proliferative effects was not observed.

In addition,

cells more resistant to steroid effects might selectively
inactivate these steroids in greater quantities than more
sensitive cells (Berliner, 1965).

Since the human
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umbilical vein cell populations used in these studies were
uncloned, it is likely that our cultures contained groups
of cells with varying sensitivity to steroid effects.
This may partially explain the lack of a dose response, as
well as the variable and equivocal nature of our findings,
concerning the effects of steroids on endothelial cellular
proliferation in vitro.
When the effects of corticosteroids in medium
containing absorbed serum were compared to those in medium
containing unabsorbed serum, the slight inhibition caused
by the DMSO solvent was somewhat greater for the former
than for the latter group.

Apparently, the use of

absorbed serum in the growth media allows the DMSO solvent
to exhibit a greater degree of inhibition upon cellular
and population growth.
Although our data suggest that endogenous steroids
in the serum used in routine media preparation might be
facilitative to cellular growth of HUVEC, the use of media
containing absorbed serum appears to modify somewhat the
response of HUVEC to corticosteroid intervention.

The

mechanism underlying this modification might concern the
regulation of steroid receptors on the endothelial
cellular surface, alluded to above in partially explaining
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the lack of a dose response regarding proliferation in
steroid-treated EC.
In using media containing unabsorbed serum, the
already high steroid (ligand) concentration present in the
serum might serve to down regulate steroid receptors on
the endothelial cellular surface.

Therefore, exogenously

added steroids may further down regulate the steroid
receptors.

On the other hand, a lower steroid (ligand)

concentration, as would be the condition when media
containing absorbed serum was used, would serve to up
regulate the steroid receptors on the cell surface.

Thus,

added steroids would have an effect on cellular
proliferation, as the up regulated steroid receptors would
then be more apt to bind the hormone, internalize it, and
effect a growth response.

According to Evans (1988), in

steroid-cellular interactions, transcriptional regulation
of cellular DNA derives from the binding of the hormone
receptor complexes to hormone response element sites on
the DNA.

Apparently the hormone binding region normally

prevents the domain for DNA binding and transcriptional
activation from functioning.

The addition of steroid

apparently relieves this inhibition (Evans, 1988).

One

can speculate that the use of media containing absorbed
serum would increase the likelihood of this disinhibition
occurring.
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In the experiments using absorbed serum, there was a
trend for higher doses of DEX(> 0.5 µM) to inhibit
growth, and lower doses of DEX(<.5 µM) to facilitate
growth.

It is possible that the higher doses of DEX,

added to cells whose steroid receptors were up regulated
due to the presence of media containing absorbed serum,
were more effective than the lower doses in engaging a
greater number of steroid receptor sites, thus resulting
in net inhibition of growth.

In comparison, the lower DEX

doses might not have been as effective in engaging as many
steroid receptor sites on the endothelial cellular
surface, thus even though the steroid receptors were in an
up regulated state due to the presence of media containing
absorbed serum, the binding of added steroids to cellular
receptors was insufficient to effect a growth inhibition
response; neutral growth or even slight growth enhancement
occurred.
Alternately, the use of absorbed serum might
modulate the number or character of ECGF and other growth
factor binding sites on EC, and thus it would be the
altered response by EC to growth factors per se, and not
to corticosteroids, that would ultimately effect the level
of cellular or population growth that was observed.
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In the male vs. female experiments, the cell harvest
was on the sixth day post plating, slightly earlier than
in other experiments in this study.

Although

dexamethasone had one day less to exert any effect, this
probably was not a significant factor in the responses
observed, as the cells were tightly confluent when they
were trypsinized and counted.

When female and male HUVEC

were compared regarding the effect of DEX on cellular and
population growth, no consistent inhibition or stimulation
of growth was observed in either group.

It was not

possible to definitively conclude from these experiments
that gender plays a crucial role in the response of HUVEC
to exogenous steroid administration.
In comparing the responses of female and male cells
(Figures 10a and lla), it was noted that there was a trend
for cellular and population growth of control cultures for
female cells to be greater than that for male cells.

This

observation lends support to the suggestion that female
and male HUVEC grow at different rates.

Further evidence

for this phenomenon can be found in the four day growth
experiments.

When the four day assessments were carried

out, two experiments were performed.

Although these

experiments were not designed to test cellular gender as a
factor in steroid response, it is informative to examine
the results for control cultures here also.

The results
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in Table 3 are those for male cells, and in Table 4, for
female cells.

The greater population growth of HUVEC

under control cultures for female cells compared to male
cells is noted.

Also, from these tables, it can be

observed that for each steroid dosage, the cell number for
female cells was approximately twice as great as that for
male cells, with both types of cells responding to steroid
treatment with growth inhibition.

In these experiments,

all culture flasks were plated at standard density two
days prior to steroid administration.

The results seemed

to indicate a trend for female HUVEC to exhibit a greater
growth ability than male cells.

However, more culture

pairs will have to be tested specifically for the gender
effects upon cellular growth to substantiate this trend.
DEX appears to be inhibitory when greatly reduced
FBS (1% vs. the usual 20%) is employed in the media used
to feed the cultures.

When 1% FBS was used in the media,

DEX consistently, but not always significantly, inhibited
population growth.

The use of medium containing 1% serum

might lead to up regulation of the steroid receptors on
the endothelial cellular surface in the same manner as
when media containing absorbed serum was employed.

The

reduced serum component in the medium would effectively
lower the concentration of steroid (ligand) available to
the steroid receptors; added steroid would then be more
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likely to engage the available receptors, thereby possibly
exerting an effect on cellular proliferation.

In this

way, a reduced serum component in the media might make the
HUVEC more susceptible to the possible inhibitory effects
of heparin-corticosteroid combinations.
The response characterized by higher doses of DEX
leading to growth inhibition and lower doses of DEX
leading to growth enhancement, observed in two experiments
when the absorbed serum paradigm was employed, was not
seen with media containing reduced FBS except in one
experiment.

But when culture medium containing a full

serum supplement (20% FBS) was used, either growth
facilitation or inhibition could occur depending on the
cell line used.

These results as displayed in the

comparison experiments could be related to the clonal
specificity theory of Longenecker et al. (1982), who
reported that EC exhibited a clonal heterogeneity
regarding glucocorticoid sensitivity.

Further testing

employing medium with a full serum supplement, using
cultures derived from cloned cells might confirm this or
perhaps demonstrate a more definitive relationship of
either growth inhibition or enhancement in cloned HUVEC
treated with corticosteroids.

Also, other steroids, in

addition to DEX, should be studied using both a full and a
reduced serum supplement in the media to determine if a
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trend toward cellular and population growth inhibition
observed with DEX would be expressed.
In the study of Longenecker et al. (1983), who
emphasized clonal variability of BAEC, it was interesting
that inhibition of proliferation of EC occurred only in
the presence of FGF.

It is possible also in our study

that the response to glucocorticoids was also growth
factor dependent.

It might be that steroids mildly

inhibit the maximal response of EC to growth factor, in
our case, ECGF.

Since ECGF is believed to be the acidic

form of FGF (Jaye et al., 1986), it would be interesting
to determine if FGF would cause the same effects, i.e.
inhibition of the endothelial cellular proliferation
response to the growth factor in HUVEC as well as BAEC.
Alternately, different cultures or clones of HUVEC may
display different responses to steroid-heparin
combinations.

Moreover, it cannot be ruled out that a

given cell clone of HUVEC can simply respond to
corticosteroid administration by either growth enhancement
or inhibition.
Based on the results from two separate experiments
where cultures of HUVEC were fed twice with medium
containing DEX dissolved in DMSO, a non-significant
inhibition in one experiment and a significant enhancement
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of cellular and population growth in a second experiment,
occurred.

Since these experiments were conducted under

identical conditions, the clonal specificity response
again appears to be supported (Longenecker et al., 1983).
However, in early experiments using EtOH as a solvent, a
second steroid feeding was routinely employed, and
cellular and population growth inhibition was rather
constant.

Perhaps then, the solvent is as important a

factor as the steroid effects themselves.
It is conceivable that certain cultures of HUVEC
could overcome the growth inhibition that was seen at four
days of culture, that is, two days after steroid
treatment.

At this point, after cessation of inhibition,

the inhibited cultures (at a lower density) might proceed
to grow more rapidly during the final days of culture than
the more dense controls, with ultimate confluent density
consisting of similar numbers of cells in treated and
control flasks.

In experiments that employed a seven day

growth assay, a cellular and population growth enhancement
was a frequent finding, suggesting that if an initial
steroid induced growth inhibition did occur, it could be
overcome.

Further support for this contention is

supplied by the observations in the four day growth
experiments and repeated steroid dosing experiments (DMSO
solvent).

Table Two and Table Four illustrate findings
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that were observed using the same cell line, at the same
passage number, and run simultaneously.

The cultures

exhibited cellular and population growth inhibition at
four days, but enhancement at seven days.

Even with a

second feeding (Table Four), significant cellular and
population growth enhancement was seen at seven days;
replicate cultures had displayed inhibition of growth just
three days previously.
The findings employing a second steroid feeding
support the suggestion made above that a given culture of
EC can respond to steroid treatment with either growth
facilitation or growth inhibition.

This is further

evidence in support of the clonal specificity theory
regarding endothelial cellular response to steroid
treatment (Longenecker et al., 1983).

However, even in a

controlled in vitro experiment there are a number of
factors that can determine the type of response by the EC.
It is also possible that, depending on other factors, such
as cellular density and medium composition, HUVEC may
reach a point in their growth cycle when they are less
responsive to any steroid induced inhibition of their
growth characteristics.

Alternately, exogenously

introduced steroids may continue to bind to the surface of
the EC, and when this is reinforced and further maintained
by a second steroid feeding, the response of the EC may be
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This might explain the growth

one of increased growth.

enhancement observed when the cultures were trypsinized
and counted on the seventh day after plating.
Henriksen et al. (1975) found that the replicative
ability of HUVEC was correlated with cell density at the
time of cell seeding.

Colony formation is an alternate

method of growth assessment in culture systems and is a
way of examining clonal growth of cells plated at very low
density.

Colony formation was employed to determine if

corticosteroids administered to sparsely plated HUVEC had
a possibly different effect than when administered to a
denser, yet still subconfluent and growing culture of
HUVEC.

In the first colony formation variation, the

effect of DEX upon growth only was assessed; a
significantly lower number of colonies was observed in
DEX-treated cultures compared to controls.

In the second

variation, HUVEC were plated in steroid containing media
for four fours only, then subsequently fed with CM-199
without steroids; there was no difference in the number of
colonies between DEX-treated and control cultures.

In the

third variation, the effect of DEX on both plating and
growth was determined.

Compared to the control, there

were significantly fewer colonies in the steroid treated
flasks when the cells are both plated in and fed with
steroid containing media.

It is noted, in comparing the

90

DEX-treated cultures in the first and third variations,
that there were fewer colonies in the DEX-treated cultures
in the latter.

The data suggest that plating with steroid

media even for a relatively short period of time can
potentiate the inhibition of colony formation in HUVEC
seen if the cells continue to be grown in the steroid
containing media.
Since steroid-induced inhibition of growth was
prominent in the colony formation experiments, where
plating density is only 1,000 cells/flask (vs. 1.2 5 x 10 5
cells/flask in the usual growth assay experiments), low
density growth of HUVEC may be inhibited by heparin and
DEX, whereas high density growth is unaffected or slightly
increased.

A low number of cells, given a uniform steroid

dosage, may not be able to metabolize it as rapidly;
therefore, growth inhibition may ensue when cell density
is low, the relatively higher steroid concentration acting
on a smaller number of cells.

This might be a possible

mechanism for the inhibition seen with the four day growth
assessments and the colony formation experiments.

Now, at

a later time, say seven days after plating, when the
culture may be approaching confluence, there are more
cells to metabolize the steroid and the concentration of
the steroid has been reduced, so that an effect on growth
does not occur.

This could possibly explain the lack of a
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consistent response to a second steroid feeding when DMSO
was used as a solvent.

Any inhibitory effects that might

have resulted if the cellular density were lower might be
minimized if the steroids were added at five days, as
during the second steroid feeding experiments.
High density cultures of HUVEC seem to respond
differently to steroid intervention.

It should be noted

that in several experiments the cultures were crowded and
postconfluent at the termination of the experiment at
seven days.

It was for this reason that the experiments

comparing the response of male and female HUVEC to
corticosteroid administration were terminated at six,
instead of seven, days.

A crowded, densely populated

culture of HUVEC may exhibit a deceleration of the
cellular growth rates in the later period just prior to
cell harvest; growth during this period may not be
responsive to exogenous steroid administration.

In our

experimental paradigms involving administration of fresh
steroids during later growth periods (i.e., experiments
employing a second steroid feeding) there might have been
little effect on growth rates during this crowded period.
It appears then that the density of a culture during the
later stages of steroid treatment may have a considerable
effect on cell number assessed at a postconfluent time.
Since the availability of physical space in the monolayer
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into which the EC can replicate is an important factor in
the growth of EC in vitro, crowded near confluent cultures
will have a lower growth rate than less dense, younger
cultures exhibiting the characteristic numerous mitotic
figures indicative of rapid growth.
Another possible mechanism for the inhibition at low
density might be related to the proportion of the
endothelial cellular surface mechanically available to
exogenously administered steroids.

It is possible that

crowded, more confluent cultures may be less responsive to
inhibitory effects of steroid treatment because only the
receptors on the apical surface of the cell would be
exposed directly to exogenous steroids.

Therefore only a

limited number of receptors on the endothelial cellular
surface would be likely to respond to steroid treatment.
In the intact endothelium in vivo, this may be a factor
where perhaps only the luminal surface of the EC would be
exposed to circulating steroids.

The clonal specificty

hypothesis (Longenecker et al., 1983) could also be
related to the inhibitory effects of DEX on colony
formation.

In colony formation, clones that are inhibited

and do not grow are therefore not counted; in a mixed
culture, loss of the cells contributed from a clone that
is totally inhibited could be compensated for by the
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greater growth potential of a neighboring clone allowed to
grow to confluence.
On the other hand, steroids administered to low
density, rapidly growing EC under in vitro experimental
conditions might prove to be too artificial a situation to
compare the responses to those which might possibly occur
during in vivo conditions.

However, when corticosteroid

preparations are administered pharmacologically to treat
various diseases where angiogenesis is an ongoing process,
the effect on open, rapidly growing microvessels where
migrating and dispersed EC are present might consequently
differ from that seen in an intact e�dothelium where
angiogenesis is not occurring.
Cell cycle analysis by cytoflourometry revealed that
1 uM DEX (EtOH solvent) almost doubled the percentage of
HUVEC in the G2-M phase of the cell cycle (Table 5).

Since the number of population doublings was significantly

suppressed by 1 uM DEX in these early growth experiments,
it is possible that the mechanism of suppression involved
arrest in the G2 phase of the cell cycle and therefore
delay of division (Goldsmith et al., 1984).

Running

additional cytofluorometric analysis simultaneously with
growth studies could enable further correlation of the
level of growth enhancement or suppression with the
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relative distribution of cells in the various phases of
the cell cycle.

This may provide more information to

answer questions concerning the cell cycle dependency of
the growth response of HUVEC to corticosteroid-heparin
treatment.

Light scatter analysis of DEX treated cells

revealed that this steroid caused an increase in cellular
size.

It is known that glucocorticoid treatment increases

protein content of cultures of HUVEC (Maca et al., 1978);
therefore, increased structural protein synthesis could be
responsible for this increase in cellular size.
Alternatively, although the exact mechanism for this
phenomenon is unclear, it may be related to an increase in
microfilament formation in association with the cell
membrane, as reported for steroid treated C6 glial cells
by Berliner et al (1978).

Quantitative studies employing

electron microscopic procedures might reveal whether a
relative increase in microfilament formation occurs in
steroid treated EC.
Rosner and Cristafalo (1979) studied a number of
non-endothelial cell lines and observed both growth
enhancement and growth inhibition when hydrocortisone was
used in the medium.

Perhaps in EC also, in this case

HUVEC, the proliferative response of the cells to
corticosteroids demonstrates a cell-line specificity, as
well as a steroid-molecular structure specificity.

In
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this light, it cannot be concluded that a given culture or
clone of HUVEC will respond with either growth
facilitation or inhibition to all steroids.
Steroid-endothelial cell reactions are conceivably
mediated by high affinity glucocorticoid binding sites on
the endothelial cellular surface (Berliner, 1981).

If the

binding sites are altered in some way, the endothelial
cellular response to corticosteroids will also be altered.
Perhaps the study of factors which can compete, either
positively or negatively, with the steroid binding sites
would yield more fruitful information concerning cellular
growth responses to corticosteroids than study of the
corticosteroids per se.

It is conceivable that various

growth factors and media components can affect the
function or regulation of these corticosteroid binding
sites on the endothelial cellular surface.

Berliner

(1981) found that although HC did not appear to have a
direct effect on thymidine incorporation in EC, the
presence of the steroid was permissive for the effects of
insulin and FGF.

Although the mechanism of action of the

steroid induced enhancement of the growth factor and
insulin interaction is not completely understood, Baker et
al. (1978) felt that it might be related to the increase
in insulin binding observed when EC were treated with HC.
It is entirely possible, according to the work of Baker et
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al.

(1978), that corticosteroids, dexamethasone in this

case, cause a permissive effect on growth by modulating
cell surface receptors for the growth factor.

To this

effect, DEX may enhance the mitogenic response of HUVEC to
growth factors, and this may be the mechanism by which
growth enhancement occurs.

Therefore, the modulation of

growth by steroids may be indirect.

One might speculate

that the level of corticosteroids in the blood exerts some
control over the growth or quiescent state of the
endothelium in vivo.

Such an effect may be mediated by

alteration of the character or structure of binding sites
for heparin and growth factors on the surface of the
endothelial cell.
Glucocorticoids can either sensitize or desensitize
various cell types to the action of serum or growth
factors added to the cell cultures, and the role of these
growth factors needs to be further understood.

Perhaps a

time factor is relevant, with growth factors being more
inhibitory in some phases of the cell cycle than others.
However, the possible interaction of added steroids and
growth factors is even more intriguing.

Longenecker et

al. (1982) reported that DEX inhibited the growth of
bovine smooth muscle cells (BSMC) but only when FGF was
absent from the medium.

This suggests that the inhibition

of cellular growth following exogenous steroid
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administration may be dependent on the absence of FGF.
However, smooth muscle cells were tested above; when
steroids were administered to BAEC (Longenecker et al.,
1983), growth inhibition was dependent on the presence of
FGF.

It is conceivable, then, that the steroids and

growth factors may be competing with the same or
interdependent binding sites on EC,

sites which are

responsible for the modulation of cellular growth.
Whether steroids compete with growth factors for binding
sites or render the latter inactive by binding to separate
but physiologically related sites is unknown.

Alterations

of the location, size and/or character of these binding
sites would also be important factors in determining
endothelial cellular responses to steroid treatment.
Since heparin was utilized in all experiments in our
cultures system, its role in steroid induced proliferative
effects in EC needs further delineation.

It is known that

heparin interacts structurally with ECGF and potentiates
the mitogenic activity in EC by altering immunological
epitopes within the structure of ECGF, stabilizing its
polypeptide structure, and increasing the affinity of ECGF
for its cell surface receptors (Schreiber et al., 1985).
The interaction and possible interdependence of these
three factors (ECGF, heparin, steroids) in modulating
proliferation of EC are topics for future study.
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Note that Longenecker et al. (1983) also found that
the steroid induced inhibition seen in one clone of BAEC
was FGF dependent.

In our culture system, we did not test

whether the inhibition seen in some experimental
conditions was ECGF dependent, as this growth factor was a
component in all experiments conducted.

It may be that

the responses of HUVEC to steroid intervention would
differ if ECGF were omitted from the culture media.
However, without ECGF, cultures of HUVEC grow slowly and
sporadically, and impaired growth could affect the
response to steroid treatment.

Further, regarding culture

conditions, an alternative to completely eliminating the
growth factor would be to modify the amount of heparin in
the media.

However, for optimal growth of HUVEC, this

would necessitate increasing the amount of ECGF (Thornton
et al., 1983).

If it is indeed true that the mechanism

behind steroid-induced inhibition or enhancement of growth
lies in the interaction of the steroid with the growth
factor, then increased concentrations of ECGF could play a
role in any growth response to exogenously administered
steroids.
Indirect support for steroid induced enhancement of
proliferation comes from the work of Jarvelainen et al.
(1985), who found that DEX and HC stabilized the monolayer
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of EC, strengthening the adhesion of cells to the
extracellular matrix, reducing their susceptibility to
separation by enzymatic agents.

stabilization of the

structural integrity of the endothelial cellular monolayer
might render the cells less susceptible to factors that
would inhibit growth via several mechanisms.

Pursuant to

this concept, since an increase of migratory activity
precedes proliferation of cells in stimulated cultures of
EC (Shelley et al., 1977), then the steroid induced
stabilization of the monolayer observed with steroid
treatment could play a role in the inhibition of
proliferation by preventing the antecedent migration or
chemokinesis.
Since angiotensin converting enzyme (ACE) activity
is increased in steroid-treated cultures of EC (Mendelsohn
et al., 1982a, 1982b; Lam et al., 1985), an in vivo

role

may exist for this phenomenon in steroid induced
inhibition of cellular proliferation.

Since the ACE

converts angiotensin I to angiotensin II, the latter a
potent vasoconstrictor,
theorized.

an in vivo correlation can be

ACE induced vasoconstriction might constrict

vessels in vivo, altering the cellular surface area, and
consequently modifying the character of steroid or growth
factor binding sites, making the cells less sensitive to
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positive growth factors.

Thus vasoconstriction would

support the phenomenon of angiostasis.

The role of extracellular matrix (ECM) is an
additional variable that should be explored in examining
factors which may be operative in effecting in vivo anti
angiogenesis.
relevant.

Concerning this, three studies are

Piovella et al. (1982) found that DEX increased

the amount of fibronectin matrix in cultured HUVEC, and
suggested that the phenomenon was responsible for better
spreading of the cells on the culture surface.

Whether

this increased spreading affects cellular proliferation is
not known.

Longenecker et al.

(1983) reported that the

FGF dependent DEX induced inhibition of cellular growth in
BAEC could be abolished by employing ECM derived from
bovine aortic smooth muscle cells.

Whether the gelatin

matrix used in our culture system or the ECM laid down by
HUVEC affects the response of the cells to steroid
treatment is unclear, but certainly is a factor that
deserves further consideration.

Lastly, Ingbar et al.

(1986) stated that basement membrane dissolution played a
role in anti-angiogenesis mediated by angiostatic steroids
in vivo.

However, exactly when this degradation of

basement membrane occurred in the sequence of events in
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steroid induced angiostasis was not pinpointed in their
study.
It must be remembered that the steroid responses
seen in the present in vitro studies were observed during
relatively acute treatment periods, and, as pointed out by
Longenecker et al. (1983), might differ significantly from
responses which might ensue due to more chronic exposure
of EC to excess glucocorticoids, such as would occur in
cells treated throughout a culture lifespan.

They

speculated that responses of the endothelium in vivo,
exposed to exogenous glucocorticoids for months or years,
would also be potentially different from those seen in
cultures treated with steroids in more acute time
periods.

Perhaps also, in the in vivo situation, a

homeostatic environment prevails in the endothelium, that
is, there is a balance between growth facilitation and
growth inhibition, and the response to physiological doses
of glucocorticoids might be such so as to provide
conditions favorable to the maintenance of endothelial
integrity.
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The following major findings in the present study
regarding the effect of heparin-corticosteroids on HUVEC
can be summarized as follows:
1.

Both DEX and HC were inhibitory to growth of HUVEC

when EtOH was used as a solvent and fully supplemented
media was employed.

The fact that these cultures were fed

twice with steroids prior to harvest might have
potentiated the effects of DEX and HC upon the growth of
HUVEC.
2.

When a full supplement of CM-199 was used as the media

and DMSO was used as a solvent, there was a tendency
toward enhancement of cellular growth when DEX was used.
3.

The cellular and population growth enhancement seen

when HC was used {DMSO solvent) was significant and was
sustained when absorbed serum was used in the media.
4.

Employing absorbed serum in the media, treatment with

DEX and DHEA, but not HC, led to inhibition of cellular
and population growth.

The inhibition seen when absorbed

serum is used may not be due solely to corticosteroid
intervention.
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5.

Although gender does not appear to be a factor in the

proliferative response of HUVEC to corticosteroid and
heparin treatment, there was a trend for female EC to
display better growth rates than their male counterparts.

6.

Using a reduced serum component (1% FBS), inhibition

of cellular and population growth was observed following
treatment with DEX, but this was not always significant.
7.

There was a trend for higher doses of DEX to effect

cellular and population growth inhibition, while lower
doses effected cellular and population growth enhancement.
This was true for HUVEC grown in absorbed media and for
female HUVEC.
8.

There was a trend for DEX to effect an early

inhibition of cellular and population growth in treated
HUVEC, an inhibition that may well be compensated for by a
subsequent cellular and population growth recovery during
the later stages of culture.
9.

Significant inhibition of cell colony formation in

HUVEC in response to DEX administration was observed.
Since cell colony experiments are conducted with a very
low density of cells (1,000 cells/T-25 flask), it may well

104
be that low density growth of HUVEC is inhibited by
steroid treatment, while higher density growth is
facilitated.

Alternatively, clonal assay may be a more

sensitive method than mass culture for detecting
suppressive effects on sensitive cells.
10.

Cytoflurometric analysis of HUVEC treated with DEX in

the presence of heparin indicated that this treatment
increased cellular size and increased the number of EC in
the S and/or G2-M phases of the cell cycle in early
passage HUVEC.
Our experiments utilizing corticosteroids and
heparin in cultures of EC demonstrated that treatment did
not always decrease proliferation as postulated on the
basis of in vivo findings (Folkman et al., 1983; Crum et
al., 1985); by contrast DEX and HC sometimes caused an
increase in proliferation.

It might well be that the

mechanism for inhibition of angiogenesis by angiostatic
steroids observed in vivo does not involve inhibition of
endothelial cell proliferation, but rather entails some
alternative process, such as the induction of capillary
basement membrane dissolution, as suggested by Ingber et
al. (1986).

But even in their work, it was not possible

to conclude definitively that basement membrane
alterations were a primary, rather than secondary effect;
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basement membrane degradation might be a primary effect of
corticosteroid treatment, or perhaps secondary to the loss
of endothelial cell viability, the latter effected by
steroid-induced growth inhibition.

studies such as the

present one, designed to elucidate the effect of heparin
corticosteroid administration on the proliferation of
HUVEC, hopefully may have assisted in clarifying their
point to a somewhat greater degree.
It is unknown whether cellular migration in HUVEC is
affected by corticosteroid treatment.

Since endothelial

cellular migration precedes proliferation both in vitro
(Shelley et al., 1977) and in vivo (Shelley et al., 1984),
factors which affect endothelial cellular migration may
indeed by important in determining the response of HUVEC
to heparin-corticosteroid treatment.

Although both

heparin and ECGF have been found to be chemotactic for
HUVEC (Maciag et al., 1984), the effect of corticosteroids
upon directed migration of EC has not been studied.
Migration assays utilizing various corticosteroids as
possible chemotactic stimuli would provide information
regarding any steroid mediated mechanisms involving
endothelial cellular movement, which could greatly
influence cellular proliferation in vitro.
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Also, in this vein, it is known that vasodilation
precedes both migration and proliferation of EC during in
vivo angiogenesis (Folkman, 1984).

Perhaps the inhibition

of prostacyclin (a potent vasodilator) activity in
cultured EC by corticosteroids (Lewis et al., 1986;
Deuterina & Walker, 1986) may be partially responsible for
the anti-angiogenic effect of these steroids observed in
vivo.
Additional studies, designed to elucidate further
the role of corticosteroids upon either endothelial
cellular growth or the endothelial basement membrane
integrity, could provide answers to these remaining
questions concerning corticosteroid mediated modifications
in the vascular system, and offer more rationale for the
use of corticosteroids in diseases where angiogenesis is a
prominent feature.
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Figure la. Effect of dexamethasone (DEX) on the growth of
HUVEC (alcohol solvent). T-2 5 flasks were plated at standard
density (1.25 x 10 5 cells/flask). Cells in the first through
third passage were used. The cultures were fed with medium
containing DEX dissolved in EtOH on the second and fourth or
fifth day after plating. The final concentration of EtOH in
the steroid containing media was 0.2% for 1 pM DEX and 0.1%
for 0. 5 ).1M DEX; For each experiment, cells were harvested
and counted in quadruplicate in a hemocytometer on the
seventh day after plating. The results shown are the
combined pool of four separate experiments: each bar
represents the cell counts from 12 flasks, with the standard
error of the mean (SEM) drawn above the bar. Dexamethasone
treatment has resulted in an inhibition of cellular growth.
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Figure 1 a.
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Figure lb. Effect of dexamethasone on population growth
(alcohol solvent). These bar graphs demonstrate the
population doubling characteristics of HUVEC for the
corresponding steroid doses and cell number data found in
Figure la. Each bar represents the mean population doubling
level from 12 flasks from four separate experiments, with the
SEM above the bar.
* Significantly different from control, 0.2% ETOH, and 0.1%
ETOH, (p < 0.05).
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Figure 1 b.
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Figure 2a. Effect of hydrocortisone (HC) on growth of HUVEC
(alcohol solvent). T-2 5 flasks were plated at standard
density (1.2 5 x 10 5 cells/flask). Cells in the first through
third passages were used. The cultures were fed with media
containing HC dissolved in EtOH on the second and fourth day
after plating. The final concentration of EtOH in the
steroid containing media was 0.2%. For each experiment,
cells were harvested and counted in quadruplicate with a
hemocytometer on the seventh day after plating. The results
shown are the combined pool of three separate experiments.
Each bar represents the mean cell counts from nine flask
determinations, with the SEM drawn above the bar.
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Figure 2a.
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Figure 2b. Effect of hydrocortisone (HC) on population
growth (alcohol solvent). The bars indicate the growth
characteristics of HUVEC for the corresponding steroid doses
and cell number data given in Figure 2a. Each bar represents
the mean population doubling value from nine separate
determinations, with the SEM drawn above the bar. The
population growth inhibition effected by HC was not
significant.
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Figure 2b.
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Figure 3a. Effect of dexamethasone (DEX) on growth of HUVEC
(DMSO solvent). T-25 flasks were plated at standard density
with second or fourth passage HUVEC. On the second day after
plating, the culture media was removed and replaced with
fully supplemented media (CM 199) containing DEX dissolved in
dimethylsulfoxide (DMSO) at the dosages indicated. The final
media concentration of DMSO for DMSO control and all steroid
treated cultures was 0.1%. Cells were harvested and counted
at seven days. The results shown are the combined pool of
two experiments; each bar represents the mean cell counts
from six separate determinations, with the SEM above the bar.
Growth enhancement is evident.
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Figure 3a.
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Figure 3b. Effect of dexamethasone on population growth
(DMSO solvent). This graph depicts the growth
characteristics of HUVEC for the corresponding steroid doses
and cell number data given in Figure 3a. Each bar represents
the mean population doubling value calculated from six
separate determinations, with the SEM above the bar. A non
dose response increase in population growth was effected by
all doses of DEX employed. * Significantly different from
DMSO control, p < 0.05.
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Figure 4a. Effect of hydrocortisone (HC) on growth of HUVEC.
(DMSO solvent). T-25 flasks were plated at standard density
with second or fourth passage HUVEC. On the second day after
plating, the culture media was removed and replaced with
fully supplemented media (CM 199) containing HC dissolved in
DMSO at the dosages indicated. The final media concentration
of DMSO for DMSO control and all steroid-treated cultures was
0.1%. Cells were harvested and counted at seven days. The
results shown are the combined pool of two experiments; each
bar represents the mean cell counts from six separate
determinations, with the SEM above the bar. An increase in
cellular growth occurred with all HC doses employed.
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Figure 4b. Effect of hydrocortisone (HC) on population
growth (DMSO solvent). This graph depicts the growth
characteristics of HUVEC for the corresponding steroid doses
and cell number data displayed in Figure 4a. Each bar
represents the mean population doubling level calculated from
the six separate determinations, with the SEM above the bar.
A non-dose response enhancement of cellular growth was
detected by all HC doses employed.
* Significantly different from DMSO control, p < 0.05.
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Figure 4b.
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Figure 5a. Effect of DHEA on growth of HUVEC (DMSO solvent).
T-25 tissue culture flasks were plated at standard density
using second or fourth passage HUVEC. On he second day after
plating, the culture media was removed and replaced with
fully supplemented media (CM 199) containing DHEA dissolved
in DMSO at the dosages indicated. The final concentration of
DMSO for DMSO control and all steroid treated cultures was
0.1%. Cells were harvested and counted at seven days. The
results shown are the combined pool of two such separate
experiments; each bar represents the mean cell counts from
six separate determinations, with the SEM above the bar.
Again steroid-induced enhancement of cellular growth is seen.
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Figure 5b. Effect of DHEA on population growth (DMSO
solvent). This graph depicts the growth characteristics of
HUVEC for the corresponding steroid doses and cell number
data given in Figure 5a. Each bar represents the mean
population doubling value calculated from six separate
determinations, with the SEM above the bar. The increase in
population growth was significant in three of the doses
employed. * Significantly different from DMSO control, p <
0.05.
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Figure Sb. Effect of DHEA on Populotion Growth
(DMSO Solvent)
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Figure 6a. Effect of dexarnethasone (DEX) on growth of HUVEC
(unabsorbed vs. absorbed FBS). The graphs compare the
effects of media containing charcoal filtered (absorbed) FBS
with those of media containing unfiltered (unabsorbed) FBS.
T-25 culture flasks were plated at standard density with
fourth passage HUVEC. On the second day after plating, CM199 was replaced with either CM-199 made from absorbed FBS or
CM-199 made from unabsorbed FBS, plus the appropriate DEX
dosage. For both absorbed and unabsorbed media, the final
concentration of DMSO in control or steroid groups was 0.1%.
Cells were harvested and counted on the seventh day. The
bars represent the mean cell counts of triplicate flasks,
given along with the SEM. The increased growth with
unabsorbed FBS-containing media is obvious. Also observed is
a decreased growth in steroid treated cultures when absorbed
FBS was used.
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Figure 6a. Effect of Dexamethasone on Growth of HUVEC
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Figure 6b. Effect of dexamethasone on population growth
(unabsorbed versus absorbed FBS). The graphs compare the
effects of unabsorbed and absorbed FBS containing media on
the population doubling characteristics of HUVEC for the
corresponding to the data given in Figure 6a. Each bar
represents the population doubling determined from triplicate
flasks at the indicated FBS parameter, with the SEM above the
bar. Note the greater difference between the control and
DMSO control group when absorbed FBS was used. Also, fewer
population doublings were achieved with the absorbed FBS in
comparison to the unabsorbed FBS.
* Significantly different from unabsorbed DMSO control,
p < o.os.
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Figure 7a. Effect of dexamethasone (DEX) on growth of HUVEC
(absorbed FBS). The cell counting experiments graphed in
Figure 6a were repeated with DEX in a non-comparison
experimental paradigm; only absorbed FBS was used. Second
passage HUVEC were plated in T-25 flasks at standard density
using regular CM-199. On the second day after plating,
cultures were fed with culture media made from FBS from which
endogenous steroids had been removed by double charcoal
filtration, plus DEX dissolved in DMSO at the dosages
indicated. The final concentration of DMSO in the DMSO
control and all steroid flasks was 0.1%. The cells were
harvested and counted on the seventh day. The bars represent
the mean cell counts of triplicate determinations, with the
SEM above the bar.
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Figure 7a. Effect of Dexamethasone on Growth of HUVEC
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Figure 7b. Effects of dexamethasone (DEX) on population
growth (absorbed FBS). The graph indicates the growth
characteristics of HUVEC grown in absorbed FBS-containing
media for the corresponding steroid doses and cell number
data given in Figure 7a. Each bar represents the mean
population doubling determined from triplicate flasks, with
the SEM above the bar. Neither the population doubling
inhibition effected by the higher DEX doses (5 J,IM, 1 }lM) nor
the population growth enhancement effected by the lower DEX
doses (0.5 .)lM, 0.1 µM) was significant. The relatively
greater difference between the control and DMSO control group
when absorbed serum was used is again noted.

144

Figure 7 b.
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Figure Sa. Effect of hydrocortisone (HC) on growth of HUVEC
(absorbed FBS). The cell counting experiments using absorbed
serum graphed in Figure 6a were repeated with HC in a non
comparison paradigm; only absorbed FBS was used. Second
passage HUVEC were plated in T-25 flasks at standard density.
On the second day after plating, cultures were fed with
culture media made from FBS from which endogenous steroids
had been removed by charcoal filtration, plus DEX dissolved
in DMSO at the dosages indicated. The final concentration of
DMSO in the DMSO control and all steroid flasks was 0.11.
Cells were harvested and counted on the seventh day. The
bars represent the mean cell counts of triplicate
determinations, with the SEM above the bar. All doses led to
growth facilitation.
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Figure Ba. Eff ect of Hydrocortisone on Growth of HUVEC
(Absorbed FBS)
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Figure Sb. Effect of hydrocortisone (HC) on population
growth (absorbed FBS). The graph depicts the growth
characteristics of HUVEC grown in media with absorbed FBS
corresponding to the given in Figure Ba. Each bar represents
the population doubling determined from triplicate flasks,
with the SEM above the bar. In contrast to DEX, all four
doses of HC employed effected growth enhancement. A
relatively greater difference (n.s.) between the control and
DMSO control group is again recognized. * Significantly
different from DMSO control,
p < o.os.
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Figure Sb. Effect of Hydrocortisone on Population Growth
(Absorbed FBS)
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Figure 9a. Effect of DHEA on growth of HUVEC (absorbed
serum). The cell counting experiments using absorbed serum
graphed in Figure 6a were repeated once again with DHEA in a
non-comparison experimental paradigm; only absorbed serum was
used. Second passage HUVEC were plated in T-25 flasks at
standard density. On the second day after plating, cultures
were fed with culture media made from FBS from which
endogenous steroids had been removed by charcoal filtration,
plus DHEA dissolved in DMSO at the dosages indicated. The
final concentration of DMSO in the DMSO control and all
steroid flasks was 0.1%. Cells were harvested and counted on
the seventh day. The bars represent the mean cell counts of
triplicate determinations, with the SEM above the bar. The
effect of CHEA on cellular growth when absorbed serum was
used is negligible.
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Figure 9b. Effect of DHEA on population growth (absorbed
FBS). The graph depicts the growth characteristics of HUVEC
grown in media containing absorbed FBS corresponding to the
data given in figure 9a. Each bar represents the PD
determined from triplicate flasks, with the SEM above the
bar. As with OEX and HC above, the relatively greater
difference between control and DMSO control groups when
absorbed serum is used is noted. The effect of DHEA on
population growth in HUVEC when absorbed serum was used is
not significant.
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Figure 9b. Effect of DHEA on Population Growth
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Figure lOa. Effect of dexamethasone (DEX) on growth of HUVEC
(female cells). Second passage female HUVEC were plated in
T-25 flasks at standard density. on the second day after
plating, cultures were fed at a wider range of DEX doses as
indicated. The final concentration of the DMSO solvent in
the DMSO control and all treatment groups was 0.1%. Cells
were harvested and counted on the sixth day. The bars
represent the mean cell counts of triplicate flask
determinations, with the SEM above each bar. Although not
significant, the trend in female HUVEC was for higher doses
of DEX to effect slight growth inhibition, while lower doses
appeared to cause slight growth enhancement, compared to the
DMSO control group.
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Figure lOb. Effect of dexamethasone (DEX) on population
growth (female cells). These bars illustrate the population
doubling characteristics of steroid-treated female HUVEC
corresponding to the data given in Figure lOa. Each bar
represents th� mean population doubling from triplicate flask
determinations, with the SEM above the bar. The population
growth response was variable, but there was a trend for
higher doses of DEX to cause slight growth inhibition, and
the lower doses, enhancement in female cultures of HUVEC.
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Figure lla. Effect of dexamethasone (DEX} on growth of HUVEC
(male cells). Second passage male HUVEC were plated at
standard density. On the second day after plating, cultures
were fed with DEX at the six dosages indicated. The final
concentration of the DMSO solvent in the DMSO control and all
treatment groups was 0.1%. Cells were harvested and counted
on the sixth day. The bars represent the mean cell count of
triplicate flask determinations, with the SEM above the bar.
Lower doses of DEX caused slight growth enhancement, much the
same as for female cells (Figure 10a), except for the slight
inhibition at 0.002 )lM DEX. Slight growth enhancement,
rather than inhibition, occurred with higher steroid doses.
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Figure llb. Effect of dexamethasone (DEX) on population
doublings (male cells). These bars illustrate the population
doubling characteristics of male HUVEC, corresponding to the
data given in Figure lla. Each bar represents the population
doubling from triplicate flask determinations, with the SEM
above the bars. Although one dose of DEX (0.01 jlM) effected
a significant ·population growth enhancement, a lower dose
(0.002 JlM) was inhibitory. Also, high doses of DEX caused an
enhancement of cellular growth. * Significantly different
from DMSO control, control, and DEX at doses of 0.5 J1M and
.002 JlM, p < 0.05.
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Figure 11b. Effect of Dexamethasone on Populotion Grow th
(Male Cells)
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Figure 12a. Effect of dexamethasone (DEX) on growth of HUVEC
(1% FBS). The bars depict the effect of six doses of DEX
upon the growth of HUVEC when a reduced serum component in
the culture medium was employed. Second passage HUVEC were
plated in T-25 flasks at standard density using media made
with 1%, instead of 20% FBS. All other media components were
identical to CM-199. on the second day after plating, the
cultures were·fed with the appropriate DEX doses. The final
concentration of DMSO solvent was 0.1% for DMSO control and
all steroid flasks. Cells were harvested and counted on the
seventh day. The bars represent the mean cell counts of
triplicate flask determinations, with the SEM above the bar.
Cellular growth inhibition occurred with all doses employed
when 1% FBS was used in the culture media.
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Figure 12b. Effect of dexamethasone (DEX) on population
growth (1% FBS). The bars illustrate the growth
characteristics of HUVEC corresponding to the data given in
Figure 12a. Each bar represents the population doublings
(PD) from triplicate flask determinations, with the SEM above
the bar. There was a significant inhibition of population
growth with all but one DEX dose (0.5 JJM) when reduced serum
was employed in the culture media.
* Significantly different from DMSO control, p < 0.05.
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Figure 13a. Effect of dexamethasone (DEX) on the growth of
HUVEC (1% vs. 20% FBS). These bars compare the effects of
DEX in media containing reduced serum (1%) or a full serum
component (20%). Fourth passage HUVEC were plated in T-25
flasks at standard density using media made with the
designated serum concentrations. On the second day after
plating, the cultures were fed with either 0.1 }lM DEX or 0.01
}lM DEX in the appropriate media. In either medium, the final
concentration of DMSO in the DMSO control and DEX treated
flasks was 0.1%. Cells were harvested and counted on the
seventh day. The bars represent the mean cell counts of
triplicate flask determinations, with the SEM above the bar.
The decreased growth that occurred with the reduced serum
component in the culture media is noted. Slight inhibition of
cellular growth occurred in media with 1% FBS,, while an
enhancement of cellular growth occurred in media with 20%
FBS.
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Figure 13b. Effect of dexamethasone (DEX) on population
growth (1% vs. 20% FBS). The bars compare the effects of 1%
and 20% FBS-containing media on the growth characteristics of
steroid-treated HUVEC for the steroid doses and cell number
data given in Figure 13a. Each bar represents the population
doubling determined from triplicate flasks. In the reduced
serum medium, DEX caused slight population growth inhibition,
while the full serum supplement media caused a significant
population growth enhancement. This finding was consistent
for many experiments when full CM 199 was employed as the
culture medium. * Significant from DMSO control, 20% FBS. (p
< 0.05).
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Figure 13b.

Effect of Dexamethasone on Population Grow th
(1% Versus 20% FBS)

Population Doublings
4.0
3.5
3.0
2.5
2.0
1.5
1.0

DMSO

lf'1i=f-1

0.1 J.JM
Treatment

20%.fBS

169

Figure 14a. Effect of dexamethasone (DEX) on growth of HUVEC
(1% vs. 20% FBS). A comparison of the effects of media
containing reduced serum with fully supplemented media was
again performed with a wider DEX dose range. Third passage
HUVEC were plated in T-25 flasks at standard density, using
media with either 1% FBS or 20% FBS. On the second day after
plating, the cultures were fed with the appropriate media
containing DEX at the doses indicated. The final
concentration of DMSO solvent was 0.1% in the DMSO control
and all experimental flasks. Cells were harvested and
counted on the seventh day. The bars represent the mean cell
counts of triplicate flask determinations, with the SEM above
the bars. The decreased cellular growth that occurred with
the reduced serum component is again noted. The effect of
DEX in the reduced media is inconstant; cellular growth
enhancement occurred when 20% FBS containing media was used.
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Figure 14b. Effect of dexarnethasone (DEX) on population
growth (1% vs. 20% FBS). The bars compare the growth in 1%
FBS and 20% FBS-containing media for the corresponding
steroid doses and cell number data given in Figure 14a. Each
bar represents the population doubling value determined from
triplicate flasks. As found previously (Figure 13b),
population growth enhancement occurred when medium with a
full (20%) serum supplement was used. The previously found
growth inhibition with 1% FBS media is not demonstrated here.
* Significantly different from DMSO control, p < 0.05.
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Figure 14b.
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Figure 15. Effect of dexamethasone (DEX) on colony formation
by HUVEC. These bar graphs illustrated the number of
colonies of HUVEC achieved with two different doses of DEX
using three different variations on attachment and growth.
For all variations, seventh passage HUVEC were plated in T-25
flasks at colony formation density (1,000 cells/flask).
After four hours, cultures were washed and then fed with
steroid or control media according to the variation employed.
Cultures were fed twice more at three day intervals with the
appropriate steroid, DMSO control, or control media, and
fixed and evaluated on the ninth day. The final
concentration of DMSO solvent for DMSO control and all
experimental flasks was 0.1%. Variation 1: To test the
effect of DEX on growth only, cells were plated in CM-199
without steroids, and refed three times as described above
with the appropriate DEX containing medium or DMSO control
medium. Vari�tion 2: To test the effect of DEX on
attachment alone, HUVEC were plated with steroid containing
or DMSO control medium, and then refed three times with CM199 without steroids or DMSO. Variation 3: To test the
effect of DEX on both attachment and growth. HUVEC were both
plated and subsequently refed three times with the
appropriate steroid containing or DMSO control medium. Bars
represent in the mean colony counts from triplicate flask
determinations, with the SEM above the bar. Colony formation
is significantly inhibited by growth in DEX; plating in
steroid media does not lead to colony formation inhibition
unless subsequent feedings are with steroid containing media
as well. * significantly different from Variation 1 DMSO
control group, p < .05. ** Significantly different from
Variation 3 DMSO control group, p < .05.
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Figure 16. This plot shows the light scatter analysis of
control HUVEC. HUVEC were plated in T-2 5 tissue culture
flasks at standard density (1.2 5 x 10 5 cells/flask). They
were fed with fully supplemented media on the second and
fourth day after plating. Cell harvest was on the seventh
day.
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Figure 17. This plot demonstrates the light scatter analysis
of HUVEC with 0.2% EtOH added to the culture media. HUVEC
were plated in T-25 tissue culture flasks at standard
density. The cultures were fed with media containing 0.2%
EtOH on the second and fourth day, with cell harvest on the
seventh day.
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Figure 18. This plot shows the light scatter analysis of
HUVEC treated with 0.5 µM DEX. HUVEC were plated in T-25
tissue culture flasks at standard density. The cultures were
fed with fully supplemented media containing 0.5% J.lM DEX
dissolved in EtOH on the second and fourth day, with cell
harvest on the seventh day. The final concentration of ETCH
in the steroid containing media was 0.1%.
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Figure 19. This plot demonstrates the light scatter analysis
of HUVEC treated with 1 )lM DEX. HUVEC were plated at
standard density in T-25 tissue culture flasks. The cultures
were fed with fully supplemented media containing 1 µM DEX
dissolved in EtOH on the second and fourth day after plating,
with cell harvest on the seventh day. The final
concentration of EtOH in the steroid continuing media was
0.2%.
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Table 1. Effect of dexamethasone (DEX) on growth
characteristics of HUVEC (second steroid feeding) Experiment I. This table illustrates the effect of a second
steroid feeding upon the cellular and population growth of
HUVEC. Second passage HUVEC were plated in T-25 flasks at
standard density. On the second and fourth day after
plating, cultures were fed with DEX dissolved in DMSO at the
doses indicated. The final concentration of the DMSO solvent
in the DMSO control and all the treatment groups was 0.1%.
Cells were harvested and counted on the seventh day. Values
represent the mean cell counts or corresponding mean
population doublings of triplicate flask determinations, and
are given with the SEM. Although not significant, there was
a trend toward cellular and population growth inhibition with
all four doses of DEX employed.

Table 1
Effect of Dexamethasone on Growth Characteristics of HUVEC
(Second Steroid Feeding) - Experiment I
Treatment

Cell Number + SEM

0.1% DMSO Control

+ .20
9.13 -

X

10 5

+ .03
3.2 5 -

1.0 µM DEX

+ .34
6.38 -

X

10 5

+ .08
2.74 -

0. 5 µM DEX

+ .80
6.86 -

X

10 5

+ .16
2.83 -

0.1 µM DEX

7.38 + .80

X

10 5

+ .16
2.93 -

0.01 µM DEX

+ 1.18
7.30 -
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X

10 5

Population Doublings
+ SEM

+ .24
2.89 -
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Table 2. Effect of dexamethasone (DEX) on growth
characteristics of HUVEC (second steroid feeding) Experiment II. This table illustrates the effect of a second
steroid feeding upon the cellular and population growth of
HUVEC. Fourth passage HUVEC were plated in T-25 flasks at
standard density. On the second and fourth day after
plating, cultures were fed with DEX at the doses indicated.
The final concentration of DMSO solvent in the DMSO control
and all the treatment groups was 0.1%. Cells were harvested
and counted on the seventh day. Values represent the mean
cell counts or mean population doublings of triplicate flask
determinations, and are given with the SEM. An increase in
cellular and population growth with all steroid doses was
noted. The increase in population growth was significant for
1.0 µM, 0.5 µM, and 0.01 µM DEX. The much greater growth
overall is apparent, compared to Table 1.

Table 2
Effect of Dexamethasone on Growth Characteristics of HUVEC
(Second Steroid Feeding) - Experiment II
Treatment

Cell Number + SEM

0.1% DMSO Control

+ .07
1.04 -

X

10 6

+ .03
2.90 -

1.0 JlM DEX

+ .03
1.33 -

X

10 6

+ .04
*3.2 6 -

0.5 }lM DEX

+ .04
1.24 -

X

10 6

+ .04
*3.1 6 -

0.1 µM DEX

+ .01 X 10 6
1.1 6 -

+ .01
3.0E -

0.01 }1M DEX

+ .07 X 10 6
1.2 6 -

+ .08
*3.18 -

Po12ulation Doublings
+ SEM

* Significantly different from DMSO controls (p < .05).

18 6
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Table 3. Effect of dexamethasone (DEX) on growth
characteristics cf HUVEC (four day counts) - Experiment I.
The table illustrates the effect of DEX upon the cellular and
population growth in a four day growth assay. The purpose of
this experiment was to determine if growth inhibition or
enhancement occurred at an earlier time period, an effect
that might have been masked in a seven day assay. Second
passage HUVEC were plated in T-25 flasks at standard density.
on the second day after plating only, cultures were fed with
DEX at the doses indicated. The final concentration of the
DMSO solvent for the DMSO control and all treatment groups
was 0.1%. Cells were harvested and counted on the fourth
day, two days after steroid administration. The values
represent the mean cell counts or corresponding mean
population doublings of triplicate flask determinations, and
are given with the SEM. An early cellular and population
growth inhibition was observed with the DEX doses employed.
The decrease in population growth was significant for 1.0 pM
and 0.1 }lM DEX.

Table 3
Effect of Dexamethasone on Growth Characteristics of HUVEC
(Four Day Counts) - Experiment I
Treatment

Cell Number + SEM

0.1% DMSO Control

+ .28
3.3 5 -

X

10 5

+ .13
1.80 -

1.0 pM DEX

+ .11
2.48 -

X

10 5

+ .06
*1.37 -

0. 5 µM DEX

+ .26
2.68 -

X

10 5

+ .14
1.48 -

0.1 pM DEX

+ .22
2. 5 2 -

X

10 5

+ .13
*1.39 -

0.01 µM DEX

+ .14
2.94 -

X

10 5

+ .07
1.62 -

Po:gulation Doublings
+ SEM

* Significantly different from DMSO Controls (p < .0 5 ).
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Table 4. Effect of dexamethasone (DEX) on growth
characteristics of HUVEC (four day counts) - Experiment II.
The table illustrates the effect of DEX upon the cellular and
population growth of HUVEC in a four day growth assay. The
purpose of the experiment was to determine if growth
inhibition or enhancement occurred at an earlier time period,
an effect that might have been masked in a seven day assay.
Fourth passage HUVEC were plated in T-25 flasks at standard
density. On the second day after plating only, cultures were
fed with DEX dissolved in DMSO at the doses indicated. The
final concentration of the DMSO solvent in the DMSO control
and all treatment groups was 0.1%. Cells were harvested and
counted on the fourth day, two days after steroid
administration. The values represent the mean cell counts or
the corresponding mean population doublings of triplicate
flask determinations, given with the SEM. Although cellular
and population growth inhibition occurred, it was not
significant for the four doses of DEX employed. Again, there
was relatively less inhibition of growth with the lowest DEX
dose.

Table 4
Effect of Dexamethasone on Growth Characteristics of HUVEC
(Four Day Counts) - Experiment II
Treatment

Cell Number + SEM

0.1% DMSO Control

6.23 + .43 X 10 5

+ .11
2.16 -

1.0 pM DEX
0. 5 µM DEX

5 .17

-+ .84

10 5

+ .23
1.86 -

+ .31 X 10 5
4.77 -

+ .09
1.78 -

0.1 pM DEX

+ .21 X 10 5
4.74 -

+ .06
1.77 -

O.01 pM DEX

+ .34 X 10 5
6.16 -

+ .08
2.1 5 -

X
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PoQulation Doublings
+ SEM
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Table 5. Effects of dexamethasone (DEX) upon endothelial
cell cycle kinetics. The table illustrates the effect of
dexamethasone on the percent of cells in the various phases
of the cell cycle as determined by cytofluorometry. Second
passage HUVEC were plated in T-25 flasks at standard density.
On the second and fourth day after plating, cultures were fed
with DEX dissolved in EtOH at the doses indicated. The final
concentration of EtOH solvent in both the EtOH control and 1
pM DEX treatment group was 0.2%, and in the 0.5 pM DEX
treatment group, 0.1%. Cells were harvested and processed
for flow cytometry on the seventh day. DEX at 0.5 pM caused
an increase in the percentage of cells in the s phase, while
at a higher dose (1 pH), effected an increase in the
percentage of cells in the G2-M phase.

Table 5
Effects of DEX on Endothelial Cell Cycle Kinetics

Culture Treatment

Q2-M

Qo-G1

Q

49.6%

36.9%

13.5%

Control 0.2% EtOH

44.2%

40.1%

15.7%

0.5 pM DEX

25.2%

56.9%

17.9%

1 pM DEX

41%

34.9%

24.1%

Control
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Introduction
The aim of the present study is to explore the
possibility that there are differences regarding the
expression of in vitro senescence between male and female
cultures of human umbilical vein endothelial cells
(HUVEC).

The objective is to provide a clearer

understanding of the senescent process in this culture
system.

The fact that primary age-associated cellular

changes occur in the endothelium in vivo engenders
relevance to the study of cellular senescence in cultured
endothelial cells (EC) (Mueller et al., 1980).

The study

of the growth characteristics and proliferative life span
of EC in vitro may be related to diseases such as
atherosclerosis and metastatic cancer (Levine and Mueller,
1979).

Human EC are characterized by finite life spans

and low frequencies of spontaneous transformations (Levine
et al., 1983).

Altered proliferative or functional

capacities in aging endothelium would have very serious
consequences for the organism in question.

Since the

endothelium occupies a very unique and strategic location
within the body, it acts as a highly selective barrier for
substances entering and leaving the blood.

The

endothelium is an essential component in wound healing and
is the site of synthesis of a wide variety of
1
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metabolically active compounds (Levine et al. 1983).
Because of its distribution in practically all tissues,
the study of endothelial cellular aging can be said to
reflect a study of aging of the body as a whole.
This review is divided into four sections.

The

first section describes the results of studies which have
explored the phenomenon of endothelial cellular senescence
in vivo.

The second section outlines senescence of EC in

vitro, with emphasis on cultured endothelial cells as an
appropriate model for in vitro senescence.

The third

section details male-female differences in the endothelium
that may affect endothelial aging or the expression of the
senescent cell phenotype in experimental model systems.
The fourth and final section, a summary,

explores the

role of the endothelium in atherogenesis.
Endothelial senescence in vivo
The occurrence of large, multinucleated cells
characteristic of aging EC in cultures have in vivo
correlates and have been described by a number of authors
(Lautsch et al., 1953; Short 1954; McGovern 1955; Scott
1956).

Multinucleated giant cells were found in the aorta

of aging humans (Lautsch et al., 1953), over venous
intimal thickenings in aged humans (Short, 1953), and in
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the veins of aging rats (McGovern, 1955).

McGovern

regarded multinucleated cells as evidence of regeneration
following injury; cellular injury may play a role in
senescent cell expression in vivo.

These large cells were

uncommon, but could be found, in young human subjects,
indicating that they were not solely a phenomenon in aged
individuals.

It is plausible that senescent cells occur

in all persons, their number increasing as a function of
age.
Scott (1956) described multinucleated cells
overlying organized thrombi in vessel walls of humans.
Hicks et al. (1983), examining Fischer rats, reported an
increase in the cytoplasmic areas of EC, and an increase
in the cross sectional areas of the basement membrane.
Cell organelles may also undergo _changes with aging.
Miranov and Miranov (1985)

found that the aortic

endothelial cell cytoskeleton in rats became more highly
structured with aging, an adaptive reaction which
increased the intracellular contacts and cell adhesion to
the underlying substrate.

The functional ramifications of

this observation were not outlined.

Multiple factors,

including anatomical and hemodynamic differences,
influence the organization of the endothelial cell
cytoskeleton in situ (White et al. 1983).

4

Poole et al. (1958) mechanically injured the aorta
of young rabbits and found that within three days, large
cells, containing up to ten or more nuclei in their
cytoplasm, appeared in the edges of the denuded area.
They hypothesized that giant cells, with multiple nuclei,
represented a syncytium which failed to break up into
individual cells, the nuclei remaining in a conglomerate
within the center of the cells.
was not entirely clear.

Exactly why this happened

Lautsch et al. (1953) observed

that the nuclei tended to be grouped centrally within the
endothelial cell cytoplasm, and that two or more groups of
nuclei could be seen within the confines of one giant
cell.

Stehbens (1965), studying endothelial cell repair

following mechanical trauma to rabbit veins, found an
increased number of multinucleated EC in the region of
injury three days after the mechanical insult. In contrast
to the above, Reidy et al. (1983) measured regrowth in
denuded rat and rabbit arteries and reported that
endothelial cellular regeneration stopped before regrowth
was complete, and that cell senescence was not
responsible.
Aside from the knowledge that senescent cells occur
with greater frequency in aged individuals and that they
can be found in proximity to mechanically wounded areas of
the endothelium in vivo, little is understood regarding
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their significance and function.

The literature suggests

that these cells do play some role in the related
processes of senescence and repair.
Senescence in Cultured Endothelial Cells
The phenomenon of age associated cellular changes
that takes place in the endothelium in vivo makes the
study of cellular senescence in cultured EC particularly
relevant.

Cells in the body extend across a range from

rapidly and continuously dividing (epithelium, hemapoietic
cells) to fixed, post mitotic, highly differentiated
(neurons, muscle fibres).

Since the vascular endothelium

is an intermediate class of cells which exhibits a slow
turnover in vivo, cellular senescence in endothelial cells
might have unique characteristics and consequences for the
organism.
With repeated passage, cultured endothelial cells
(EC) undergo morphological and proliferative changes which
are similar in many respects to the changes observed in
aged or senescent EC in vivo.

The basic cause of the

senescent process in vitro is unknown, although Grove and
Cristafalo (1977) viewed cellular aging as being due to a
transition from a rapidly proliferating state through a
series of progressively slower cycling ones, to a
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condition in which the cells were arrested or were
proliferating so marginally so as to be incapable of
repopulating the culture vessel.

Whether the decline in

proliferating capacity is due to a uniform increase in the
generation time of the cells or to an increase in
heterogeneity in the culture (resulting in a mixed
population in which some cells divide normally, while
others are incapable of division) remains unknown.

The

latter theory, that of a mixed cell population, is
plausible on empirical grounds but has not been proven
definitively (Cristafalo, 1972).

Heterogeneity of the

cell population was supported by Schwartz et al. (1981),
who felt that the limitations to replicative lifespan
manifested in cell culture might have been a result of
random distribution of proliferative potential in the
culture, rather than a true limitation of the ability of
individual cells to have divided.
In general, all non-transformed cell cultures
undergo a natural history which includes three phases.
The first phase consists of the primary culture up to the
first confluence.

The second phase is characterized by

rather luxuriant cell growth necessitating subcultivation.
The third and final phase marks the period of cellular
aging, senescence, loss of growth potential, and eventual
cell death. (Haymark, 1976).

It is of interest that the
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transition between Phase II and Phase III may be rather
abrupt in EC in comparison to other cell lines fibroblasts, for example (Grove and Cristafalo, 1977).

A

limitation which must be kept in mind, however, in
evaluating aging, is the fact that all well-documented
reports of in vitro senescence are based upon paradigms
where subculturing is via enzymatic dissociation
(trypsin), which introduces a major source of artifact in
the experimental process (Ruben and Rafferty, 1978).
Cellular aging probably has multiple components, and in
vitro methodology should reflect, as best as possible, the
interaction of cells with hormones and other factors in
their environment, a process that occurs in vivo
(Cristafalo, 1976).
A number of researchers have documented the
expression of the senescent phenotype and lowered growth
rate with aging in various human and animal endothelial
cell cultures.

Mueller et al. (1980) found a replicative

life span of approximately 80 cumulative population
doublings (CPD) in BAEC; growth rates decreased and cell
size increased as the CPD increased.

Rosen et al.

(1981)

extended these studies and suggested that cellular
senescence in EC may contribute to the genesis of
atherosclerosis and the process of tumor invasion and
metastasis.
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Weber et al. (1984) studied cultured BAEC and found
that senescent cells appeared at approximately the eighth
passage.

The senescent cells were often multinucleated

and two to three times larger than regular EC; they had
vacuoles present in the perinuclear regions; and contained
giant or irregular mitochondria, abundant RER, and
occasional Weibel-Palade bodies.

The Weibel-Palade body,

a rod shaped cytoplasmic inclusion, is an endothelial
specific organelle and as such can be used as an
identifying marker for EC (Gimbrone, 1976).

The curious

longitudinal fibers observed running parallel to the long

axis of the, cell often bridged over the nucleus, these
fibers were hypothesized to be ''stress" fibers not related
to cellular motility (Weber et al., 1984).
Pursuant to this, it has been speculated that the
giant cells may form as a result of some type of repair
process, obtained through cell spreading.

The origin of

senescent cells was felt by Wright (1972) to be due to
mitosis occurring in some instances without cytoplasmic
division, giving rise to the giant multinucleated cells.
Either process might possibly explain the thin, veiled
cytoplasmic cords (see below) frequently seen in senescent
cells.

Duthu and Smith (1980), supporting

the findings

of Weber et al. (1984), remarked on the increase in the
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number of pinocytotic perinuclear vacuoles in EC in
confluent BAEC cultures, a phenomenon even more striking
in senescent cells.
Rosen et al. (1981) depicted senescent BAEC as
having

increased cellular areas and volumes, and

increased protein content.

Senescent cells, however,

qualitatively retained their ability to express Factor
VIII antigen, corroborating their earlier study (Mueller
et al., 1980).

A large proportion of their cells were

rapidly dividing until 75% of their life span was
completed; also at this point an increase in cell
attachment area paralleled a decrease in the number of

labeled nuclei in a (3HJ thymidine study.

However, the

cells still could achieve confluent monolayers until 90%
of their life span was completed.

Bierman and Schwartz

(1984) documented increased binding and degradation of low
density lipoproteins in BAEC, and suggested that this
finding played a role in arterial wall changes that
occurred with age in vivo.

There was a gradual decrease

in glycosaminoglycans and collagen in cultured porcine EC
with age

(Bihari et al. 1981).

Bowersox and Sorgente (1982), studying the
chemotactic response of BAEC to fibronectin and
endothelial cell mitogens, such as endothelial cell growth
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factor (ECGF) and tumor extracts,

demonstrated that cells

from later passages (i.e. after 15-16 in vitro
subculturings), were less responsive to chemotactic
stimulation when compared to early passage cells. Johnson
& Longenecker (1982) described senescence in BAEC; the
onset of Phase III in these cells could be delayed if the
cells were maintained under fibroblast growth factor (FGF)
dependent conditions.

They believed that in vitro studies

should focus on a cell type which begins its cultured life
span expressing its differentiated phenotype and which
also is known to be involved with an age-related pathology
in vivo.

HUVEC meet these criteria.

Although most studies of in vitro senescence have
been performed on BAEC, current perspective has included
the exploration of senescence in human endothelium in
culture as well.

The question of whether cellular density

at plating may be a factor in the senescence of human
endothelial cell cultures was raised by Glassberg et
al. (1982) who cultured human iliac artery EC and reported
that the cells became senescent and lost viability after
8-10 passages when passed at a 1:3 split ratio.

According

to Cristafalo (1976), there is a tendency for HUVEC to
grow differently and senesce at different rates depending
on the split ratio at passage (1:5 vs. 1:10 split ratios,
for example).

Cells passed at a greater density (i.e., a
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lower split ratio) may be affected by contact inhibition
and not proliferate as rapidly as cells passed at a
somewhat lower density (Maciag et al., 1981).
culture, the "split ratio"

In cell

used in passage procedures

could effect the total number of population doublings
achieved in a given assay.
Duthu and Smith (1980), in examining culture
conditions for BAEC, found that the effect of FGF upon
cell proliferation in BAEC was inoculation density
dependent.

The cell division rate was significantly

increased at inocula less than 1 x 10 4 cells/cm 2 , but
there was no effect at higher densities.

Glassberg et al.

(1982), in comparing HUVEC to iliac artery EC, felt that
species differences regarding growth and function might be
more apparent than differences between arteries and veins,
or diversities between adult and newborn vessels.

Since

it is possible to correlate the replicative ability in
HUVEC cultures with cell density at the time of plating
(Henriksen et al., 1975), this parameter is also important
in examining the growth patterns and senescent expression
in HUVEC.
Mayurna (1963), the first author to report the
isolation of HUVEC in culture, described many binucleated
and multinucleated cells in his primary cultures.
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Although not all binucleated EC in culture are senescent
cells, the majority of the multinucleated cells do exhibit
the characteristics of the senescent phenotype.

Fryer

(1966), in an early discussion of "atypical cells" in
HUVEC, described large, circular, sometimes multinucleated
cells, that increased in number with increasing age of the
culture.

The cells contained abundant fat droplets, and

showed a greater affinity for india ink stain than normal
EC.

Gimbrone et al. (1973) mentioned a morphologically

distinct subpopulation of large cells in HUVEC,
occasionally multinucleated, which could be separated from
certain primary cultures.

Maciag et al., (1981) described

the occurrence of large, multinucleated senescent cells in
HUVEC, adding that they were occasionally found in primary
cultures.
This senescent phenomenon can be observed repeatedly
in long term culture of HUVEC.

It is of interest that

similar, large senescent veiled cells have been observed
in the edge of intimal lesions and in the aorta of aging
humans (Haudenschild et al., 1975).

These authors wrote

of large multinucleated "veil'' like cells seen in their
cultured HUVEC, starting after the second passage.

In

senescent cells, the cytoplasm takes on a curious webbed
appearance; cytoplasmic spokes will appear to extend from
the nucleus(i) in radial fashion, much like broad spokes
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on a wheel.

Senescent cells are commonly

five to ten

times larger than typical EC in culture, contain fewer 6070 A filament bundles in the cell periphery, and lack
specific endothelial granules, or Weibel-Palade bodies
(WPB) (Haudenschild et al., 1975).

Gimbrone et al.

(1973) rendered an account of cells significantly larger
than normal HUVEC, lacking WPB, but containing cytoplasm
filled with myofibrillar elements and fusiform densities.
Another in vivo correlation was provided by Weber et al.
(1984), who remarked that while the arteries of children
were covered by a homogeneous sheet of small to medium
sized EC, adult arteries displayed a polymorphic luminal
surface due to the presence of large, giant EC which
tended to accumulate in areas of repeated endothelial
injury or high cell turnover.
Gospodarowicz et al. (1978), studied HUVEC and
corroborated the earlier descriptions of senescent cells
in these cultures, noting that the use of FGF and thrombin
in the culture media could prevent precocious senescence.
They noted that in the umbilical veins, the vascular cells
may be pre-programmed to senesce rapidly after birth,
although there was no evidence that the expression of
senescence in culture differed as a function of the
different sources of origin of cells, or among species.
In conclusion, Gospodarowicz et al. (1978) warned that
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studies performed on cell populations with excessive
senescence might lead to misleading conclusions regarding
the actual capability of the cells in reference to the
function or behavior in question.
Grinspan et al. (1981) further characterized the in
vitro senescence of human umbilical vein endothelial cells
(HUVEC) in culture.

After continued subculture, the

proliferation rate of EC slows and harvest cell densities
decrease.

Morphological changes ensue which are typical

of in vitro senescence: cells become larger and have an
increased
area

cytoplasmic to nuclear ratio; the attachment

of individual cells increases; and large,

multinucleated cells with veil-like cytoplasm appear in
the culture.

They also raised the question of whether

culture life span was limited by the number of cell
division (genomic time) or by a fixed amount of
chronological "metabolic" time.

Since a wide variety of

human tissues of fetal, neonatal, or adult origin are
incapable of unlimited proliferation, it has been thought
that the phenomenon of limited life span must be
programmed in some way.

In addition, Cristafalo (1972)

felt that the aging of fixed post-mitotic cells (i.e.
neurons) quite probably proceeds by a different mechanisms
compared to that observed in proliferating tissues (i.e.
epithelium).

What remains obscure is the relationship, if
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any, between the observed programmed limit of population
doublings for a particular cell line, and the actual
events that limit cellular functions during senescence in
vivo.
Evidence for a pre-programmed process of senescence
can be found in HUVEC.

Subcultures of HUVEC tended to

exhibit increasing pleomorphism of cells, with increased
numbers of veil-like cells.

Also, the tendency to form

confluent monolayers was decreased with cell passage
(Maciag et al., 1981).

Although the large, multinucleated

cells typically appeared in greater numbers in later
passages of EC (Haudenschild et al., 1975),

the fact that

large veil-like cells can occasionally be found in primary
HUVEC cultures suggests that senescence of EC is a
preprogrammed event.
Knaver and Cunningham (1983) grew HUVEC on a
fibronectin matrix, using ECGF to potentiate the growth of
the cells.

They found that there was a change in the

gross morphological appearance of the cells between early
and late passages; cells in the latter were larger in size
and more irregular in shape.

They estimated the incidence

of multinucleated "veil" cells as comprising one to two
percent of cells in early cultures and 10-12% of the total
cells by passage 16.

It was suggested that in all culture
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systems, there were deficiencies which resulted in the
gradual decrease in the differentiated state of the
culture.
That the substratum-matrix upon which cells grow in
culture can be an integral factor in determining
proliferative rates of EC was underscored by Furcht et al.
(1986) who found that there were different substratum
requirements for microvascular EC and large vessel EC.
This differential phenotypic behavior of EC from different
sources regarding their response to matrix or basement
membrane components exemplifies the fact that many factors
are influential in promoting or inhibiting endothelial
cell growth in culture.

However, the suggestion that

basement membrane components may modulate the cellular
phenotype of the endothelial cell indicates the
possibility of these entities influencing the expression
of senescence in some way.

Cristafalo (1972) hypothesized

that the many and varied environmental effects by which
the cell life span could be influenced were superimposed
on an existing program for a preset life span, thus
perhaps modifying its duration, but in the end, not its
ultimate disposition.
Maciag et al. (1981) carried HUVEC cultures through
34 population doublings, but not to the end of their life
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span.

He was one of few authors to attempt a quantitative

assessment of senescer.t cells in HUVEC.

starting in the

eighth passage, giant, multinucleated cells with broad,
veil like cytoplasm appeared in culture.

Their initial

density was one/10 3 cells, but by the fourteenth

passage,

they increased in number, achieving a density of one/10 2
cells.

The authors called for detailed studies of

cellular senescence in HUVEC, to see if EC growth rates
indeed did decline at later stages, as did the doubling
rates of adult (Schwartz, 1978) and fetal (Rosen et al.,
1981) bovine aortic endothelial cell cultures.
Kan et al. (1985), using fibroblast conditioned
medium, cultured HUVEC through 50 population doublings but
did not specifically address the senescence phenomenon.
In this study, medium conditioned from human diploid
fibroblast cultures markedly enhanced the division of
HUVEC at low seeded density.

They defined the end of a

proliferative life span as that cumulative population
doubling at which the EC density did not double beyond the
inoculation density ( 2 x 10 4 cells/ 3 5 mm dish) after two
weeks.

Rosen et al. (1981) suggested three weeks at the

above inoculation density as a criteria for judgment as to
when "end of life span" ensues.
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In summary, quantitative assessment of in vitro
senescence in EC has not been comprehensively reported in
the literature.

Many studies regarding endothelial

cultures pool the results from numerous cell passages,
although it has recently been demonstrated that there is a
significant variability in properties of and growth
characteristics during in vitro propagation (Goldsmith et
al., 1984).

This variability should be entertained when

exploring properties of subcultured endothelium.
Male-Female Differences in EC
Exploring the male-female differences in growth and
senescence of HUVEC is of strong relevance, since no
studies have addressed this aspect in vitro.

Balconi et

al. (1983) examined factors which affected success rates
of primary HUVEC cultures; the sex of the newborn did not
significantly influence the successful establishment of
primary cultures of HUVEC.

Unfortunately, secondary and

later passage cultures were not studied.
On a functional level, male HUVEC synthesized more
PGI2 and PGE2 than female HUVEC when the cells were

stimulated with thrombin (Batres and Dupont 1986).

The

sex steroids 17 beta estradiol and testosterone were found
to stimulate PGI2 secretion in female, but not male,
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piglet EC in culture (Seillan et al., 1983).

In addition,

female, but not male EC could convert testosterone into
the estrogens estriol, estrone, and estradiol.

The fact

that 17 beta estradiol induces stimulation of the
production of PGI2, which inhibits platelet aggregation,
could provide a partial explanation

for the beneficial

role generally attributed to naturally occurring estrogens
in preventing cardiovascular diseases (Seillan et al.,
1983).

Lennon and Poysner (1986), studying the effect of

age on the vascular prostaglandin production in male and
female rats, found that PGI2 production decreased in males
and in aged rats, and linked this process to the

difference in vascular disease incidence in males and
females.

Cunard et al. (1986) outlined the response of

ring pulmonary artery preparations to the synthetic
endoperoxide analog U46619, and reported that in denuded
vessels, a significantly lower U46619-elicited maximum
tension occurred in female vs. male rat preparations.
Nordoy et al. (1978) studied the inhibitory effects
of a monolayer of HUVEC and PGI2 upon platelet

aggregation, and found less of an inhibitory effect of a

monolayer of HUVEC or PGI2 upon ADP or collagen induced
platelet aggregation in females than males.

Karanian et

al. (1981) studied whole thoracic aorta preparations in
the rabbit and rat and found that the maximum contractile
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response to various prostaglandins was greater in male
specimens than female specimens; prostaglandin receptors
in the thoracic aorta appeared to be gender related.

A

further link to gender differences in incidence and
expression of cardiovascular diseases could be made if
additional studies indicated parallel gender differences
in the growth and senescence of endothelial cells.
It is believed that exposure of the vascular
endothelium to increases in shear stresses, as typically
occurs in hypertension, creates an increased demand on the
normal cellular mechanisms involved in anchorage of the
cells to the substratum.

These cellular mechanisms

include microfilamints containing both actin and myosin;
these "stress fibers" are seen much more frequently in
arterial, rather than, venous, endothelium (White et al.
1983).

These authors reported that the proportion of EC

containing stress fibers in the descending aorta was
significantly greater in males vs. females in both normal
and spontaneously hypertensive rats.

Also, in male rats,

the stress fibers were thicker and had more prominent
striations.
Male/female differences in senescent phenotypic
expression have not been studied previously.

Experiments

examining gender differences in HUVEC regarding in vitro
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senescence will augment the knowledge of the aging process
of male and female EC in this culture system.

Also, it

seems likely that continued experimentation with EC in
vitro will suggest pertinent questions to be asked
regarding in vivo pathologies, and serve as a ground for
exploring methodology that can be used in answering these
questions.
The Role of EC in Atherosclerosis
Age related changes in the endothelium lining the
blood vessels are believed to be significant events which
are integral in the expression of two major pathologic
processes: atherosclerosis and tumor invasion and
metastasis (Mueller and Levine 1979; Grinspan et al.
1981).

It is well known that the incidence of

atherosclerosis and thrombosis is higher in males than in
females (Batres and Dupont 1986).

Atherosclerotic lesions

tend to occur more frequently in hypertensive individuals,
and in areas of the vascular system subject to hemodynamic
stress, such as the aortic bifurcation (Clarkson et al.,
1985).

Sauer et al. (1981) described the age-related

intimal alterations, including endothelial cellular
changes, in spontaneously hypertensive rats.

They

demonstrated a proliferation of organelles in EC, most
notably in Weibel Palade bodies, in contrast to previous
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in vitro findings {Haudenschild et al. 1975, Weber et al.
1984a).

Haudenschild et al. (1981) compared intimal

changes in normal, spontaneously hypertensive, and
deoxycortisone/salt treated rats and found the latter two
groups to exhibit an overall increased number of EC, and
to contain a greater number of EC with bizarre shapes,
nuclear folding, and nuclear bulging toward the lumen.
These changes were observed in aged normotensive animals,
but to a lessor extent and with slower progression.
Scannning electron microscopy of these changes revealed EC
with a raised appearance and irregular surfaces.
Ross and Glomset (1976) in a detailed two part
report outlined the then current theories of the
pathogenesis of atherosclerosis.

They described the early

lesion of atherosclerosis as being the fatty streak, a
focal accumulation of smooth muscle cells {SMC) surrounded
by lipid deposits.

Macrophage derived foam cells were a

major constituent of this early pathological entity.
These fatty streaks come to cover a significant percentage
of the intimal surface as a person ages.

The fibrous

plague, a more advanced lesion, consisted of an
accumulation of intimal, lipid laden SMC and collagen,
elastic fibers, and proteoglycans.

This fibrous cap

covered a large, deeper deposit of free extracellular
lipid and cellular debris.

Long standing lesions were
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characterized by fibrous caps altered by hemorrhage,
calcification, and mural thrombosis.
The role of EC in this process was unclear, but some
role indeed was entertained, since the endothelium
separates the blood from the endothelial substratum and
underlying connective tissue, the latter areas known to be
involved in the development of the atherosclerotic
pathology.

Ross and Glomset (1976), in implicating the

vascular endothelium, were among the first authors to
propose the endothelial cellular injury hypothesis as a
major event leading to atherosclerotic lesion
manifestation.

Basically, areas in the vessel wall,

subject to the mechanical stresses of hypertension and
the proposed desquaminative effects of hyperlipidemia,
were subject to endothelial barrier disruption.

Platelets

adhering to the subendothelial connective tissue at the
sites of injury released a factor which was capable of
promoting the proliferation of SMC.

Eventually, a fatty

streak developed, and the cascade of events leading to the
full blown clinical presence of the atherosclerotic plaque
ensued (Ross and Glomset, 1976).

EC of the vessel wall

were thought to exhibit diminished activity with aging,
eventually affecting the endothelial barrier by reduced
reparative ability.

The injury theory of plaque formation

lent support to the additional hypothesis that endothelial
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injury occurred more frequently and/or was repaired less
efficiently or completely with increasing age (Levine et
al. 1983).

The older an organism, the much more likely it

was that a significant degree of endothelial injury had
been sustained.
The theory came to be refined as knowledge
concerning the contributing factors increased.

Basically,

an undefined injury to the endothelium led to
desquamination of EC, which exposed the thrombogenic
basement membrane to the circulating blood.

Platelet

adhesion and degranulation were subsequent to release of
platelet derived growth factor, mitogenic and chemotactic
for SMC.

It is of interest that a dying endothelial cell

can produce in less than three days as much PDGF- like
proteins as a healthy cell can produce over a 19 day
period.

It would appear, then, that denuded, dying EC

would hasten or enhance growth factor release from
platelets, thus accelerating the process of proliferation
and infiltration of SMC.

After intimal proliferation of

SMC, the cascade of processes then continues through lipid

accumulation and macrophage infiltration, combining to
form the well characterized atherosclerotic plaque
(DiCorleto and Chisolm 1986).
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Levine and Mueller (1979) felt that injury to the
endothelium increased vessel permeability, allowing
extravasation of potentially atherogenic macromolecular
substances into the arterial wall.

Even subtle injury

might promote an increase in transendothelial pinocytosis,
thereby transporting atherogenic substances into the
subendothelium.

Also, endothelial cell injury apparently

occurred more frequently and/or was repaired less
efficiently with increasing age.

White et al. (1983)

proposed that the prominent microfilament bundles (stress
fibers) observed in the aortic endothelium of hypertensive
rats might play a part in cell contractility, thereby
possibly affecting this altered vessel wall permeability.

It was observed by both Lautsch et al.

(1953) and

Haudenschild et al. (1975) that large senescent cells
occured in the edge of intimal lesions of the vascular
system and in the aortas of aging humans.

Raised levels

of cortisol in the plasma correlated with an increased
risk of coronary heart diseases (Jarvelainen et al. 1982).
It was thought that cortisol acted neutrally or in a
protective manner, attenuating endothelial cell effects
upon SMC growth.

In lesions already induced by other

factors, it was believed that cortisol accentuated the
atherosclerotic process due to increased formation of
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connective tissue macromolecules in the SMC.

Thus EC may

play an indirect but vastly significant role in the
development of this pathological lesion.

However, that an

intact endothelium was active in regulating proliferation
of SMC was proposed by Willems et al. (1982), who
described the inhibitory effect of media conditioned by
confluent HUVEC monolayers upon smooth muscle cell and
endothelial cell (3H] thymidine incorporation.

Apparently

then, HUVEC possess growth inhibitory activity which
inhibits DNA synthesis and proliferation in EC as well as
SMC.

Their findings also lend support to the theory that

substances released by confluent EC may contribute to the
density dependent regulation of endothelial growth that
has been observed by scientists studying EC in culture.
However, it became obvious that not all features of
the atherosclerotic lesion could be explained by the
reaction-to-injury hypothesis (Thorgeirsson and Robertson
1978).

For example, it would be presumptive to conclude

that endothelial cellular replication results simply from
the disruption of the normal cell-cell contact.
Endothelial cellular mutation leading to altered growth
patterns may occur spontaneously or perhaps be genetically
influenced- other concepts that should be entertained in
exploring factors which may influence endothelial behavior
in atherosclerosis.

Also, although endothelial cell
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replication may be increased in response to hypertension
or hyperlipidemia, this does not automatically imply areas
where the endothelium has become denuded (Schwartz et al.
1981).

A critical period or degree of denudation, and

unique or characteristic location of the denudation injury
may also be factors involved.
Schwartz et al. (1981) remarked that there was no
convincing evidence that excessive growth of the
endothelium contributed to the atherosclerotic lesions.
That the endothelium partakes in some way in the process
was evident in the fact that platelet derived, endothelial
cell derived, and macrophage derived growth factors could
all stimulate the growth of SMC.

Schwartz et al. outlined

three ways in which endothelial cellular functions could
lead to the proliferation of SMC: either by altered
transport, altered platelet interactions, or altered
control of the production and release of growth factors.
Interestingly, though, it is not known whether the
endocytotic process observed in cell culture of EC is the
same as the mechanism involved in the transport of LDL
across the vessel wall in vivo.
DiCorelto and Chisolm (1986) admitted that although
the response to injury hypothesis of atherosclerotic
lesion development had a marked influence regarding
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atherogenesis, evidence had not been produced convincingly
that frank denudation of the endothelium occurs as an
early event in atherogenesis.

They contended that only in

advanced plaques had regions of vessel wall without
endothelium been identified morphologically, and that
endothelial denudation by itself could not be used to
identify an early vascular wall lesion.

They hypothesized

an attractive theory that called for an active role of EC
in atherogenesis.

In an activated state, EC could express

binding sites for monocytes; secrete monocyte activators;
secrete oxygen free radicals which could conceivably
modify surrounding LDL; and finally synthesize and secrete
a PDGF-like protein or other mitogens and chemoattractants
for SMC in the media of the vessel.

Since not all

mitogens secreted by EC have been identified, it is rather
clear that the endothelial injury hypothesis will undergo
further modification as research unfolds in this area.
Ross (1986) later modified his approach to the
injury hypothesis of atherosclerosis.

He felt that

cultured endothelium was a useful yet limited model of
endothelium in vivo.

However, cultured confluent

endothelial models have a low but definite rate of
turnover, which may approximate the state of "injury" in
vivo.

Ross proposed that EC in vitro may be in an

abnormal or "injured" state, and were continuously
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stimulated to form and secrete growth factors, including
PDGF.

It was further postulated that in its subtle form,

injury to the endothelium might cause no morphologic
alterations in EC, but might be sufficient to stimulate
the cells to form and secrete growth factors.

In the in

vivo lesion, chronic repeated bouts of injury might cause
EC to proliferate repeatedly at the edge of intimal
lesions, eventually undergoing senescence.

Whether these

senescent cells release mitogenic substances or other
factors more readily or efficiently is not known, but is
an interesting speculation in the pathogenesis of
atherosclerosis.
Glagov et al.

(1987) emphasized that a variety of

tissue responses occurred within atherosclerotic lesions.
They stressed the fact that the endothelial transport
system may undergo modification, making transport of LDL
and other substances facilitative in atherogenesis
development.

There was no evidence that there was

microinjury of the endothelium at sites of lesion
formation; only when the atherosclerotic lesions became
large did the overlying endothelium demonstrate
intercellular separations or perforations with focal
bridging.

Also, plaques tended to occur in zones of

relatively low flow velocity, where flow fields were
complex, and reversed during the cardiac cycle.

Perhaps,
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they felt, the "low•• flow could favor transendothelial
transfer of atherogenic substances into the arterial wall,
and such interactions in the presence of an otherwise
morphologically intact endothelium, rather than one with
focal desquamination, could be major factors in lesion
development.

Finally, Reidy et al. {1987) removed zones

of aortic rat endothelium with a thin, flexible nylon
catheter, and found no replication of medial SMC and no
intimal thickening underlying the mechanical denudation
sites.

Additional studies along these parameters will

illuminate the many factors involved in atherosclerotic
plaque progression.
In summary, large, senescent multinucleated EC have
been described in both in vivo and in vitro experimental
systems, but their exact significance and role in normal
or pathologic processes has not been established.

Since

these senescent cells are associated with atherosclerotic
lesions in humans and animals, and have been found with
increasing frequency with aging in both in situ and
culture conditions, their relevance to aging and systemic
changes in the vascular tree needs further clarification
and definition.

Also, due to the pronounced differences

in incidence and severity of atherosclerotic disease in
males and females, basic gender differences may play some
role.

Materials and Methods
Experimental Methodology
Culture of HUVEC.

Harvest of EC from umbilical cord veins

was based on the method of Gimbrone et al. (1974).

Term

umbilical cords were obtained from the Department of
Obstetrics and Gynecology at the Medical College of
Using sterile technique, unclamped umbilical

Virginia.

cord segments at least 10 cm. long were cannulated at both
ends using one-way stopcocks and the blood flushed by
perfusion of 200-400 ml. of phosphate buffered saline
solution (PBS- pH 7.2).

The lumen of the vein was filled

with 0.1% collagenase (Clostridium histolyticum, type I,
Sigma Chemical Company, St. Louis, MO) in PBS with calcium
and magnesium [CaC12 (anhyd), 0.10 gm/L, and Mgcl2·6 H2o.

0.10 gm/LJ, and the stopcocks closed.

The cord segment

was then incubated in a bath of PBS at 37 degrees C for 15
minutes.

The collagenase solution was collected in a

conical centrifuge tube with an equal volume of Hank's
Balanced Salt Solution (HBSS) without calcium or
magnesium.

The EC were then pelleted by centrifugation at

200 x g for 5 minutes.
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Defined fetal bovine serum (FBS, Hyclone
Laboratories, Logan, UT) was used.

Other media and

reagents were from Gibco Laboratories (Grand Island, NY)
or Meloy Laboratories (Springfield, VA).

The pelleted EC

were resuspended in complete Medium 199 (CM 199)
containing

Earle's Salts, L-glutamine, 100 U/L

penicillin, 100 pg/ml streptomycin, 0. 2 5 y.g/ml Fungizone,
2 0%

FBS, 90 µg/ml heparin (sodium salt, grade 1, from

porcine intestinal mucosa, Sigma Chemical Co., St. Louis,
MO), and
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ug/ml endothelial cell growth factor (ECGF,

tissue culture grade, Meloy Laboratories, Springfield, VA
or a generous gift from Dr. Thomas Maciag of the American
Red Cross, Rockville, MD).

Thornton et al. (1983) have

described the use of such concentrations of ECGF when
heparin is used in the medium, the heparin potentiating
the effects of the ECGF.
coated T-25 flasks.

Cultures were grown in gelatin

Gelatin (0. 2 % wt/vol) promotes the

attachment and growth of HUVEC (Gordon et al., 1983;
Folkman et al., 1979; Thornton et al., 1983; Walker et
al., 1984).

Except for periods of time when passing or

other experimental manipulations were being performed,
cultures were incubated continuously at 37 degrees C in a
humidified atmosphere of 95% air, 5%
Identification of HUVEC.

co 2 .

The endothelial nature of the

cultured cells was determined by observing the typical
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"cobblestone" morphological appearance of the monolayer
when viewed under phase contrast microscopy (Nikon
Inverted Phase Contrast Microscope, Model M}, and by
irnrnunofluorescent staining for the factor VIII antigen.
Staining for factor VIII antigen was performed on selected
confluent cultures.
Identification of Senescent HUVEC.

Senescent EC were

readily identified by their morphological appearance under
phase contrast microscopy.

Using a 200 x magnification,

senescent cells demonstrated large cytoplasmic areas
(larger than non-senescent EC) and a thin, veiled
cytoplasm.

Senescent cells were often multinucleated, the

nuclei clustering centrally.

Senescent HUVEC frequently

displayed indistinct borders under phase constrast
microscopy.

If a particular mono-nucleated cell was

equivocal concerning size, the presence of veiled
cytoplasm
senescent.

was the criterion upon which a cell was judged
Text Figures 1 and 2 demonstrate senescent

cells in female and male cultures respectively.
Fixation of EC.

At selected times after plating,

depending on the experimental paradigm, cultures were
fixed using the following procedure.

After removal of the

medium, the cells were washed twice in fresh PBS (pH 7.2)
with calcium and magnesium in order to remove the residual
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Text Figure 1. C57 PlO. This contrast photomicrograph shows
female HUVEC in the tenth passage. Primary cultures of
female HUVEC were passed at a 1:10 split ratio for the first
three passages. Starting with the fourth passage (P4), the
cultures were passed at a 1:5 split ratio. The cells are in
a typical swirled configuration, showing darkened, granular
cytoplasm, with paler nuclei and prominent nucleoli. Cells
still formed a crowded swirled monolayer seven days after the
tenth passage. x 260.

Text Figure 2. C58 PlO. This phase contrast photomicrograph
shows male HUVEC in the tenth passage. Primary cultures of
male HUVEC were passed at a 1:10 split ratio for the first
three passages. Starting with the fourth passage (P4), the
cultures were passed at a 1:5 split ratio. The cells
demonstrate changes typical of in vitro senescence, with
increased cellular size, larger cytoplasmic/nuclear area
ratio, a greater accumulation of peri-nuclear cytoplasmic
granules, and veil-like cytoplasm. A characteristic
multinucleated veiled senescent cell can be seen (arrow) with
its large area and "spoke wheel'' cytoplasmic cords extending
radially from the nuclei to the cell border. At seven days
after the tenth passage, the monolayer is less crowded and
swirled in appearance when compared to tenth passage female
HUVEC. (Text Figure 1). x 260.
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serum containing medium.

Each flask was washed

individually and then immediately fixed, as PBS caused
cells to round up and detach if left on the cells after a
few minutes.

After each flask was washed, 2.5%

glutaraldehyde in O.lM Na cacodylate buffer (pH= 7,3) was
added, and the flask was incubated at room temperature for
one hour.

After incubation, the glutaraldehyde fixative

was removed and the flasks were rinsed once with 0.1 M Na
cacodylate (pH= 7.3) containing 7% sucrose.

The cultures

were then stored in the sucrose cacodylate buffer at 4
degrees

c until further processing and evaluation were

undertaken.

Selected fixed flasks were photographed under

phase microscopy using 35 mm Pan X film and a Nikon EFM
camera system.
Assessment of Male-female senescent patterns.

To assess

male and female senescent patterns, selected male-female
culture pairs from the same desired passage were grown for
seven days and fixed as described above.

In certain

cases, cultures were fixed at four days after passage.
Cellular counting to determine the percentage of veiled
(senescent) cells was done with the aid of a 25 cm 2 etched
glass plate aligned to the bottom of the culture flask.
The glass plate divided the culture surface of the flask
into 25 separate squares, each measuring one square
centimeter.

In order to eliminate experimental bias
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during flask evaluation, counting was performed using a
single blind method.

The flasks were coded by someone

other than the evaluator after identifying labels were
removed from the flask.

In this way, the origin, gender,

and passage number of the cells were unknown to the
evaluator during the counting process.

The experimental

code was not broken until all flasks from a particular
experiment had been evaluated.
Cellular counting was performed with the aid of an
ocular grid in combination with a lOx widefield ocular and
a 20 x objective lens on a Nikon binocular phase contrast
microscope.

With this 200x magnification, the area

encompassed by the grid was 0.117649 sq. mm.

Sixteen grid

areas per flask, within 16 of the 25 large (1 cm 2 squares,
were evaluated

(please see the Senescent Data Assessment

Form in the Appendix).
cells were counted (S).

Within all 16 grids, all senescent
In four of the sixteen grids

(grids 1,6,11,and 16), all non-senescent cells were
counted (N) and multiplied by a factor of four (4N).

The

total number of cells (T) in the 16 grids was estimated as
4N +

s.

The percentage of senescent cells was equal to

the sum of senescent cells in the 16 grids divided by the
total number of cells in the grids, or S/T x 100.

From

this information, the cellular density of the flask
(number of cells per cm 2 ) was calculated.

By multiplying
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cellular density by the percentage of senescent cells, the
senescent cell density was derived.

For each flask at

each passage, the data were expressed according to the
following three parameters: the percentage of senescent
cells, the senescent cellular density, and the total
cellular density.

Experimental Designs
Effect of Culture Gender on Senescent Expression and
Passage Number (1:5 split ratio).

In order to determine

the effects of gender and passage number on the percentage
of senescent cells and cellular density, three different
male-female culture pairs were used.

Each male-female

culture pair was begun on the same day.

The culture pairs

were fed with CM-199 every two or three days and passaged
on a weekly basis at the split ratios indicated below.
Beginning at selected passage numbers, cultures from the
male-female culture pairs were fixed on the seventh day
after passage and the percentage of senescent cells in the
cultures determined as described above.

Cellular density,

i.e. the number of cells per square centimeter, was also
determined.

The male-female differences, if present, were

also related to the cell passage number, so that variation
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in the amount of senescence could be determined as the
culture increased in age.
The C 57(F) - C 58(M) culture pair (Pair I) was
passed at a 1:10 split ratio through the fourth passage
(Pl-4).

Beginning with P5, the cultures were passed at a

1:5 split ratio.

The rationale for the early passage at a

higher split ratio lay in the fact that premature
confluence and overcrowding ensued if primary and early
passage cultures were passed at a 1:5 split ratio.

At

each passage for Pair I, four or five female and four or
five male flasks were plated, and the cultures refed with
CM 199 every two or three days.

On th� seventh day after

plating, a male and female flask were selected to continue
the cell line and passed at the desired split ratio.

The

cultures were carried in this manner through the twentieth
passage.

Beginning with PlO and continuing through P20

inclusive, a male and a female flask from each passage
were glutaraldehyde-fixed weekly on the seventh day after
plating and stored in sucrose-cacodylate buffer at 4
degrees

c and subsequently evaluated for senescent

expression.

Thus, the three parameters of senescence

expression (percentage of senescent cells, senescent
cellular density, and total cellular density) for each of
22 flasks (11 female and 11 male) from 11 passages (Pl020 inclusive) comprised the data for C 57(F) and

c 58(M).
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The primary cultures of the Pair II, c 59(F) and C
60(M) were passed weekly at a 1:10 split ratio through the
third passage (Pl-P3).

Beginning with P4, the cultures

were passed weekly at a 1:5 split ratio.

The cultures

were fed with CM 199 every two or three days.

The culture

pair was continued in this manner through the nineteenth
passage.

Beginning with P9 and continuing through P19

inclusive, a male and female culture from each passage
were glutaraldehyde fixed weekly on the seventh day after
plating, stored in sucrose cacodylate buffer at 4 degrees
C and subsequently evaluated for senescent expression.
The three parameters of senescent expression for each of
22 flasks (11 female and 11 male) from 11 passages (P9-19
inclusive) comprised the data for C 59(F) - C 60(M).
In order to assess senescent expression in HUVEC at
an earlier point in the culture life span, the primary
cultures of Pair III, C 63(F) and C 64(M), were passed
weekly at a 1:10 split ratio through the third passage
(Pl-P3).

Beginning with P4, the cultures were passed

weekly at a 1:5 split ratio.

Cultures were fed with CM

199 every two or three days.

The culture pair was

continued in this manner through the ninth passage.
Beginning with Pl and continuing through P9 inclusive, a
male and female culture from each passage were
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glutaraldehyde fixed weekly on the seventh day after
plating, stored in sucrose-cacodylate buffer at 4 degrees
C and subsequently evaluated for senescent expression.
The three parameters of senescent expression for each of
the 18 flasks (nine female and nine male) from nine
passages (Pl-9 inclusive) comprised the data for Pair III.
Effects of Culture Gender and Passage Number on Senescent
Expression (standard density).

In order to determine the

effects of gender and passage number on senescent
expression in HUVEC plated at standard density (1.25 x 10 5
cells/flask), a male female culture pair (C 67(F) and C
68(M)) was begun on the same day.

The primary cultures of

this pair were trypsinized and passed at standard density
at seven days.

At weekly intervals, one male and one

female culture per culture pair were used to plate flasks
at standard density for each succeeding passage.

Passage

was repeated until terminal senescence, defined as failure
of the cultures to double in population in seven days.
Beginning with P2 and continuing through P16 inclusive, a
male and a female flask from each passage were
glutaraldehyde-fixed on the seventh day after plating,
stored in sucrose buffer, and then evaluated for senescent
expression.

The three parameters of senescent expression

for each of the 30 flasks (15 female and 15 male) from 1 5
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passages (P2-16) comprised the data for this phase of the
study.
In the above experiments, when the flasks were fixed
at seven days after plating, most of the cultures so
evaluated tended to be confluent or subconfluent,
especially in earlier passages.

Since crowding may affect

the number of senescent cells in a given culture, it was
decided to evaluate male and female cultures at five days
after plating.

In order to assess senescent expression at

this earlier time, the same male-female culture pair (C
67(F)

-c 68(M)) was used.

Beginning with P2 and

continuing through P14, a male and female culture from
each passage were glutaraldehyde-fixed weekly on the fifth
day after standard density plating, stored in sucrose
buffer, and subsequently evaluated for senescent
expression.

The three parameters of senescent expression

for each of the 26 flasks (13 female and 13 male) from 13
passages (P2-14 inclusive) comprised the data for the five
day assessment.

Enough culture flasks were plated at

standard density each week to run both the five and seven
day assessments concurrently.
Effect of Plating Density on Senescent Expression.

It has

been our observation that cultures plated at a 1:10 split
ratio actually showed more sustained proliferative ability
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In order to maintain

than those passed at a 1: 5 ratio.

the cell turnover, thereby "aging" the culture at a more
rapid rate, the primary cultures of a male-female pair (C
69(F) - C 70(M)) were passed weekly at a 1:10 split ratio
Cultures were fed with

through the ninth passage (Pl-9).
CM-199 every two or three days.

Beginning at PlO, the

cultures were trypsinized and passed at standard density
(1.2 5 x 10 5 cells/flask) at weekly intervals.

Passage was

repeated until the cell number failed to double within
seven days.

The female cultures were carried through P19,

and the male cultures through P17.

Beginning with P6 and

continuing through P17, a male and female culture from
each passage (except PlO) were glutaraldehyde-fixed on the
seventh day after passage, stored in sucrose buffer, and
subsequently evaluated for senescent expression.

The

three parameters of senescence expression for each of the
22 flasks (11 female and 11 male) from 11 passages (P6-17,
exclusive of PlO) comprised the data.

It should be

reiterated that flasks fixed and evaluated from P6-9 were
from a 1:10 split ratio passage, while flasks fixed and
evaluated from Pll-17 were from a standard density
passage.
Effect of a 1:4 vs. a 1:16 Split Ratio on Senescent
Expression.

In order to ascertain if cultures plated at

higher density express a greater degree of senescence than
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cultures plated at a lower density, the following
experiment was done.

The primary cultures of a male

female pair (C 75(F) - C 76(M)) were passed weekly at a
At

1:10 split ratio through the third passage (Pl-P3).

P4, three male and three female cultures were plated at
four times standard density ( 5 x 10 5 cells/flask).

The

cultures were fed with CM 199 every two or three days.
Beginning with P 5 , the cultures were passed weekly at a
1:4 split ratio.

For comparison, cultures were plated at

a lower density as follows.

Using the same male-female

pair, three male and three female cultures were plated at
P4 at standard density.

Beginning with P 5 , the cultures

were passed weekly at a 1:16 split ratio.

The cultures

were fed with CM 199 every two to three days.

Cultures

plated at both densities were carried through the
sixteenth passage.

Two male and two female flasks from

each passage were glutaraldehyde-fixed on the seventh day
after plating, stored in sucrose buffer, and subsequently
evaluated for senescent expression.

A total of 96 flasks

were assessed: 48 male flasks (24 at a 1:4 split and 24 at
a 1:16 split) and 48 female flasks (24 at a 1:4 split and
24 at a 1:16 split).

Comparisons regarding senescent

expression were thus made for both gender and split ratio.

Results
Effect of Culture Gender and Age on Senescent Expression
(1:5 split ratio)
The purpose of these experiments was to determine if
culture gender and age had an effect on senescent
expression in HUVEC.
pairs were used.

Three separate male-female culture

In these and all experiments described

in this study, even numbered cultures were female EC, and
odd-numbered cultures were male EC.

The primary cultures

were passed at a 1:10 split ratio from Pl-4 for the C 57C 58 pair (I),

and from Pl-3 for the

c 59 - C 60 pair

(II), and at a 1:5 split ratio for both thereafter.

Table

1 illustrates the total cells, the total senescent cells,
and the percentage of senescent cells, generated in a cm2
area over ten passages (Pl0-19).

The percentage of

senescent cells is also illustrated by bar graphs in
Figure 1.

Chi square analysis, using the total number of

senescent cells and the total number of non-senescent
cells generated in a cm2 area,

was the test statistic

used to compare the percentages of senescent cells in this
and all subsequent experiments.

Likewise, for all

experiments, the Wilcoxon Rank Sum Test was the test
45
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statistic employed to compare the total cells generated in
a cm 2 area over the passages indicated.

In this results

section, and the discussion section that follows, total
senescent cells

and total cells always signify the number

of senescent cells or total cells generated in a cm 2 area
over the passages indicated.
Table 1 and Figure 1 show that for ten passages
(Pl0-19), in both Pair I and Pair II, male HUVEC showed a
significantly greater percentage of senescent cells and
significantly fewer total cells than female HUVEC.

In

Pair I, male flasks generated almost three times as many
senescent cells over ten passages as female flasks.

The

number and percentage of senescent cells for male cultures
increased with increasing passage number, yet the total
cell number was significantly lower than that for female
cultures.

In Pair II, these same relationships held true.

As in Pair I, male cultures had a significantly greater
total senescent cell number and percentage of senescent
cells than females, yet significantly fewer total cells.
The bar graphs in Figure 1 demonstrate the percentage of
senescent cells for the two culture pairs; the
significantly greater percentage of senescent cells in the
male cultures compared to female cultures should be noted.
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Table 2 is a comparison of senescence in the five
earli8r passages (Pl0-14) versus the five later passages
(PlS-19) for the male-female culture pairs described in
Table 1.

The percentage of senescent cells for each

culture and passage series are shown by bar graphs in
Figure 2.

Table 2 and Figure 2 demonstrate that the male

female differences in percentage of senescent cells are
sustained for both culture pairs for both the earlier
(Pl0-14) and later (P15-19) passages.

There was a

significantly greater number of total cells in the Pl0-14
passages than the P15-19 passages for female cultures.
However, this was not true for male cultures (C58 and
C60).

Table 2 also shows that when female cultures were

compared to male cultures regarding total number of cells 1
there was a significant difference for the Pl0-14 passages
but not the Pl5-19 passages.

This implies, then

that

most of the male-female difference regarding cumulative
cellular density occurred during the first five passages
(Pl0-14).

However, the percentage of senescent cells did

not differ significantly between Pl0-14 and Pl5-19 for any
of the culture pairs, although there was a trend toward an
increase in later passages.

Again, comparing earlier and

later passages, the sum of senescent cells increased while
the total number of cells decreased.
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In order to assess senescent expression in HUVEC
earlier in the culture life span, male-female culture Pair
III (passed at a 1:10 split ratio until P4, then at a 1:5
split ratio through P9), was studied in passages Pl-9.
Table 3 compares total cells, sum of senescent cells, and
the percentages of senescent cells for passages Pl-4 with
those for passages P5-9.

Although the percentages of

senescent cells were higher in male than in female
cultures, these differences were not statistically
significant.

However, the percentages of senescent cells

were significantly greater for later passages (P6-9)
compared to earlier passages (Pl-4) for both male and
female cultures.
I or Pair II.

Note that this was not the case for Pair

Whether the increase in senescent

expression in Pair III (C 63 -

c

64) during P6-9 over that

observed in Pl-4 was due to the higher density (1:5 vs.
1:10 split ratio) of plating cannot be ascertained
definitively; a later experiment (Table 7) addresses this
question more specifically.

Since Pair III was not

continued beyond P9, it is not possible to determine if
the increase in senescence which occurred during P6-9
would have been moderated in later passages (i.e. Pl0-19),
as in the first two culture pairs studied.

Table 3 also

shows that there was a significantly greater total number
of cells in Pl-4 vs. P6-9 for female cultures, but not for
male cultures.
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In summary, when primary cultures of HUVEC were
passed initially at 1:10 split ratios followed by a longer
series of passages at 1: 5 split ratios, there was a
significantly greater expression of senescence in male
cultures than in female cultures.

Concerning the total

number of cells generated over an equal number of
passages, a significant difference between earlier and
later passage groups was found for female cultures but not
for male cultures.
Effect of Culture Gender and Passage Number on Senescent
Expression (standard density plating)
In the previous experiments, primary cultures that
were cobblestone in appearance and confluent were passed
at 1:10 split ratios followed by 1: 5 split ratios.

The

purpose of the next set of experiments was to correct for
possible differences in confluent cell density between
male and female primary cultures.

This was done by

plating at a standard density (SD- 1.2 5 x 10 5 cells/flask)
in all passages.

As in the previous experiments, two

passage series were compared to determine the effect of
passage number, as well as gender, on senescent
expression.

Both five day and seven day assessments were
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performed, and the results are depicted in Tables 4 and 5
and in Figure 3.
Table 4 compares total cells, sum of senescent
cells, and percentages of senescent cells for three series
of four passages each for male and female cultures in a
five day assessment.

There was no significant difference

in senescent expression between female (C 67) and male (C
68) cultures for any of the three passage series compared.
Nor were there significant differences in percentages of
senescent cells among the three passage series for male or
female cultures.

Note that in the male cultures, the

percentage of senescent cells �as greater in earlier
passages (P2-5) than later passages (P6-9 or Pl0-13), a
finding which is somewhat unexpected.

In the later

passages, there was a trend for female cultures to show a
greater percentage of senescent cells than male cells, but
the difference was not significant.
Regarding total number of cells generated over the
passages indicated, the only significant difference
between male and female cultures was in the Pl0-13 group
(Table 4).

In the SD study, in contrast to earlier

findings, the difference in total cells generated during
early (P2-5) passages vs. later passages (P6-9, Pl0-13)
was significant for male cells but not for female cells.
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In fact, in contrast to male-female culture pairs passed
at a 1:5 split ratio, Table 4 shows that the total number
of cells increased during passages 6-9 compared to 2-5 for
both females and males, although significant only in the
latter.

This is paradoxical, since one would have

expected the total number of cells to decrease in
succeeding passages.

However, since this was a five day

assessment, cultures evaluated at seven days might not
show this "reverse" phenomenon.

Indeed, this increase in

total cell number generated in later passages was not true
for the seven day assessment (see Table 5).
Table 5 compares total cells, sum of senescent
cells, and the percentages of senescent cells for three
series of four passages each for the same male and female
cultures described above, this time in the usual seven day
assessment.

Again it is seen that there was no

significant difference in percentages of senescent cells
between males and females for any of the three passage
series studied.

The percentages of senescent cells

increased in succeeding passage groups for both male and
female cultures.

For female cultures, the percentage of

senescent cells was significantly greater in the later
passage series (Pl0-13) compared to either the P2-5 or the
P6-9 series; a similar trend in the male cultures was not
significant.
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When the total cells generated in the three passage
series were compared, no significant differences were
found between male and female cultures for any of the
three series.
other,

In fact, the three series parallelled each

with similar decreases in cumulative cellular

density as the culture age progressed (Table 5).

For both

male and female cultures, there were significantly more
total cells generated in P2-5 than in Pl0-13.

This

finding contrasted with earlier experiments (1:5 split
ratio), in which only the female cultures displayed a
similar significant difference.
When one compares the five and seven day assessments
(Tables 4 and 5, Figure 3), some interesting patterns are
noticed.

There were no significant differences between

five and seven day assessments regarding percentages of
senescent cells generated over the three passages series
for either female or male cultures.

However, Figure 3

reveals a trend toward greater percentages of senescent
cells in cultures assessed at five days vs. seven days.
This was true for all three passage series in female
cultures and for the P2-5 series in male cultures.

Since

multinucleated veiled (senescent) cells have not been
observed to proliferate in cultures of HUVEC, these cells
would be passed along at a relatively fixed number,
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increasing only slightly as a result of terminal
differentiation in each passage.

The relatively constant

number of senescent cells would then constitute a higher
percentage of the total cell population at five days than
they would at seven days, when a continued proliferation
of non-senescent cells would have increased the total cell
number.
In comparing total cells at five versus seven days,
the increase at seven days was significant only for
earlier passages (P2-5) for both male and female cultures
(Tables 4 and 5).

In fact, there was a decrease in total

cells generated in later passages at seven days for male
cultures but not female cultures (Tables 4 and 5).
In summary, when cultures of HUVEC were passed at
standard density, there was no significant difference in
total cells, sum of senescent cells, or percentages of
senescent cells between male and female cultures.

This

was true for both five day and seven day assessments.
There was a trend for the percentage of senescent cells to
be greater in cultures assessed at five days than at seven
days, but the difference was not significant.

There was a

significant decrease in the total cells generated between
early and later passages for both male and female
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cultures, in contrast to earlier experiments where this
difference was significant for female cultures only.
The total cells generated at five days for later passage
male cultures was actually greater than that found at
seven days.
Effect of 1:10 Split Ratio Passage Followed by SD Passage
The purpose of the next set of experiments was to
compare senescent expression between male and female
cultures that had been ''aged" in terms of population
turnover by repeatedly passing the cultures at a low
density (1:10 split ratio).

In these experiments, a

primary male-female culture pair (P 69 and P 70) was
passed at a 1:10 split ratio up to and including P9, then
subsequently at standard density.

Table 6 compares the

total cells, sum of senescent cells, and the percentages
of senescent cells for two series of four passages (P6-9,
Pll-14) and one series of three passages (P15-17) for male
and female cultures.

There were no significant

differences in the percentages of senescent cells between
male and female cultures for any of the three passage
series studied (Table 6 and Figure 4).

However, there was

a larger, albeit non-significant, difference between male
and female cultures for P6-9, where the cultures were
passed at a 1:10 split ratio, than there was between male
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and female cultures for Pll-14 or P15-17, where the cells
were passed at standard density.

This is better

illustrated by the bar graphs in Figure 4.
As in previous experiments, differences in total
cell number were apparent for female, but not male
cultures.

There was a significant difference in total

cells between P6-9 and Pll-14 for female, but not male,
cultures.

As in previous experiments, the percentage of

senescent cells increased, while total cells decreased
with increasing passage number.
Comp�rison of 1:4 and 1:16 Split Ratio Passage
Although our earlier experiments with a 1:5 split
ratio passage demonstrated a greater expression of
senescence in male cultures than in female cultures, this
difference was not sustained when initial cell number was
corrected for by passage at standard density.

The

possibility of differences in passage density being a
factor in senescent expression was examined in the present
experiment, which was designed to determine if cultures
passed at a higher density (1:4 split ratio) would show a
greater degree of senescence than cultures passed at a
lower cell density (1:16 split ratio).

Male and female

differences were also examined within this experimental
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paradigm.

Table 7 compares total number of cells, sum of

senescent cells, and the percentages of senescent cells
generated for male and female cultures for five earlier
passages (P5-10) with those of five later passages (Pll16) for the 1:4 split ratio cultures and the 1:16 split
ratio cultures.
Table 7 shows that there was not a significant
difference between male and female cultures regarding
percentage of senescent cells for either the 1:4 split
ratio group or the 1:16 split ratio group.

When early

(P5-10) and later passages (Pll-16) were compared, there
was a significantly greater percentage of senescent cells
in later passages of both male and female cultures when
the cultures were passed at a 1:4 split ratio (high
density), but not when they were passed at a 1:16 split
ratio (low density).

Also, the difference in number of

senescent cells was greater for the former vs. the latter.
Lastly, for both early and late passage series, and for
both male and female cultures, there was a trend toward
cultures passed at a 1:4 split ratio to show a greater
percentage of senescent cells than cultures passed at a
1:16 split ratio.

However, this difference was

significant only for female cultures at a later passage
(Table 7 - C 75, 1:4, Pll-16 compared to C 75, 1:16, Pll-
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16).

The percentage of senescent cells is illustrated by

bar graphs in Figure 5.
Table 7 demonstrates that there were significantly
more total cells generated in earlier (P5-10) than in
later (Pll-16) passages for both male and female cultures
passed at high density, as well as for female cultures
passed at low density.

In comparing the high density

cultures to the low density cultures, there was a
significantly greater total number of cells generated for
female cultures from later passages (Pll-16) at low
density (1:16 split ratio) than in later passage female
cultures at high density (1:4 split ratio).

This

difference parallels the significant difference seen in
the percentages of senescent cells between these passage
series.

In viewing Table 7 and Figure 5, there was a

trend for both male and female cultures passed at low
density to generate a greater number of cells and exhibit
fewer senescent cells for comparable passages than their
companion cultures passed at a high density, although this
difference was significant only for the female cultures
mentioned above.

From the above, it appears that culture

density at passage may be at least as important in
determining cellular senescent expression in HUVEC as
culture gender.

Discussion
The existence of multinucleated, veiled cells,
considered to be senescent, has been known since the
earliest successful cultures of endothelium were
established from human umbilical veins.

Mayuma (1963),

the first author to report the successful culture of
endothelial cells isolated from human umbilical veins,
described senescent cells in his cultures.

Since in vitro

aging is now a recognized phenomenon in cultures of human
EC (Levine and Mueller, 1979), the present study was begun
to document quantitatively the occurrence and expression
of senescence in cultures from male and female cords, in
early and late passages, and at various passage densities.
Since our initial observations suggested that there was a
difference between male and female cultures of HUVEC
regarding the incidence and progression of endothelial
cellular senescence,

experiments were undertaken to

determine quantitatively if cellular gender was a
significant factor in the expression of endothelial
cellular senescence.

Male-female differences in senescent

phenotypic expression have not been addressed previously
in the literature.

The working hypothesis of this study

was that possible gender differences regarding expression
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of in vitro senescence might help to explain the
variations in growth and culture life span observed in
cultures from different umbilical cords (previously of
unknown sex).
The major findings of this paper can be summarized
as follows:
1.

When primary cultures of HUVEC are passed at a 1:10

split ratio for the first three or four passages, and
subsequently passed at a 1:5 split ratio, there was a
significant difference in senescent expression between
male and female cultures.

This difference was expressed

for both the Pl0-14 and the P15-19 passage series,
suggesting that gender differences in senescent expression
were sustained through the passages studied.

Under these

passage conditions, there was a significant difference in
total number of cells generated over equal numbers of
passages between earlier (Pl0-14) and later passage (Pl519) groups for female, but not male, cultures.
2.

When cultures of HUVEC are passed at standard

density, there were no significant differences in total
cells, total senescent cells, or percentages of senescent
cells between male and female cultures.

This phenomenon

was true in both five day and seven day assessments.
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There was a significant decrease in the total cells
generated between early and later passages for both male
and female cultures, in contrast to earlier experiments
where this difference was significant for female cultures
only.

The total cell generated at five days for later

passage male cultures was actually greater than that found
at seven days.
3.

When cultures of both male and female HUVEC were

passed at high density (1:4 split ratio), significantly
greater senescence expression occurred in later passages
vs. earlier passages, an effect not seen when the cultures
were passed at a lower density (1:16 split ratio).

This

suggested a hastening of the senescent rate when cultures
are passed at a higher density, an effect which appears to
be gender independent.
4.

There was a trend for both male and female cultures

passed at a lower density to generate a greater number of
cells, fewer senescent cells, and exhibit a lessor
percentage of senescent cells over comparative passage
series when contrasted with male and female cultures
passed at a higher density.
Our results demonstrated that when primary cultures
of HUVEC are passed at low density (1:10 split ratio) for
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the first several passages and subsequently passed for a
longer period at high density (1:5 split ratio), male
cultures developed a significantly greater percentage of
senescent cells than female cultures.

However, when

initial cell numbers were standardized by passing the
primary cultures at a uniform density, significant
differences in senescent expression between male and
female cultures did not occur.

Further experiments

suggested that cultures passed consistently at a low
density exhibited a lessor degree of senescent expression
than cultures passed at a higher density, and that this
effect was apparently gender-independent.

This implied

that cellular density at passage might be more important
than gender in the expression of senescence in HUVEC.
When cultures of HUVEC were passed at standard
density, there were no significant differences in
senescent expression or total cells generated between male
and female cultures (Tables 4 and 5; figure 3) at either
the five day or the seven day assessment.

At five days,

the percentage of senescent cells was greater in earlier
passages (P2-5) than later passages (P6-9 or Pl0-13) in
the male cultures, and this finding was accompanied by
significantly fewer cells generated at earlier passages
than at later passages, which might explain the greater
senescent expression in the earlier passage male cultures.
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Another factor might be that the number of senescent cells
did not increase appreciably during later passages for
male cultures assessed at five days (Table 4). It is
possible that male cultures exhibited slower growth during
later passages (P6-9, Pl0-13) at seven days; total cells
actually decreased in later passage male cultures at seven
days compared to five days.
The transition from Phase II to Phase III in the
life history of a cell culture, signified by an increase
in the number of senescent cells and a decrease in
cellular growth, may be rather abrupt in fibroblasts
(Grove and Cristafalo, 1977; Haymark, 1976).

This appears

to be true in the culture system using EC, particularly
when cells are passed at standard density.

Note Table 5,

which shows an abrupt change in the total cells, total
senescent cells, and percentages of senescent cells
between the P6-9 passage series and the Pl0-13 passage
series for female cultures.
The "aging" of HUVEC by passing primaries at a 1:10
split ratio for nine passages followed by standard density
passing did not produce a significant difference between
male and female cultures regarding senescent expression or
total cells generated for any of the three passage series
(Table 6).

However, Table 6 shows that male-female
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differences that did exist were greater for earlier
passages (P6-9) compared to later passages (Pll-14).

It

is interesting that male-female differences in senescent
expression tend to decrease when cultures are passed at
standard density.

This is illustrated in Table 6 which

demonstrates that there were fewer senescent cells and a
lower percentage of senescent cells for early passage
female cultures (P6-9), accompanied by a greater cellular
density, compared to early passage male cultures.
The results in Table 6 and Figure 4 further
encouraged the author to explore cellular density at
passage as a possible factor in senescent expression in
male and female HUVEC.

Glassberg et al. (1982), who

cultured EC from the human iliac artery, found that cells
became senescent, losing viability at passages 8-10, when
passed at a 1:3 split ratio.

However, no comparisons were

made with cultures passed under different density
conditions.

Cristafalo (1976) contended that HUVEC

senesce at different rates, depending on the split ratio
at passage, although he did not offer quantitative data to
support his statement.
It is known that senescent EC are more common in
confluent cultures than in less crowded cultures.

Since

endothelial cellular senescence represents a form of
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differentiation (whether it is terminal differentiation is
currently controversial), our findings suggest that
inhibition of expression of this differentiated phenotype
can be done by increasing the split ratio at passage, i.e.
passing the cultures at a lower density.

This results in

less crowding in each passage, giving the cells more room
to grow and proliferate, thereby decreasing the chances
for the senescent phenotype to be expressed.

Passing at a

1:16 split ratio would decrease the chances of the
relatively fewer number of senescent cells reaching the
next passage.

This, in combination with relatively

greater growth in the cultures passed at lower density,
might result in a lower senescent percentage for the low
density passage cultures.

On the other hand, since the

growth of EC is generally contact inhibited, passing the

cultures at a high density (1:4 split ratio) would cause
the cells to reach confluence rapidly, stop proliferating,
and undergo senescence.

Subsequently passing the cultures

further at a 1:4 split ratio would increase the likelihood
of the senescent cells appearing in the next passage.
An additional factor here might be the period of
time spent at confluence prior to culture fixation and
evaluation.

Endothelial cultures passed at high density

(1:4 split ratio) would reach confluence sooner than
cultures passed at lower density (1:16 split ratio), the
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former conceivably spending a longer time in the confluent
state than the latter.

This would create a greater

tendency for the senescent phenotype to be expressed,
hence, the greater percentage of senescent cells in
cultures passed at a high density.
Confluent cultures of HUVEC will senesce rapidly if
not passed.

As total cell number decreases as the culture

ages, the percentage of senescent cells increases.

Note

that this can occur without an appreciable increase in the
absolute number of senescent cells from passage to
passage.

Regarding senescent expression,

the culture

density at passage may be a stronger factor in senescent
expression than the number of population doublings that
the culture has undergone by that same passage.
Only a few authors have attempted to estimate
quantitatively the incidence of senescent veiled cells in
human umbilical vein endothelial cellular cultures.
Knaver and Cunningham (1983) estimated the incidence of
endothelial cellular senescence to be 1-2% in early
cultures, and up to 10-12% at approximately Passage 16,
although they did not indicate the cellular plating
density or passage split ratio used.

Their estimates are

comparable to those found in this study, except that there
was a much higher percentage (24-28%) of senescent cells
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in later passage (P15-17) HUVEC passed at a 1:10 split
ratio followed by standard density passage (See Table 6
and Figure 4).

Maciag et al. (1981) estimated the density

of senescent EC in cultures of HUVEC (1/1000 cells, 0.1%
initially increasing to 1/100, 1% by passage 14).

Their

estimates are somewhat lower than those reported in this
research, as the percentage of senescent cells averaged
much more than 1% by passage 14 in all passage paradigms
that were used.
The heterogeneity of the endothelial cellular
culture, mentioned by Schwartz et al. (1981), might be a
factor in senescent expression in both male and female
cultures.

Senescence observed in endothelial cells in

vitro might be the result of the random distribution of
senescent cells during passage of the culture, rather than
abrupt increases in senescent cells derived from normal
cells during that particular passage.

In a like manner,

limitations in the replicative lifespan of cultures of
HUVEC might be due to random distribution of proliferative
potential in the culture.
According to Gospodarowicz et al.
in HUVEC may be a pre-programmed event.

(1978), senescence
The question of

whether human umbilical vein endothelial cells are
programmed to die shortly after the birth of the child has
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not been answered.

Or do these cells die because the

umbilical cord is severed, and the EC, dissociated from
their normal connection to the placenta, then die.

No one

has kept an umbilical cord viable in situ for much longer
than nine months, so this question remains unanswered.
The fact that senescent cells can be found in primary
cultures of HUVEC (Maciag et al., 1981) suggests that
senescent cells were present in vivo in situ.

Since the

umbilical cord forms and degenerates within nine months,
senescent cells in primary cultures may be due to the
"accelerated aging" in human umbilical vein endothelium,
or alternatively, the cells may became senescent or
undergo senescent-like changes when they are plated.

It

is clear that factors which would affect senescent
expression in primary and early passage cultures of HUVEC
need further study and exploration.
Are multinucleated cells evidence of attempted
regeneration following cellular injury?

There is the

possibility that enzymatic dissociation, as occurs when
the cultures are passed, may play a role in senescent
expression in HUVEC (Ruben & Rafferty, 1978).

In vitro

senescence is typically evaluated in cultures of EC where
subculturing methods are via this enzymatic dissociation
(collagenase for primaries, trypsin for secondary and
subsequent subculturing).

The actual effect of repeatedly
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breaking the bonds between cells and their extracellular
substrate upon senescence, as occurs during trypsinization
and passing, is unknown.
The question of whether senescent cells represent a
syncytium, where an endothelial cell divides but fails to
break up into individual cells, the nuclei remaining
within the center of the senescent cell, remains
unanswered.
known.

Why this would specifically occur is not

Future research might employ "wounding" an aged

culture, and then exploring the leading edge of the
migrating, dividing EC and determining the effect on
senescent patterns.
The role of the senescent endothelial cell in the
process of tumor invasion and metastasis constitutes a
largely unexplored area of research.

By nature of its

structure, the senescent cell, with its veiled, thread
like cytoplasmic extensions bridging the nucleus and its
large area, might be more susceptible to the ability of an
attached tumor cell to invaginate the endothelial cell,
thus making the senescent cells more susceptible to
transendothelial intravasation or extravasation of primary
or metastatic tumor cells respectively.
purely speculative at this time.

However, this is
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Rosenthal et al. (1981) suggested that cellular
senescence in EC may contr.ibute to the genesis of
atherosclerosis.

Haudenschild et al.

(1975) remarked that

veiled, senescent endothelial cells are commonly observed
on the edge of intimal lesions in vivo.

Weber et al.

(1984) suggested that endothelial cellular senescence in
vivo may be the result of either high cell turnover or
repeated endothelial injury.

High cell turnover is a

likely possibility when one considers that the incidence
of senescent endothelial cells increases with cell passage
number.

However, repeated endothelial injury, although

not sufficient to mechanically denude the vessel wall, may
encourage endothelial cellular turnover.

If, however,

the cells are prevented from proliferating due to lack of
room in which to divide, as in confluent cultures of EC in
vitro, division may occur without cytoplasmic separation,
with senescent cells ensuing.

Whether the senescent

phenotype is more apt to be expressed in areas of
endothelial cellular microinjury is unknown.

However, it

should be remembered that confluent EC have a low but
definite rate of cell turnover, which may approximate the
state of "injury'' in vivo.

In the in vivo situation,

chronic repeated bouts of subtle endothelial ''injury"
might cause the EC to proliferate repeatedly at the edge
of intimal lesions, which can result in senescent cells.
However, the data from the 1:4 and 1:16 comparison
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experiment would refute the concept that simple continuous
cell turnover in EC, as would occur to a greater degree in
the 1:16 split ratio passage cultures, would increase the
number of senescent cells present.

In fact, this study

has suggested that passage at the 1:16 split ratio reduces
senescent expression compared to higher density passage,
where proliferation is less.

Maciag et al. (1981)

reported that endothelial cells passed at a greater
density may be affected by contact inhibition, and may not
proliferate as rapidly.

This might well affect the

expression of endothelial cellular senescence.
It can be recalled that in any culture system, there
will be deficiencies in the media or procedural components
of cellular culture, perhaps contributing to the gradual
differentiated state of the culture in question.

How much

of the senescent process in vitro can be attributed to the
culture environment and how much to senescent phenotypic
expression of the cells themselves is an unsettled
question.
Do the senescent cells secrete or promote activation
of growth factors of other substances which enhance the
proliferation of smooth muscle cells and/or induce
alterations in the endothelial substrata?

Or are the

senescent cells the result of the transformation induced
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in the endothelium by the atherosclerotic lesion itself?
Presumably, an expanding mural lesion would stretch the
overlying EC, perhaps making them more likely to express
their senescent phenotype.
The translation of information obtained from the in
vitro situation to the events observed in vivo is not
always easy, and in many cases purely speculative.
However, the above questions and additional courses of
inquiry concerning senescent expression of HUVEC afford
attractive future avenues of study of this remarkable process.
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Figure 1. Effect of culture gender on senescent expression
in HUVEC passed at a 1:5 split ratio (PlO - Pl9). The C
57(F) and c 58(M) culture pair and the C 59(F) and C 60(M)
culture pair were passed weekly. A male and a female flask
from each culture pair were fixed and evaluated weekly. The
bar graphs illustrate the percentage of senescent cells
calculated by dividing the sum of of senescent cells/cm2
generated during PlO - P19 by the total number of cells/cm 2
generated during these passages. F = female; M = male. a
significantly different from b and c from d, p < 0.001.
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Figure 1. Effect of Culture Gender on Senescent Ex press ion
in HUVEC Passed at a 1 :5 Split Ratio (P1O-P19)
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Figure 2. Effect of culture gender and passage number on
senescent expression in HUVEC (1:5 split ratio). The same
male-female culture pairs described in Table 1 and Figure 1
were used to compare senescent percentages for five earlier
passages (PlO - Pl4) with those of five later passages (Pl5 Pl9). The bar graphs show the percentage of senescent cells
exhibited by each culture, calculated by dividing the sum of
senescent cells generated during the passages indicated by
the total number of cells generated during the same passages.
a significantly different from c; b from d; e from g, all p <
0.001. f significantly different from h, p < 0.01.
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Figure 2. Effect of Culture Gender 8c Passag e Number
on Senescent Expression in HUVEC (1 :5 Split Ratio)
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Figure 3. Effect of culture gender and passage number on
senescent expression in HUVEC (standard density). Comparison
of a five day vs. seven day assessment. The primary cultures
of c 67(F) and c 68(M) were passed weekly at standard density
(1.2 5 x 10 5 cells/T 2 5 flask) through Pl4. From P2 through
P14, a male and female flask were fixed and assessed each
week at both five days and seven days after plating. The bar
graphs compare the percentages of senescent cells between
male and female cultures for three series of four passages
each: P2- 5 , P6-9, and Pl0-13. a significantly different from
c, p < 0.01; b significantly different from c, p < 0.0 5 .
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Figure 3. Effect of Culture Gender 8c Passage Number
on Senescent Exp ression in HUVEC (Standard D ensit y)
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Figure 4. Effect of 1:10 splits followed by SD plating on
senescent expression in male and female HUVEC. The primary
cultures of C 69(F) and C 70(M) were passed weekly as
described in Table 6. A male and female flask were fixed
weekly from P6 through P9, and from Pll through P17 (At PlO,
all available cells were used to plate subsequent flasks at
standard density. The bar graphs compare the percentages of
senescent cells between male and female cultures for two
groups of four passages each (P6-9, Pll-14) and one group of
three passages (P15-17). Senescent expression did not differ
significantly between male and female cultures in this
experiment.
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Figure 4. Effect of 1:10 Splits Followed by SD Plating
on Senescent Expression in Male 8c Female HUVEC
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Figure 5. Effect of 1:4 vs. 1:16 splits on senescent
expression in early vs. late passage HUVEC. Comparison of
male and female cultures. The primary cultures of C 75(F)
and C 76(M) were passed weekly as described in Table 7. At
each passage from P4 through Pl6 inclusive, two male and two
female flasks from each split ratio were fixed and evaluated.
Senescent expression parameters as outlined in this figure
are the result of the mean of two such flask determinations
for each culture and passage number. The bar graphs compare
the percentages of senescent cells between male and female
cultures for five earlier passages (P5-10) with those of five
later passages (Pll-16) for the 1:4 and the 1:16 split ratio
groups. a significantly different from b, p < 0.01; d
significantly different from e, and b significantly different
from c, p < 0.05.
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Figure 5. Effect of 1:4 vs 1:16 Splits on Senescent
Expression in Early vs. Late Passage HUVEC
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Table 1. Effect of culture gender on senescent expression in
HUVEC passed at a 1:5 split ratio (PlO - Pl9). The primary
cultures of c 57(F) and c 58(M) were passed weekly at a 1:10
split ratio through P4, and then at a 1:5 split ratio
beginning with P5 and extending through P 2 0. The primary
cultures of C 59(F) and c 60(M) were passed weekly at a 1:10
split ratio though P3, and then at a 1:5 split ratio
beginning with P4 and extending through Pl9. A male and
female flask were fixed weekly from PlO to Pl9 inclusively.
The sums of total cells/cm 2 and total senescent cells/cm 2
generated from PlO - Pl9 (ten passages inclusive) are
illustrated in the table. The percentages of senescent
cells, calculated by dividin� the sum of senescent cells/cm 2
by the sum of total cells/cm for each culture, is
illustrated in the last column. F= female; M= male.
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Table 1
Effect of Culture Gender on Senescent Expression
in HUVEC Passed at a 1: 5 Split Ratio (P 10 - P 19)
Culture
C

5 7 (F)

C

5 8(M)

C 5 9(F)
C

60 (M)

Total Cells*
a3,99 X 105

b 2 ,06 X 105

C5 ,5 1 X 105

d 2. 25 X 105

Senescent
Cells*
135 94
3481 2

Percent
e3,41

f16.90

779 2

gl. 40

19696

ha.75

2
*generated over 10 passages in a cm area.
a significantly different from b, c from d, and a from c,
p < 0.05 ; e significantly different from f, and g from h,
p < 0.001.
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Table 2. Effect of culture gender and passage number on
senescent expression in HUVEC (1:5 split ratio). Using the
same male-female culture pairs described in Table 1, Table 2
compares both the total cell number and the sum of senescent
cells generated in five earlier passages (Pl0-14) with those
in five later passages (PlS-19). The percentages of
senescent cells for each culture and passage group,
calculated as described in Table 1, are compared in the last
column.
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Table

2

Effect of Culture Gender and Passage Number on Senescent
Expression in HUVEC (1: 5 Split Ratio)
Culture
C 57(F)
p 10-14
p 1 5 -19

C

a 2 .3 2

Senescent
Cells*

Percent

X

10 5

54 5 0

i 2 .3 5

X

10 5

8144

j4_97

Cl. 10 X 10 5

13716

bl.6 4

5 8(M)

P 10-14
P 1 5 -19
C

Total Cells*

5 9(F)

P 10-14
P 1 5 -19
C 60(M)

d9.70 X 104

e3.07 X 10 5

f 2 .44 X 10 5

2 1096

2810

m.9 2

4 98 2

P 10-14

gl.08 X 10 5

8948

0 8.29

P 1 5 -19

hl.1 2 X 10 5

107 48

q9_ 5 9

*generated over the indicated number of passages in a cm 2
area.
a significantly different from b, a from c, e from f, and
e from g, p < 0.01; i significantly different from k, j
from 1, and m from o, p < 0.001; n significantly different
from q, p < 0.01.
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Table 3. Effect of culture gender and passage number on
senescent expression in HUVEC - 1:10 followed by 1:5 split
ratio. The primary cultures of C 63(F) and C 64(M) were
passed weekly at a 1:10 split ratio through P3, and then at a
1:5 split ratio from P4-9. A male and female flask were
fixed weekly from Pl-9. The table compares the total cell
number and sum of senescent cells generated for four earlier
passages (Pl-4) with those of four later passages (P6-9).
The percentages of senescent cells for each culture and
passage group are compared in the last column.
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Table 3
Effect of Culture Gender and Passage Number on Senescent
Expression in HUVEC- 1:10 Followed by 1: 5 Split Ratio
(P 1 - P 9)
Culture
C 63 (F)
p 1-4
p 6-9

Total Cells*

a3.89 X 10 5

bl.77 X 10 5

Senescent
Cells*

18 2 9
787 5

Percent

c.47

d4.4 5

C 64(M)
P 1-4

3. 2 8 X 10 5

4274

P 6-9

1.08 X 10 5

10337

f9_ 5 7

2
*generated over the indicated number of passages in a cm
area.
a significantly different from b, p < 0.0 5 ; c
significantly different from d, p < 0.01; e significantly
different from f, p < 0.001.
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Table 4. Effect of culture gender and passage number on
senescent expression in HUVEC - five day assessment (standard
density). The primary cultures of C 67(F) and C 68(M) were
passed weekly at standard density (1.2 5 x 10 5 cells/ T 2 5
flask) through P14. Flasks from each culture were fixed and
assessed at five days after plating. The table compares the
total cell number and sum of senescent cells generated for
three series of four passages each: P2- 5 , P6-9, and Pl0-13.
The percentages of senescent cells for each culture and
passage series are compared in the last column.
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Table 4
Effect of Culture Gender & Passage Number on Senescent
Expression in HUVEC - Five Day Assessment
(Standard Density)
Culture

Total Cells*

Senescent
Cells*

Percent

C 67 (F)
p 2- 5

1. 5 6 X 10 5

6476

4.1 5

p 6-9

2.10 X 10 5

10321

4.91

12822

9.94

7791

5 .12

7 505

3.18

9078

4.49

p 10-13

al.29 X 10 5

C 68(M)
P 2- 5
P 6-9
P 10-13

C2.36 X 10 5

d2.02 X 10 5

2
*generated over the indicated number of passages in a cm
area.
a significantly different from d, b from c, and b from d,
p < 0.0 5 .
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Table 5. Effect of culture gender and passage number on
senescent expression in HUVEC - seven day assessment
(standard density). The primary cultures of c 67(F) and c
68(M) were passed weekly at standard density through Pl4. A
male and female flask were fixed weekly from P2 through Pl3.
The table compares the total cell number and sum of senescent
cells generated for P2-5, P6-9, and Pl0-13 as in Table 4.
The percentages of senescent cells for each culture and
passage series are compared in the last column.
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Table

5

Effect of Culture Gender & Passage Number on Senescent
Expression in HUVEC - Seven Day Assessment
(Standard Density)
Culture
C 67(F)
p 2-5
p 6-9

Total Cells*

a2.85 X 105
2 .76

X 105

Senescent
Cells*

675 2
805 8

Percent

e2.37

f3.11

bi.6 2 X 105

13416

g8. 28

P 2-5

c2.5 7 X 105

6043

2.5 0

P 6-9

2. 25 X 105

8762

3.89

10888

5 .85

p 10-13

P 68(M)

P 10-13

dl.86 X 105

2
*generated over the indicated number of passages in a cm
area.
a significantly different from b, c from d, and f from g,
p < 0.05 ; e significantly different from g, p < 0.01.
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Table 6. Effect of 1:10 splits followed by standard density
(SD) plating on senescent expression in male and female
HUVEC. The primary cultures of C 69(F) and C70(M) were
passed weekly at a 1:10 split ratio through P9, and then at
standard density beginning at PlO and extending through Pl7.
A male and female flask were fixed weekly from P6-P9 and from
Pll-Pl7. The table compares the total cell number and sum of
senescent cells generated for two series of four passages
each (P6-9, Pll-14) and one series of three passages (Pl517). The percentages of senescent cells for each culture and
passage series are compared in the last column.
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Table 6
Effect of 1:10 Splits Followed by Standard Density
Plating on Senescent Expression in Male and Female HUVEC
Culture
C 69 (F}
p 6-9
p 11-14

Total Cells*

al.63 X 10 5

Senescent
Cells*

Percent

5.10

bi.0 2 X 10 5

8316
11691

11.4 6

4 . 50

X

104

11086

2 4 .64

P 6-9

1.19

X

10 5

11076

9.31

P 11-14

1.10

X

10 5

112 54

10. 2 3

P 1 5-17

4 .90 X

104

13794

2 8.1 5

p 1 5-17

C 70 (M}

2
*generated over the indicated number of passages in a cm
area.
a significantly different from b, p < 0.0 5.
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Table 7. Effect of 1:4 or 1:16 split ratio passage on
senescent expression in early vs. late passage HUVEC.
Comparison of male and female cultures. The primary cultures
of C 7 5 (F) and C76(M) were passed weekly at a 1:10 split
ratio through P3. At P4, both male and female cultures were
either plated at standard density or four times standard
density (5 x 10 5 cells/flask). Beginning with PS and
extending through P16, the flasks plated at four times SD
were passed weekly at a 1:4 split ratio, and the flasks
plated at SD were passed at a 1:16 split ratio. Beginning
with P4 and continuing through P16 inclusively, two male and
two female flasks from each passage and from each split ratio
were fixed and evaluated. The raw data consisted of the mean
of two determinations for both male and female cultures at
each passage. The table compares both the total cell number
and sum of senescent cells generated for five earlier
passages (PS-10) with those of five later passages (Pll-16)
for the 1:4 split ratio group and the 1:16 split ratio group.
The percentages of senescent cells for each male-female
culture pair, split ratio, and passage series, calculated as
described in Table 1, are compared in the last column.
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Table 7
Effect of 1:4 or 1:16 Split Ratio Passage on Senescent
Expression in Early vs. Late Passage HUVEC
Comparison of Male and Female Cultures
Culture
C 7 5 (F) 1:4
p

5 -10

p 11-16

Total Cells*

a2 .3 5 X 10 5

Senescent
Cells*

2 079 2

bi.38 X 10 5

26710

C 2 .33 X 10 5

13181

Percent

98.80

h19. 35

C 76(M) 1:4
P

5 -10

P 11-16

dl.40 X 10 5

174 5 4

C 75(F) 1:16
P

5 -10

14673

4.70

169 2 1

k9.oo

2.47 X 10 5

1 2 988

5 .26

1. 5 6 X 10 5

11093

7.11

P 11-16
C 76(M) 1:16
P

5 -10

P 11-16

2
*generated over the indicated number of passages in a cm
area.
a significantly different from b, c from d, g from h, and
i from j, p < 0.01; e significantly different from f, b
from f, and h from k, p < 0.0 5 .
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Senescent Data Assessment Form

Code No.

-------

Flask No.

I

5
9

13

AREA

NON-SENESCENT

2

17
20
23

6

no
P4

SENESCENT

18

21
24

--------

3
7
I

19
22
25

5

AREA

Male

Female_

4
8

2
6

NON
SENESCENT

SENESCENT

NON
SENESCENT

SENESCENT

7
2

8

3

9

4

10

5

11

6

12

AREA

NON-SENESCENT

SE'<ESCENT

AREA

13

19

14

20

15

21

16

22

17

23

18

24
25
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Senescent Data Assessment Form

Calculation of Percentage of Senescent Cells
Cllde No.

-----

Flask No. ________

Male__

Female__

Sum of numbers of non-senescent cells in areas 1,6,11&16 • N • _____

-----

Calculated number of non-senescent cells in areas 1-16

•4N •

Sum of numbers of senescent cells in areas 1-16

• s • -----

Total number of cells in areas 1-16

• T•

-----

•S/T•

%

• 4N + S

Percentage of senescent cells

Calculation of Cellular Density
Same flask as above
At 200X, the area of each sample grid• 0.117649 mm

2

Mean of total cell numbers iq areas 1,6,11&16 • _____
Number of cells per cm

2

2

100 mm
X Mean
0.117649mm2
X Mean
849.986

=========

Vita
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